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1  INTRODUCTION 
 
1.1  Tetrapyrroles 
 
1.1.1  Structure and Relevance of Tetrapyrroles 
 
The family of tetrapyrroles comprises a group of biosynthetically related pigment 
molecules which are present in most organisms on earth. There, they are 
integral part of essential processes of life. They fullfill important functions as 
prosthetic groups in various enzymes, as redox active molecules in electron 
transport chains of energy generation or as photoreceptors during 
photosynthesis (Jahn et al., 1996; Frankenberg et al., 2003). Tetrapyrroles 
consist of four covalent attached pyrrole rings which are interconnected via 
methyine bridges in a linear or cyclic form (Fig. 1). The corrinoides are an 
exception because the fourth carbon bridge is lacking between the fourth and 
the first ring (C20, Fig. 1). The pyrrole rings of a cyclic macrocycle are linked to 
each other clockwise in the following order: first ring A, then rings B, C and D. 
The carbon atoms in α-position are directly adjacent to one nitrogen atom  
(e.g. C1, Fig. 1). The carbon atoms which form the methine bridges are located 
in meso-position (e.g. C5, Fig. 1), the rest of them are situated in β-position  
(e.g. C2, Fig. 1). 
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Fig. 1: The porphyrin ring, the general basic structure of cyclic tetrapyrroles. 
Pyrrole rings are denoted A - D, nitrogen and carbon atoms are termed as N21 - N24 and C1 -
C20. 
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A characteristic property of the tetrapyrroles is their variegation due to the 
expanded pi-electron system. Tetrapyrroles are named the ‘colors of life’ due to 
obviously visible quantities of chlorophylls and bacteriochlorophylls (green) in 
nature and of heme in hemoglobin of blood (red). Tetrapyrroles differ in the rate 
of saturation of their ring systems, the structure of the side chains as well as in 
the chelated metal ion in the center of the porphyrin ring (Frankenberg et al., 
2003; Heinemann et al., 2008; Layer et al., 2010). They can be divided into 
eight categories: hemes, chlorophylls, bacteriochlorophylls, siroheme, heme d1, 
corrinoides, coenzyme F430 and linear tetrapyrroles with uroprophyrinogen III as 
a common precursor, respectively (Fig. 2). An important feature of cyclic 
tetrapyrroles is their ability to chelate diverse divalent metal ions such as Fe2+, 
Mg2+, Ni2+ and Co2+. Iron-containing heme constitutes the active centers in 
cytochromes, peroxidases and reductases. Heme-containing cytochromes are 
important in respiration and photosynthetic electron transport chains (Panek 
and O’Brien, 2002). Heme is involved in the oxygen transport in blood and 
tissue as a cofactor of hemoglobin and myoglobin. It also serves as a prosthetic 
group in catalases, peroxidases and oxygenases including cytochromes P450 
and in sensor proteins for diatomic gases like O2, CO and NO as well as for 
CO2 in signal transduction pathways (Heinemann et al., 2008; Munro et al., 
2009). Siroheme has a greenish color and acts as a cofactor in reactions during 
assimilatory nitrite or sulfite reduction (Murphy et al., 1974; Raux et al., 2003). 
The yellow coenzyme F430 with a chelated nickel ion is the cofactor of methyl 
Coenzyme M reductase and involved in methane formation in methanogenic 
archaea (Thauer and Bonacker, 1994). Cobalt is found in vitamin B12 and 
structural related compounds. Derivatives of the cobalt-containing vitamin B12 
are the cofactors of a number of enzymes that catalyze radical-dependent 
reactions such as methyl transfer reactions or nucleotide reduction (Banerjee 
and Ragsdale, 2003). 
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Fig. 2: Structures of important types of the eight tetrapyrrole categories and their 
common precursor uroporphyrinogen III. 
The cyclic as well as the non-cyclic tetrapyrroles derive from the common precursor 
uroporphyrinogen III.  
A = acetate side chain; P = propionate side chain; M = methyl group; V = vinyl group. 
 
Magnesium-complexes of chlorophylls and bacteriochlorophylls are the active 
components in the reaction centers of the light accumulating complexes of 
photosynthesis. They generate the conversion of sunlight energy into chemical 
energy (Jahn et al., 1996; Beale, 1999; Vavilin and Vermaas, 2002; 
Frankenberg et al., 2003; Layer et al., 2010). In contrast, bilins are linear 
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tetrapyrroles with only three bridged carbons. They are the result from the 
cleavage of previously cyclic tetrapyrroles. Furthermore, there is no tightly 
bound metal ion in linear tetrapyrroles. They serve as chromophoric 
photoreceptors in cyanobacterial and higher-plant light-harvesting systems 
(Frankenberg and Lagarias, 2003). 
 
1.1.2  Tetrapyrrole Biosynthesis  
 
The pathway for the tetrapyrrole biosynthesis is save from a few exceptions 
highly conserved and the first branching point occurs after formation of the first 
cyclic tetrapyrrole, uroporphyrinogen III. This intermediate is converted into 
protoporphyrin XI or precorrin-2. The former is required to synthesize hemes, 
chlorophylls and bacteriochlorophylls while the latter is utilized for the synthesis 
of siroheme, heme d1, coenzyme F430 and corrinoids (Warren and Smith, 2008). 
Eukaryotes are only able to synthesize hemes, siroheme, chlorophyll and bilins 
while prokaryotes also synthesize additional tetrapyrroles like corrinoids, 
coenzyme F430 and heme d1 (Jahn et al., 1996). Tetrapyrrole biosynthesis starts 
in all organisms with the synthesis of 5-aminolevulinic acid (ALA).  
 
Fig. 3 shows the tetrapyrrole biosynthesis and its different pathways.  
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Fig. 3: Tetrapyrrole biosynthesis. 
Enzyme names and corresponding bacterial genes are given above the arrows.  
A = acetate side chain; P = propionate side chain; M = methyl group; V = vinyl group. 
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1.1.3  Aminolevulinic Acid Formation 
 
Tetrapyrrole biosynthesis starts in all organisms with the synthesis of ALA  
(Fig. 3) representing the sole source of carbon and nitrogen atoms required for 
heme formation. There are two different, unrelated biosynthetic pathways to 
form ALA. In α-proteobacteria, yeast and animal mitochondria ALA is formed via 
the ‘Shemin (C4-)-pathway’. Here, the pyridoxal-5’-phosphate (PLP-) dependent 
enzyme, 5-aminolevulinic acid synthase (ALAS, encoded by hemA,  
EC 2.3.1.37), catalyzes the condensation of glycine and succinyl-Coenzyme A 
(succinyl-CoA) that gives CO2, Coenzyme A (CoA) and ALA (Shemin and 
Russel, 1953; Kikuchi et al., 1958; O’Brian and Thöny-Meyer, 2002). In 
chloroplasts from green algae and plants, cyanobacteria, archaea and in most 
other bacteria, ALA is synthesized from the C5-skeleton of glutamic acid (Beale 
and Castelfranco, 1973; Jahn et al., 1992). This pathway is called ‘C5-pathway’ 
and the reaction is catalyzed by two different enzymes: glutamyl-tRNA-
reductase (GluTR; encoded by hemA, EC 6.1.1.17) and glutamate-1-
semialdehyde-2,1-aminomutase (GSAM; encoded by hemL, EC 5.4.3.8). The 
first step is a reduction from tRNA-bound glutamate in a nicotinamide adenine 
dinucleotide hydrate (NADPH)-dependent reaction into the unstable glutamate-
1-semialdehyde (GSA) by the GluTR, in which the tRNAGlu is released (Jahn et 
al., 1991; Moser et al., 1999; Jahn and Heinz, 2009). The initial substrate, 
glutamyl-tRNA, is used for heme formation as well as for protein synthesis. The 
final step is a PLP-dependent transamination reaction of the semialdehyde to 
ALA by the action of GSAM (Ilag and Jahn, 1992). Thereby the C5-skeleton of 
glutamate is incorporated into ALA which is the eponym for this pathway. The 
aldehyde GSA is highly reactive in free solution. Therefore, a proposal of a 
GluTR/GSAM complex existed which was in accordance with the structural 
complementarity of GluTR and GSAM (Moser et al., 2001). This complex was 
verified in vivo and thus explained the direct channeling of the instable 
intermediates by obviation of solvent exposure (Luer et al., 2005).  
Euglena gracilis, a photosynthetic phytoflagellate, is the only organism known 
that uses both pathways, the ‘Shemin-‘ and the ‘C5-pathway’ for heme 
biosynthesis (Iida et al., 2002). Here, ALA for mitochondrial tetrapyrroles 
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derived from ALAS while ALA for plastidic pigments is formed by the  
‘C5-pathway’ (Weinstein and Beale, 1983). Another interesting route of heme 
biosynthesis occurs in the malarian parasite Plasmodium falciparum. This 
organism has, besides its mitochondrion, a second unique organelle known as 
apicoplast which represents a relict plastid with ‘plant-like’ characteristics, yet 
devoid of photosynthesis. The apicoplast is believed to have once contained a 
complete set of heme biosynthesis proteins with ALA synthesis occurring via 
the ‘C5-pathway’. However, the ‘C5-pathway’ components seem to have been 
lost in the course of evolution. Thus, in P. falciparum ALA is exclusively 
synthesized by ALAS in the mitochondrion and then shuttled to the apicoplast 
for further conversion into porphobilinogen (PBG, Lim and McFadden, 2010). 
 
1.1.4  The Common Step of Tetrapyrrole Biosynthesis: From 
Aminolevulinic Acid to Uroporphyrinogen III 
 
The next three steps after ALA formation are common for all tetrapyrroles with 
uroporphyrinogen III as central intermediate product. Following ALA formation is 
the synthesis of PBG through an asymmetrical condensation of two ALA 
molecules. This is catalyzed by the porphobilinogen synthase (PBGS, encoded 
by hemB, EC 4.2.1.24, also known as ALA dehydratase; Frankenberg et al., 
1999b). This enzyme usually functions as a homooctameric protein with the 
exception of the Rhodobacter capsulatus enzyme which was shown to be a 
hexamer (Bollivar et al., 2004). PBGS enzymes from different organisms can be 
divided into subgroups according to their dependency on different metal ions. 
Human and yeast PBGS contain two zinc ions, one of them playing a role in 
catalysis which are coordinated by highly conserved cysteine residues (Gibbs et 
al., 1985; Senior et al., 1996; Senior et al., 1997; Shoolingin-Jordan et al., 
2002). Escherichia coli PBGS contains zinc in the active site and an additional 
magnesium ion. Pseudomonas aeruginosa PBGS harbors magnesium ions at 
an allosteric site and monovalent cations in the active site (Frankenberg et al., 
1999a; Frankenberg et al., 1999b; Mitchel and Jaffe, 1993). Furthermore, it was 
reported that some PBGS enzymes are metal-independent (Bollivar et al., 
2004). The PBGS enzymes possess two different ALA binding sites, called  
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‘P-site’ and ‘A-site’. The first ALA molecule which contributes the propionate 
group of PBG forms a Schiff’base to a conserved lysine residue within the  
‘P-site’. In addition, a second ALA molecule also forms a Schiff’base to a 
second strictly conserved active site lysine residue to produce the acetate group 
carrying half of PBG. The Schiff’base at the ‘A-site’ is then transformed into an 
enamine. In an aldole addition reaction the C-3 atom of the ‘A-site’-ALA attacks 
the C-4 of the ‘P-site’-ALA with the result of the C-C bond between the two ALA 
molecules. Subsequently, the amino group of the ‘P-site’-ALA attacks the 
Schiff’base at the C-4 atom of the ‘A-site’-ALA leading to a C-N bond formation 
and release of the ‘A-site’-lysine. Liberation of the ‘P-site‘-lysine and the 
reaction intermediate is triggered by protonation and possibly by conformational 
changes of the enzyme. A final proton abstraction leads to the aromatization 
and PBG release. (Erskine et al., 2001; Frere et al., 2002; Erskine et al., 2003; 
Jaffe, 2004; Frere et al., 2006). 
In most investigated bacteria the genes for the next two enzymes of heme 
biosynthesis, porphobilinogen deaminase or hydroxymethylbilane synthase 
(PBGD, HMBS) and uroporphyrinogen III synthase (UROS), are located in one 
operon. A reason for the coordinated expression of these two genes could be 
the formation of an enzyme complex to channel the pre-uroporphyrinogen 
intermediate to prevent formation of the toxic uroporphyrinogen I (Fig. 4A), via 
spontaneous cyclisation of pre-uroporphyrinogen (Jordan, 1991).  
The PBGD (encoded by hemC, EC 4.3.1.8; Burton et al., 1979; Battersby et al., 
1979; Battersby et al., 1982) catalyzes the stepwise condensation of four PBG 
molecules under eliminiation of an amino group at each step to form the linear 
and unstable tetrapyrrole intermediate pre-uroporphyrinogen (1-hydroxy-
methylbilane). In mammalian cells and yeast the enzyme is located as a soluble 
protein in the cytosol. In higher plants and algae it is located in the stroma of the 
chloroplasts (Elder, 1976; Labbe-Bois and Labbe, 1990; Smith, 1988; Spano 
and Timko, 1991). The PBGD occurs in all so far determined organisms as a 
monomer with a size range from 33’000 Da to 45’000 Da and is composed in 
three domains. The dipyrromethane cofactor is a PBG dimer and covalently 
attached to domain three through its free amino group (Jordan and Warren, 
1987; Warren and Jordan, 1988). The cofactor serves as a primer for the 
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oligomerization of another four PBG molecules with the result of a protein 
bound linear hexapyrrole. Furthermore, the cofactor is anchored inside the cleft 
between domain one and two over expanded salt bridges and hydrogen bonds 
(Louie et al., 1992). The active site is located between these both domains 
(Louie et al., 1996). A highly conserved aspartate residue plays an important 
role during the deamination process of PBG after it is linked to the growing 
oligopyrrole chain (Louie et al., 1992; Woodcock and Jordan 1994).  
 
 
 
 
 
 
 
 
Fig. 4: Uroporphyrinogen I and uroporphyrinogen III. 
A. Uroporphyrinogen I. B. Uroporphyrinogen III.  
 
Pre-uroporphyrinogen is converted into the cyclic, asymmetric 
uroporphyrinogen III by the UROS (encoded by hemD, EC 4.2.1.75). UROS is a 
monomeric protein consisting of two α/β-domains which are connected by a 
flexible, two-stranded linker. Domain I belongs to the flavodoxin-like fold family 
while domain II shows a DNA glycosylase-like fold (Mathews et al., 2001). The 
asymmetry of the tetrapyrrole intermediate provided by UROS is caused by the 
inversion of ring-D via a spiro-mechanism with spiro-pyrrolenine as an 
intermediate (Chadwick, 1994; Shoolingin-Jordan and Cheung, 1999). In the 
first step of UROS catalysis the hydroxyl group on ring A of pre-
uroporphyrinogen is lost as a water molecule with the result of the first 
azafulvene intermediate. Subsequently, the spirocyclic pyrrolenine intermediate 
is formed by reaction of the azafulvene with the substituted α-position of ring D. 
The second azafulvene intermediate at the C-ring is formed by bond breakage 
between rings C and D. In the final steps of catalysis the enzyme has to 
orientate the ring-D-pyrrole in such a way that the C-ring azafulvene can react 
with its free α-position. Finally, uroporphyrinogen III is formed by deprotonation 
  
A B 
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and bond rearrangements (Stark et al., 1986; Cassidy et al., 1996; Pichon et al., 
1994; Shoolingin-Jordan, 1995; Silva and Ramos, 2008). The product of this 
reaction, uroporphyrinogen III (Fig. 4B), is the last common product of the 
biosynthesis of all tetrapyrroles (Fig. 3).  
 
1.1.5 From Uroporphyrinogen III to Heme 
 
The biosynthetic pathways of the porphonoides like siroheme and the cofactor 
F430 as well as the corrinoids get already separated after five steps from the 
pathway of porphyrine formation. The fifth enzyme in the heme and chlorophyll 
biosynthesis, uroporphyrinogen III decarboxylase (UROD, encoded by hemE, 
EC 4.1.1.37), catalyzes the formation of coproporphyrinogen III (coprogen) by 
the sequential displacement of carboxyl groups from the four acetate side 
chains of the uroporphyrinogen III into methyl groups (Luo et al., 1993), starting 
on ring D, then A, B and finally C (Akhtar, 1991; Luo and Lim, 1993). UROD is 
an unusual decarboxylase in that it is not dependent on any prosthetic goup or 
cofactor. Furthermore, it is a dimeric protein in which the two single-domain 
subunits are orientated head-to-head with the active site clefts facing each other 
at the dimer interface resulting in one large active site (Martins et al., 2001). 
One proposal for the UROD reaction mechanism suggests a reorientation of the 
substrate by 90° for each decarboxylation step. A h ighly conserved aspartate 
residue seems to be involved in substrate binding and catalysis. The first step in 
the proposed reaction mechanism is the protonation of the substrate pyrrole 
ring at the α-position close to the C-atom bearing the acetate side chain. An 
aspartate residue stabilizes the formed positively charged reaction intermediate. 
Decarboxylation of the acetate side chain results in another intermediate which 
has to be protonated at the methylene carbon and deprotonated at the  
α-C-atom to yield the reaction product. A highly conserved arginine residue 
within the active site was proposed to be involved in the final protonation step. 
The subsequent decarboxylation takes place after substrate rotation by 90° at 
the same active site and in the same manner as the first one (Phillips et al., 
2003; Lewis and Wolfenden, 2008). The two protonation steps are supported by 
two arginine residues (Arginine 37 and Arginine 41) lying in the active site and 
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serving as acid catalysts. It was proposed that the flexibility of Arginine 37 
allows this residue to donate protons to each of the four pyrrole rings without 
substrate rotation (Silva et al., 2010). 
The next enzyme, coproporphyrinogen III oxidase (CPO, encoded by hemF, 
hemN, EC 1.3.3.3) catalyzes the sequential oxidative decarboxylation of the 
propionate groups in position three and eight (ring A and B) of 
coproporphyrinogen III to vinyl groups yielding protoporphyrinogen IX. The 
decarboxylation of the propionate side chain of ring A occurs prior to that on 
ring B via the reaction intermediate harderoporphyrinogen (Cavaleiro et al., 
1974; Elder et al., 1978; Rand et al., 2010). This reaction is catalyzed under 
aerobic and anaerobic conditions by two different, structural unrelated enzymes. 
HemF performs this task under aerobic conditions. HemN, a ‘Radical-SAM’ 
enzyme catalyzes this reaction under anaerobic conditions and should rather be 
named coproporphyrinogen III dehydrogenase (CPDH, EC 1.3.99.22; Breckau 
et al., 2003; Layer et al., 2002). Bacterial and plant CPOs are soluble proteins 
while yeast and animal enzymes are loosely associated with mitochondrial 
membranes (Smith et al., 1993; O’Brian and Thöny-Meyer, 2002). The oxygen-
dependent CPO is a dimeric enzyme with molecular oxygen as terminal 
electron acceptor. Each monomer consists of a single domain adopting an 
exceptional fold in which a large seven-stranded antiparallel β-sheet is covered 
on both sides by α-helices. Both β-sheets face each other and the subunits are 
rotated by approximately 40° relative to another. T he oxygen-independent CPO 
(CPDH) needs another terminal electron acceptor than oxygen for the oxidative 
decarboxylation reaction. The reaction sequence and its stereochemistry is the 
same as for the oxygen-dependent CPO (Seehra et al., 1983). CPDH is a 
monomeric protein with a C- and an N-terminal domain with the N-terminal 
domain being the larger one (Layer et al., 2003). As a member of the ‘Radical-
SAM’ protein family it harbors an oxygen-labile [4Fe-4S] cluster. Three of the 
four iron atoms are coordinated by three highly conserved cysteine residues of 
the characteristic CX3CX2C motif (Layer et al., 2002). The fourth iron atom is 
ligated by an S-adenosyl-L-methionine (SAM) molecule serving as cofactor by 
initiating the radical based catalysis (Layer et al., 2003). 
Introduction 
 
12 
 
The penultimate enzyme of heme formation, protoporphyrinogen IX oxidase 
(PPO, encoded by hemG, hemY, EC 1.3.3.4) is the last common enzyme of the 
heme and chlorophyll biosynthesis. The relative molecular masses of PPO 
monomers range from Mr = 36’000 to Mr = 65’000. In contrast, the HemG 
enzyme of E. coli only has a molecular mass of approximately Mr = 21’000. 
PPO converts protoporphyrinogen IX to protoporphyrin IX (proto) which requires 
the elimination of six electrons and results in the formation of a planar system of 
completely conjugated double bonds. In eukaryotes and some bacteria HemY, 
the oxygen-dependent flavin-containing enzyme form, catalyzes this reaction 
and requires molecular oxygen as final electron acceptor (Hansson and 
Hederstedt, 1994a; Koch et al., 2004). PPOs which require oxygen are usually 
homodimeric, membrane-associated proteins with the exception of monomeric 
PPO from Bacillus subtilis and Aquifex aeolicus (Hansson and Hederstedt, 
1994a; Hansson et al., 1997). B. subtilis PPO was found to be soluble in the 
cytoplasm (Corrigall et al., 1998). Each monomer of dimeric PPOs as well as 
the monomeric B. subtilis enzyme consists of three domains, an FAD-binding, a 
substrate-binding and a dimerization domain. The dimerization domain is 
responsible for membrane association (Hansson and Hederstedt, 1994a; Dailey 
and Dailey, 1997). In contrast to oxygen-dependent PPOs, oxygen-independent 
PPOs are one of the first examples for the direct coupling of anabolic heme 
biosynthesis with catabolic ATP generating electron transport chains. Under 
aerobic conditions HemG abstracts six electrons from its substrate and 
transfers them via ubiquinone, cytochrome bo3 (Cyo) and cytochrome bd (Cyd) 
oxidase to oxygen. Under anaerobic conditions electrons are transferred via 
menaquinone, fumarate (Frd) and nitrate reductase (Nar) to fumarate and 
nitrate, respectively. Cyo, Cyd and Nar contribute to the proton motive force that 
drives ATP formation (Jacobs and Jacobs, 1976; Dailey and Dailey, 1996; 
Möbius et al., 2010). 
In the ultimate step of heme biosynthesis, chelatases catalyze the insertion of 
metals into the centers of the generated tetrapyrroles. The ferrochelatase  
(FC, encoded by hemH, EC 4.99.1.1; Dailey, 2002) forms heme b by insertion 
of iron into protoporphyrin IX. In eukaryotes FC is a membrane-associated 
homodimer while it is monomeric in bacteria (Wu et al., 2001; Wang et al., 
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2001; Grzybowska et al., 2002). In Gram-positive bacteria, e.g. B. subtilis, FC is 
a soluble protein located in the bacterial cytoplasm (Hansson and Hederstedt, 
1994b). Compared to the eukaryotic FCs which contain one [2Fe-2S] cluster per 
subunit, the bacterial counterparts have been described with and without FeS 
clusters (Dailey et al., 1994; Day et al., 1998; Dailey and Dailey, 2002; 
Shepherd et al., 2006). Furthermore, it was shown that the position of the 
propionate side chains on rings C and D are critical for catalysis in contrast to 
the substituents on rings A and B which are variable. FCs are also able to insert 
divalent metal ions like Ni2+ and Zn2+ into porphyrins whereas others like Mn2+ 
or Pb2+ have inhibitory effects (Hunter et al., 2008; Medlock et al., 2009). The 
eukaryotic enzyme consists of two similar domains with a C-terminal extension 
forming a helix-turn-helix structure and which is involved in coordination of the 
FeS cluster. In the FC homodimer this C-terminal extension is responsible for 
the interaction between the monomers of the dimer. Moreover, the C-terminal 
extension is lacking in bacteria explaining their monomeric structure. Both 
active site pockets of dimeric human FC are located on the same hydrophobic 
surface which is believed to be integrated within the membrane (Medlock et al., 
2007). In Thermosynechococcus elongatus the metabolic channeling between 
PPO and FC has been shown in vivo that prevent solvent exposure of the 
photoreactive protoporphyrin IX (Masoumi et al., 2008). 
 
1.2  Aminolevulinic Acid Synthase 
 
Aminolevulinic acid synthase (ALAS, EC 2.3.1.37) is the first enzyme in 
tetrapyrrole biosynthesis in humans, animals and the α-proteobacteria. It 
catalyzes the condensation of the amino acid glycine and succinyl-CoA to the 
products ALA, carbon dioxide and CoA (Fig. 5). 
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succinyl-CoA glycine 5-aminolevulinic acid
Fig. 5: ALAS catalyzed reaction. 
The ALAS catalyzes the condensation of glycine and succinyl-CoA that gives carbon dioxide, 
CoA and ALA. 
 
1.2.1  The Different Aminolevulinic Acid Synthases 
 
The ALAS is a homodimer with an active site at the subunit interface. Within the 
α-family of PLP-dependent enzymes ALAS belongs to the aminotransferase 
fold-type II subfamily which catalyzes the condensation of a carboxylic acid CoA 
thioester and small amino acids (Nandi, 1978b; Fanica-Gaigner and Clement-
Metral, 1973a; Alexander et al., 1994; Astner et al., 2005; Schulze et al., 2006). 
The relative molecular masses of the monomers range from Mr = 43’000 to  
Mr = 66’000. It catalyzes the PLP-dependent condensation of two substrates, 
succinyl-CoA (produced in the citric acid cycle) and glycine in non-plant 
eukaryotes as well as the α-subclass of purple bacteria (Christen and Mehta, 
2001; Ferreira and Zhang, 2002; Schulze et al., 2006). This step is the rate-
limiting one and leads to the product ALA, the first common precursor of all 
tetrapyrroles. Some bacteria, e.g. Rhodobacter sphaeroides, and humans 
encode two different ALAS genes. In humans there are an erythroid-specific 
(ALAS2), and a housekeeping ALAS (ALAS1; Riddle et al., 1989; Bishop et al., 
1990). The erythroid ALAS is difficult to purify because of a short biological half-
life (Furuyama and Sassa, 2002). In R. sphaeroides there are HemA and HemT 
(encoded by hemA or hemT, respectively; Neidle and Kaplan, 1993). In contrast 
to humans, R. sphaeroides can survive with only one intact ALAS gene, in 
humans the two different isoforms cannot replace the function of each other. 
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Fig. 6: Crystal structure of Rhodobacter capsulatus ALAS. 
A. The ALAS of R. capsulatus is a homodimer. Each monomer consists of one chain, chain A is 
depicted in blue and chain B in green. The α-helices are displayed as spirals and β-sheets as 
arrows. B. Magnification of the active site with two bound PLP-molecules, displayed as grey-
blue-red-orange stick-and-ball molecules (Astner, 2007). 
 
ALAS is highly conserved from α-proteobacteria to humans with amino acid 
sequence identities ranging from 40 to 80 %. The cofactor is bound to an active 
site lysine residue (e.g. in mouse: Lysine 313) via a Schiff’base linkage (Ferreira 
et al., 1993a). Its ε-amino group undergoes changes in absorptive properties 
during substrate binding and catalysis. Moreover, substrate binding triggers 
closure of an extended loop over the active site (Astner et al., 2005). Kinetic 
and crystallographic studies propose the availability of such an active site loop 
that affects the rate of ALA production coincident with product release (Hunter 
and Ferreira, 1999; Astner et al., 2005; Hunter et al., 2007). 
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1.2.2  ALAS Reaction Mechanism 
 
The ALAS-catalyzed reaction involves the mechanistically cleavage of two 
amino acid α-carbon bonds. This reaction mechanism is highly unusual for PLP-
dependent enzymes. Contrary to ALAS that cleaves two α-carbon bonds, most 
commonly known PLP enzymes (Percudani and Peracchi, 2003) catalyze only 
the cleavage of a single α-carbon substrate bond. There are only three other 
enzymes known that also catalyze the cleavage of two α-carbon bonds i.e.  
8-amino-7-oxononanoate synthase (AONS; Alexeev et al., 1998), serine 
palmitoyltransferase and dialkylglycine decarboxylase (Mehta and Christen, 
1994). In contrast to the first two of them which catalyze a reaction similar to the 
ALAS reaction, dialkylglycine decarboxylase (Toney, 2005) uses a ping-pong 
reaction mechanism involving transamination and decarboxylation half-
reactions. 
Dunathan proposed that for efficient electron delocalization into the conjugated 
ring system, the bond to be cleaved must be oriented perpendicular to the plane 
of the PLP ring (Dunathan, 1966). The ALAS reaction with cleavage of two  
α-carbon bonds is difficult to align with Dunathan’s hypothesis. Granted that the 
sequential cleavage of two of the glycine α-carbon bonds in the ALAS reaction 
is in agreement with Dunathan’s hypothesis, the stereochemistry in the ALAS 
mechanism would assume torsion about the aldimine linkage of approximately 
60° at some point during the time interval between formation of the two 
quinonoid intermediates. Another possibility to explain the unusual ALAS 
reaction is that the decarboxylation of the 2-amino-3-ketoadipate intermediate 
occurs through the β-keto-group rather than into the cofactor ring, as was 
suggested for AONS (Alexeev et al., 2006). The third possibility is that ALAS is 
an exception to Dunathan’s hypothesis. Recently, it could be shown that 
decarboxylation occurs through the carbonyl group with Histidine 207 of murine 
ALAS acting as a general acid catalyst. Furthermore, it is the enol intermediate 
(VI, Fig. 7) in which the alkene bond is aligned orthogonal to the plane of the 
cofactor that gives rise to the resonance stabilized quinonoid (VII, Fig. 7). 
Fig. 7 shows the postulated reaction mechanism for ALAS using the example of 
the mouse enzyme.  
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Fig. 7: Postulated ALAS reaction mechanism (Hunter et al., 2007). 
Postulated ALAS reaction mechanism for the mouse enzyme. 
I = internal aldimine; II = external aldimine; III = first quinonoid; IV = condensation with succinyl-
CoA; V = 2-amino-3-ketoadipate intermediate; VI = enol acts as electron sink; VII = second 
quinonoid; VIII = ALA-bound external aldimine. ALA will be released and the holoenzyme is 
regenerated. 
 
The ALAS reaction mechanism is an ordered bi-bi-kinetic mechanism with 
glycine binding prior to succinyl-CoA, and ALA release after carbon dioxid and 
CoA (Fig. 7; Fanica-Gaigner and Clement-Metral, 1973b; Nandi, 1978a; Astner 
et al., 2005). The internal aldimine consists of the covalently bound PLP-
cofactor at an active site lysine residue and the enzyme (I, Fig. 7; Ferreira et al., 
1993a). It was shown that a conserved tyrosine residue (murine ALAS2 
Tyrosine 121) is essential for cofactor binding while a conserved lysine residue 
(murine ALAS2 Lysine 313) is essential for catalysis (Ferreira et al., 1995a; Tan 
et al., 1998). The first step in the reaction is the formation of the external 
aldimine, i.e. association of glycine with the enzyme (II, Fig. 7). The first 
quinonoid (III, Fig. 7) will be formed by stereo-specific murine ALAS2 K313-
catalyzed abstraction of the pro-R-proton from the PLP-glycine external 
aldimine. The next step is the attachment of the electrophilic carbonyl group of 
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succinyl-CoA to the glycine α-carbon (IV, Fig. 7) that provides the second 
proposed intermediate, 2-amino-3-ketoadipate (V, Fig. 7). The existence of this 
intermediate has as of yet not been definitively confirmed. However, the 
occurrence of the corresponding intermediate in AONS (Kerbarh et al., 2006) 
and 2-amino-3-ketobutyrate ligase (Schmidt et al., 2001), enzymes that are 
structurally and mechanistically related, points to the ALAS reaction pathway. 
The release of CoA from this tetrahedral intermediate, 2-amino-3-ketoadipate, 
and decarboxylation of the carboxyl carbon of glycine leads to the formation of 
an enol (VI, Fig. 7). This species is the third intermediate in this reaction 
pathway and serves as electron sink. Additionally, it is in equilibrium with the 
second quinonoid (VII, Fig. 7; Hunter and Ferreira, 2009) as well as with the 
ALA-bound external aldimine upon protonation of the C-5 position. The last 
steps are protonation (VIII, Fig. 7) of the quinonoid intermediate (formation of 
the ALAS-ALA-aldimine) and ALA release. An active site histidine residue acts 
as a general acid, and finally regeneration of the internal aldimine in a 
transaldimination reaction occurs (Hunter and Ferreira, 1999; Zhang and 
Ferreira, 2002). ALA release represents the rate-limiting step of the reaction 
and is kinetically influenced by a conformational change of the enzyme (Hunter 
and Ferreira, 2009). 
The holoform of the R. capsulatus ALAS (ALASRc) was crystallized and the  
X-ray crystal structure was solved at 2.1 Ǻ resolution (Astner et al., 2005) as 
well as enzyme-substrate complexes with glycine and succinyl-CoA, 
respectively. With the ALASRc crystal structure it was possible to create a 
structural model of the human erythroid ALAS dimer for the first time. Both 
monomers of the ALASRc homodimer are closely connected with each other. 
The ALAS consists of three domains, an N-terminal domain (amino acids in  
ALASRc 1 - 53), a central catalytic domain (amino acids in ALASRc 54 - 296) and 
a C-terminal domain (amino acids in ALASRc 297 - 401). The C- and N-termini 
are located at the protein surface and they are easily accessible. Each of the 
three domains of one monomer is connected to two domains of the second 
monomer (Astner, 2007).  
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Fig. 8: Schematic representation of the active site of the R. capsulatus ALAS (Astner et 
al., 2005). 
Glycine-bound PLP and succinyl-CoA are highlighted by black bonds while surrounding 
residues show a dark orange color. Hydrogen bonds are displayed by dotted lines (green 
numbers) and salt bridges (red numbers) between substrates or cofactor and ALAS. Van der 
Waals interactions are denoted by green semicircles. Residues from the second monomer are 
marked with an asterisk. K248, the lysine residue involved in PLP binding and catalysis, is 
marked by a blue box while residues affected by mutations in human ALASe are marked by a 
red box. 
 
In R. capsulatus the PLP-cofactor is tightly bound via interactions like hydrogen 
bonds from the oxygen atoms of the phosphate residue to the main chain 
amides from Alanine 115, Tyrosine 116 and Threonine 278* from the catalytic 
domain and to the side chains from Serine 277*, Threonine 278* and  
Threonine 245* (* residues from the second monomer; Fig. 8). The plane of the 
PLP-pyridine ring is sterically focused via hydrophobic stacking with Valine 216 
and Histidine 142. A hydrogen bond between the PLP-hydroxyl group and 
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Histidine 217 stabilizes the cofactor, too (Astner et al., 2005; Turbeville et al., 
2007). In mouse erythroid ALAS Asparagine 279 was identified as an important 
residue in this enzyme-catalyzed reaction by enhancing the electron 
withdrawing capacity of the PLP-cofactor and stabilizing the protonated form of 
the PLP-pyridinium ring nitrogen (Gong et al., 1998). Additionally, Arginine 439 
seems to play a role in recognition and binding of glycine by forming an ionic 
bond between its guanidinium side chain and the carboxylate of the substrate 
glycine (Tan et al., 1998). The ALAS dimer forms a hole close to the  
PLP-cofactor, called the active site, located at the subunit interface. In the 
absence of the two substrates the PLP-cofactor is covalently attached to the 
active site lysine as a Schiff’base in the active site pocket. There are two 
channels leading to the active site. The first one is built from the catalytic 
domain, the C-terminal domain from the PLP-giving monomer and part of a 
strand of the N-terminal domain. The second one is smaller and here the  
N-terminal domain is the main component that builds this channel, C-terminus 
and catalytic domain are also involved (Astner et al., 2005). Glycine and 
succinyl-CoA can enter the active site pocket via these channels. Glycine is 
covalently linked to PLP as an external aldimine. Thereby, Arginine 374 of  
R. capsulatus is highly conserved and essential for binding of the glycine 
carboxyl group. Furthermore, the position of the carboxyl residue is stabilized by 
hydrogen bonds to Asparagine 54 and Serine 189 (Astner et al., 2005). There 
are two different conformations in the ALAS enzyme, an open and a closed one. 
In the open conformation the substrates are bound; the closed conformation is 
formed, induced by the binding of the second substrate, succinyl-CoA (Zhang 
and Ferreira, 2002). The existence of the 2-amino-3-ketoadipate intermediate 
has not be confirmed yet, but it is known that the corresponding intermediates 
occur in AONS (Kerbarh et al., 2006) as well as in ketobutyrate ligase (Schmidt 
et al., 2001). 
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1.3  Typical Features of Pyridoxal-5’-phosphate-dependent Enzymes 
 
Several enzymes like ALAS utilize PLP, the active form of vitamin B6 (Pyridoxin; 
Heyl et al., 1951), as coenzyme for their catalytic reactions. PLP-dependent 
enzymes catalyze a variety of different reactions, e.g. racemizations, 
decarboxylations or transaminations (Eliot and Kirsch, 2004). Almost all PLP 
enzymes follow a similar reaction mechanism: The aldehyde group of PLP is 
covalently linked to an active site lysine residue whereby the so called internal 
aldimine is formed. In a first common step a Schiff’base is generated after 
condensation of the amino acid substrate and the PLP-cofactor, also known as 
external aldimine. In a following step one of the bonds to the α-carbon atom is 
broken with PLP serving as an electron sink and stabilizing the negative charge 
at the α-carbon atom by delocalization through its pi-system. The subsequently 
formed and stabilized carbanion is called quinonoid (Schneider et al., 2000; 
Eliot and Kirsch, 2004). For bond breaking and efficient electron delocalization 
into the conjugated ring system the cofactor weakens the sigma bonds around a 
carbon atom which is oriented perpendicular to the pyridine ring of the cofactor 
in the transition state of the reaction (Corey and Sneen, 1956; Dunathan, 1966). 
The exceptions to this mechanism are the PLP-dependent phosphorylases. 
Their reaction chemistry is different in that they use the phosphate group of the 
cofactor for catalysis (Schneider et al., 2000). PLP-catalyzed reaction types can 
be divided into several groups depending on the position at which the net 
reaction occurs. Fig. 9 shows the quinonoid formation after deprotonation of the 
external aldimine (Eliot and Kirsch, 2004). 
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Fig. 9: Quinonoid formation in PLP-catalyzed reaction (Eliot and Kirsch, 2004). 
After loss of a proton from the external aldimine the negative charge is delocalized in the  
pi-system of the cofactor whereby the quinonoid is formed. Residues deriving from the amino 
acid are marked in red. 
R = residue. 
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1.4  Succinyl-Coenzyme A Synthetase Synthesizes one ALAS 
Substrate 
 
One of the substrates of ALAS is succinyl-CoA which is formed by an enzyme 
called succinyl-Coenzyme A synthetase (SCS; EC 6.2.1.4 for the adenosine 
diphosphate (ADP) forming enzyme and EC 6.2.1.5 for the guanosine 
diphosphate (GDP) forming enzyme). The SCS’s catalyze the solely substrate-
level phosphorylation step of the tricarboxylic acid cycle. It uses the energy of 
succinyl-CoA to form nucleotide triphosphate from inorganic phosphate and 
nucleotide diphosphate (Equation (1) with N denotes guanosine or adenosine): 
 
succinyl-CoA + NDP + Pi                succinate + CoASH + NTP (1) 
 
Equation 1: SCS catalyzed reaction. 
Under aerobic conditions SCS couples succinyl-CoA hydrolysis to the synthesis of nucleotide 
triphosphate. In the anaerobic metabolism it provides succinyl-CoA. 
 
During aerobic metabolism the enzyme couples the hydrolysis of succinyl-CoA 
to the synthesis of adenosine triphosphate (ATP). In the anaerobic metabolism 
it provides succinyl-CoA when the oxidative route from 2-ketoglutarate is 
severely repressed (Buck et al., 1985) or when succinyl-CoA is necessary for 
heme biosynthesis (Miles and Guest, 1987). Succinyl-CoA for the ALAS 
reaction is formed exclusively within mitochondria by SCS. Furthermore, the 
SCS is composed of two dissimilar subunits, an α- and a β-subunit. The  
α-subunit has a relative molecular mass of around Mr = 30’000 while the  
β-subunit is a little larger (Mr = 40’000). The binding sites for CoA and the 
nucleotide substrate are located in the α-subunit and there exists a histidine 
residue that is phosphorylated during catalysis (Histidine 246 in the E. coli 
enzyme; Wang et al., 1972; Buck and Guest, 1989). The succinate binding site 
is located in the β-subunit (Bailey et al., 1993; Fraser et al., 1999). The 
complete catalytic sites are formed by regions of contact between the  
α- and β-subunits (Wolodko et al., 1994). 
The SCS found in mammalian mitochondria, Gram-positive bacteria and yeast 
are α-β-dimers while the enzyme of E. coli and other Gram-negative bacteria 
are (αβ)2-tetramers with two active sites, one in each dimer (Wolodko et al., 
- O2 
+ O2 
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1986; Bailey et al., 1993). Mammalian cells contain two distinct isoforms of the 
enzyme that are either guanosine triphosphate (GTP)- or adenosine 
triphosphate (ATP)-specific, while the bacterial enzymes have a degenerated 
nucleotide specificity but prefer adenosine (Bailey et al., 1993; Wolodko et al., 
1994). Enzymes preferring ADP/ATP are referred to as ‘A’-form (A-SCS) and 
enzymes with a favor for GDP/GTP are referred to as ‘G’-form (G-SCS; Birney, 
1997). The mammalian α-subunit shows 70 % sequence identity to its bacterial 
counterpart and 45 % to the β-subunit (Henning et al., 1988; Bailey et al., 1993). 
The two isoforms, A-SCS and G-SCS, contain an identical α-subunit, but they 
differ in their β-subunit indicating that in this subunit the specificity for one of the 
two nucleotides is determined (Johnson et al., 1998a; Johnson et al., 1998b). 
The E. coli SCS was crystallized and its structure solved with 2.5 Å resolution 
(Wolodko et al., 1984; Fraser et al., 1999). The α-subunit is composed of  
10 α-helices and 14 β-strands forming two predominantly parallel β-sheets of 
seven strands each where one strand is antiparallel to the other resulting in an 
N- and a C-terminal β-sheet. The nucleotide-binding motif is the result of a 
doubly wound parallel β-sheet formed by the N- and the C-terminal β-sheet, 
sandwiched by α-helices (Fraser et al., 1999). At the nucleotide-binding motif of 
the N-terminal sheet CoA is bound. The loop containing the phosphorylated 
histidine residue is found at the carboxy termini of the strands that are part of 
the nucleotide-binding motif in the C-terminal domain. 
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Fig. 10: Crystal structure of E. coli SCS. 
A. The SCS is a (α-β)2-tetramer. Each dimer consists of two subunits, the α-subunit is depicted 
in blue and the β-subunit in light green. The α-helices are displayed as spirals and the β-sheets 
as arrows. B. Magnification of the active site with bound Coenzyme A in each α-subunit, 
displayed as grey-blue-red-orange stick-and-ball molecules (Wolodko et al., 1984; Fraser et al., 
1999). 
 
Similar to each domain of the α-subunit, the C-terminal domain of the β-subunit 
also has a nucleotide-binding motif. Here, the β-sheets consist of five parallel 
and one antiparallel β-strand and six α-helices (Fraser et al., 1999). Within the 
N-terminal domain of the β-subunit are two subdomains of unequal size. The 
SCS subunits are connected via the C-terminal domain of the β-subunit with the 
C-terminal domain of the α-subunit. Through a second major interface between 
residues of the larger N-terminal subdomain of the β-subunit and residues in 
both domains of the α-subunit, the subunits in the α-β-dimer are also 
connected. (Fraser et al., 1999). The fold of the N-terminal domain of the  
β-subunit also was observed in other nucleotide-binding enzymes including 
glutathione synthetase (Yamaguchi et al., 1993; Murzin, 1996), pyruvate 
phosphate dikinase (Herzberg et al., 1996) or biotin carboxylase (Waldrop et al., 
1994). Both subunits of the E. coli SCS are encoded by the genes sucC  
(β-subunit) and sucD (α-subunit), at the distal end of the sucABCD operon, 
which also encodes the specific 2-oxoglutarate dehydrogenase (E1o, encoded 
by sucA, EC 1.2.4.21) and dihydrolipoamide succinyltransferase (E2o, encoded 
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by sucB, EC 2.3.1.61). These enzymes are components of the 2-oxoglutarate 
dehydrogenase complex employed in the citric acid cycle (Darlison et al., 1984; 
Spencer et al., 1984; Buck et al., 1985; Buck and Guest, 1989). 
 
1.4.1  Cooperativity of Succinyl-Coenzyme A Synthetase and 
Aminolevulinic Acid Synthase during Heme Biosynthesis 
 
The ALAS is responsible for the production of ALA, the first common precursor 
of all tetrapyrroles. It needs succinyl-CoA and glycine for ALA formation. One of 
these two substrates, succinyl-CoA, is formed by SCS. A specific association of 
human ALAS2 with the β-subunit of A-SCS was demonstrated (Furuyama and 
Sassa, 2000). This interaction seems to be an important process and its failure 
is responsible for some forms of X-linked sideroblastic anemia (XLSA). Today it 
is known that the expression of ALAS2 is well controlled at several levels during 
transcription (Fujita et al., 1991b), translation (Melefors, 1993) and import into 
mitochondria (Lathrop and Timko, 1993), but also by interaction with other 
proteins. Mutation of ALAS2 (e.g. D190V) resulted in an unstable protein 
(Furuyama et al., 1997). In vitro expression lead to a pre-ALAS2 of normal size, 
but after translocation into mitochondria the D190V protein was processed in a 
product with higher molecular weight than the normal mature ALAS form. The 
D190V ALAS2 variant showed drastically decreased protein-protein interaction 
with the β-subunit of A-SCS. This leads to the suggestion that the β-A-SCS 
plays a major role in protecting ALAS2 from degradation (Furuyama and Sassa, 
2000). 
 
1.5 Control of Aminolevulinic Acid Synthase Biosynthesis 
 
Usually, heme biosynthesis is a tightly controlled mechanism and the amount of 
formed heme is equal to the amount needed by the body. ALAS seems to be a 
perfect target for regulation because of its low endogenous activity and its short 
half-life. At the level of ALA formation a negative ‘feedback’ control mechanism 
was found, which means ALA controls its own production (Meissner et al., 
2001). Nevertheless, the heme concentration needed for inhibition of enzyme 
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production is around 10-7 M, but for inhibition of enzyme activity a larger amount 
is required (10-5). The conclusion is that ALAS availability and activity depend 
on the intracellular heme concentration and the heme requirement in metabolic 
processes (James and Hift, 2000).  
In humans heme acts as a regulator by controlling the amount of ALAS1 mRNA, 
in avian even the mRNA stability (Srivasata et al., 1988; Yamamoto et al., 1988; 
Drew and Ades, 1989; Hamilton et al., 1991). Furthermore, the translocation of 
ALAS1 from cytosol to mitochondria is also controlled by heme (Yamauchi et 
al., 1980). The control mechanisms of ALAS2 is different. Erythroid-specific 
transcription factors interact with the promoter and regulate transcription of the 
ALAS2 gene (Drew and Ades, 1989; May et al., 1995). Posttranscriptional 
regulation occurs via a cis-acting regulatory iron responsive element (IRE) in 
the 5’-untranslated region of the ALAS2 mRNA (Cox et al., 1991). This element 
is analogous to the stem-loop structure that could be found in the  
5’-untranslated region of ferritin mRNAs (Klausner et al., 1993). If iron is absent 
the mRNA translation is inhibited by an IRE binding protein. Once iron is 
available the protein dissociates, so that the mRNA binds to ribosomes where 
its translation is initiated (Melefors et al., 1993). 
In bacteria the hemA gene is subject to oxygen tension and heme-dependent 
regulation (Zeilstra-Ryalls and Kaplan, 1996). In R. capsulatus the expression of 
the ALAS encoding hemA gene seems to be one of the key regulatory points of 
tetrapyrrole biosynthesis. The hemA transcription was found to be up-regulated 
under conditions of low oxygen tension mediated by the transcriptional regulator 
RegA while a down-regulation takes place in the presence of excess heme 
(Zappa et al., 2010). 
 
1.6 Diseases Caused by Tetrapyrrole Deficiency 
 
1.6.1  Porphyrias 
 
Genetic defects in any of the seven enzymes involved in heme biosynthesis or 
gain of function mutations in the ALAS gene (Whatley et al., 2008) result in 
several genetic disorders, known as porphyrias (Sarkany, 1999; Ajikoa et al., 
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2006; Poblete-Gutierrez et al., 2006; Sassa, 2006). The different porphyrias are 
consequently the result of heme biosynthetic enzyme deficiencies and result in 
the accumulation of heme precursors. Usually, porphyrias are the result of 
inherited genetic diseases, but they can also be acquired by chemical 
inactivation of the involved enzymes. Porphyrias are classified as hepatic 
porphyrias (acute porphyrias) and erythropoetic (cutaneous) porphyrias, 
dependent on the site of the overproduction and accumulation of the porphyrins 
or their biosynthetic intermediates. The two major clinical manifestations are 
rather the effect of heme intermediate accumulation than the lack of heme itself. 
In case of acute porphyrias the porphyrin level in blood is elevated and leads to 
skin rashes and blistering (Roehl et al., 1988), but also to neurovisceral 
symptoms like nausea or confusion which can be life-threatening. The 
characteristical feature of cutaneous porphyrias is photosensitivity (Lecha et al., 
2009; Puy et al., 2010).  
 
Fig. 11 shows a schematic representation of tetrapyrrole biosynthesis and the 
location of known porphyria constitutions in humans (adapted from Puy et al., 
2010). 
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Fig. 11: Schematic representation of tetrapyrrole biosynthesis and the location of 
porphyria constitution in humans (adapted from Puy et al., 2010). 
The mitochondrion is marked in brown and the cytosol in beige. Intermediates in tetrapyrrole 
biosynthesis are highlighted in blue and porphyrias in white. Catalyzing enzymes are found next 
to the arrows. ALAS1 = housekeeping ALAS; ALAS2 = erythroid ALAS; ALA = 5-Aminolevulinic 
acid; PBGS = Porphobilinogen synthase (also known as ALAD = Aminolevulinic acid 
dehydratase); PBG = Porphobilinogen; PBGD = Porphobilinogen deaminase; UROS = 
Uroporphyrinogen III synthase; UROD = Uroporphyrinogen III decarboxylase; CPO = 
Coproporphyrinogen III oxidase; PPOIX = Protoporphyrinogen IX oxidase; FC = Ferrochelatase. 
 
1.6.2  X-linked Sideroblastic Anemia 
 
Humans and other mammals have two different ALAS isoforms, the 
housekeeping (ALAS1) and the erythroid-specific (ALAS2) enzyme. Both 
isoforms show 50 % amino acid identity. While the ALAS1 gene is located on 
chromosome 3p.21, the ALAS2 gene could be found on chromosome Xp11.21 
(Cox et al., 1994). Mutations in the ALAS2 lead to an interruption in interaction 
with the β-subunit of human ATP-specific SCS and this causes a disease called 
mitochondrion cytosol 
Succinyl-CoA 
+ 
Glycine 
ALA PBG 
X-linked dominant protoporphyria 
ALAS2 
ALAS1 ALAD 
ALA dehydratase porphyria 
Pre-uroporphyrinogen 
Uroporphyrinogen I Uroporphyrinogen III 
Coproporphyrinogen I Coproporphyrinogen III 
Acute 
intermittent 
porphyria 
PBGD 
UROIIIS 
UROD 
Congenital erythropoietic 
porphyria 
Spontaneous 
cyclisation 
Porphyria cutanea tarda 
Protoporphyrinogen IX 
Protoporphyrin IX 
Heme 
CPO 
PPOIX 
FC 
- 
Hereditary coproporphyria 
Variegate 
porphyria 
Erythropoietic protoporphyria Fe2+ 
Introduction 
 
30 
 
X-linked sideroblastic anemia (XLSA; Furuyama and Sassa, 2000). In this case 
red cell mitochondria are iron-overloaded and heme-deficient (May and Bishop, 
1998; Bottomley, 2004). Generally, the iron concentration is tightly controlled so 
that non-specific iron binding cannot occur (Andrews, 1999). If the iron 
concentration is too high, the cellular reduction-oxidation state is interrupted and 
cellular lifetime is reduced (Harigae et al., 2003). One example for an XLSA 
causing mutation is the replacement of the Arginine 517 of human ALAS2 by a 
cysteine. Usually this Arginine 517 is crucial for glycine recognition and 
discrimination. Furthermore, in ALASRc Threonine 245 (Threonine 388 in human 
ALAS2) is involved in hydrogen bonding of the PLP-phosphate group. The 
replacement by serine leads to an XLSA form where patients can be treated by 
supplemental pyridoxine (Astner et al., 2005).  
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1.7  Aim of This Study 
 
Aminolevulinic acid synthases are studied since the fifties of the last century. 
However, only recently a solved crystal structure for a bacterial ALAS became 
available and opened the door to structure-function-analyses at the atomic 
level. In this thesis the following three major questions were to be answered: 
 
1.  Is 2-amino-3-ketoadipate the second elusive intermediate of ALAS 
catalysis? What is the role of N54 of ALASRc in its formation and 
stabilization? 
 
2. How are the both substrates succinyl-CoA and glycine functionally 
recognized, bound and metabolized? 
 
3. What is the detailed molecular basis of ALAS-β-SCS interaction, latter 
enzyme synthesizing the succinyl-CoA ALAS substrate? 
 
To answer these questions a variety of mutant ALASRc variants should be 
designed, constructed, purified and their steady state kinetics be determined. 
Single turnover experiments and substrate analog studies should help to 
complete the picture. The crystal structure of selected variants was of interest. 
A close cooperation with Prof. Dr. Gloria C. Ferreira for the advanced kinetic 
characterizations with a 6 months stay at the corresponding laboratory in 
Tampa, Florida, USA was envisaged.  
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2 MATERIALS AND METHODS 
 
 
2.1   Materials 
 
 
In the following tables (Tab. 1 and Tab. 2) the equipment as well as the 
chemicals, enzymes and kits used in this work are listed. 
 
 
2.1.1  Equipment 
 
 
In Tab. 1 all used equipments are listed. 
 
 
Tab. 1: Equipment 
Equipment Model Source 
Agarose gel electrophoresis Agagel Biometra 
Agarose gel documentation GelDoc Bio-Rad 
Anaerobic chamber MACS-MG-1000 anaerobic workstation DW Scientific 
Autoclave LVSA 50/70 Zirbus 
Blotting equipment Semidry-Blot Trans-Blot®SD Bio-Rad 
Centrifuges 5804 Eppendorf 
 Avanti®J-26XP Beckmann Coulter 
 Biofuge primoR Heraeus 
 L8-70M ultracentrifuge Beckmann 
 Minispin Eppendorf 
 Qik Spin QS 7000 Edwards instruments 
 RC 5B Plus Sorvall 
 Speed Vac SPD 110B Savant 
96 Well CrystalQuick™ plates 
96 well plates for sitting drop 
applications Greiner Bio One 
 Crystal Clear tape tesa 
Dialysis visking  type 27/32 exclusion 14000 Roth 
DNA sequencing Genetic Analyzer ABI Prism™ 310 Applied Biosystems 
Electrophoresis power supply PowerPac 300 Bio-Rad 
FPLC ÄKTApurifier™ 900 series Amersham Bioscience 
Homogenizer FastPrep®24 Instruments MP Biomedicals 
Stopped-flow 
spectrophotometer  OLIS model RSM-1000 
On-line Instrument Systems 
Incorporation 
pH-determination pH meter C 6840 B Schott 
Photometer Ultrospec 2000 Amersham Bioscience 
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Tab. 1 (continued): Equipment 
Equipment Model Source 
Pipettes Reference Eppendorf 
Protein concentration cells VIVASPIN 4 concentrator Sartorius stedim biotech 
 VIVASPIN 15 concentrator Sartorius stedim biotech 
Prepacked columns Superdex®200 FPLC® HR 10/30 Pharmacia Biotech 
 MonoQ™ HR 10/10 Pharmacia Biotech 
Scales BL 1500 Sartorius 
 BL 61S Sartorius 
 SBA 52 Scaltec 
SDS-PAGE system Mini Protean II Bio-Rad 
Thermocycler Tpersonal Biometra 
Thermomixer Thermomixer compact Eppendorf 
Ultrasonic bath  Merck eurolab 
UV/visible Spectrophotometer Ultrospec 2000 Amersham Bioscience 
 Jasco V-550 with ETC-505T  Jasco® 
 Temp controller  
Vortex Vortex Genie 2 Scientific Industries 
Water purification Milli-Q-System Millipore 
 
 
2.1.2  Chemicals, Enzymes and Kits 
 
 
Tab. 2: Used chemicals and enzymes 
 Product Source 
Antibodies 
 
Anti-Glutathione-S-Transferase (rabbit-anti-GST) 
Anti-Rabbit IgG, Alkaline Phosphatase Conjugated 
Sigma 
Pierce 
Blotting material Gel blotting paper Roth 
 Roti-PVDF-membrane Roth 
Chemicals 5-aminolevulinic acid hydrochloride Sigma 
 Pyridoxal-5’-phosphate monohydrate Fluka 
 α-ketoglutaric acid sodium salt Sigma 
 Bradford reagent Sigma 
 Succinyl-Coenzyme A sodium salt Sigma 
 Complete Mini, protease inhibitor cocktail tablets Roche 
Crystal Screens Classics Lite Suite Qiagen 
 Classics II Suite Qiagen 
 PEGs II Suite Qiagen 
 Cryos Suite Qiagen 
Enzymes Benzonase®Nuclease Merck 
 Phusion DNA polymerase Finnzymes 
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Tab. 2 (continued): Used chemicals and enzymes 
 Product Source 
 PreScissionTM Protease GE Healthcare 
 T4 DNA Ligase New England Biolabs 
 Restriction enzymes 
New England Biolabs, 
Qiagen, Fermentas 
 
α-ketoglutarate dehydrogenase from porcine 
heart Sigma 
Kits BigDye Terminator v1.1 Cycle Applied Biosystems 
 QIAquick Gel Extraction Kit Qiagen 
 QIAquick PCR Purification Kit Qiagen 
 QuikChange®II Site-Directed Mutagenesis Kit Stratagene 
Molecular weight standards GeneRuler™ DNA Ladder Mix MBI Fermentas 
 MassRuler™ DNA Ladder Mix MBI Fermentas 
 PageRuler™Prestained Protein Ladder MBI Fermentas 
 Unstained Protein Molecular Weight Marker MBI Fermentas 
PCR materials Oligonucleotides Metabion, Biomers 
 Nucleotides (dNTPs) Fermentas 
Other materials Econo-Pac Chromatography Columns Bio-Rad 
 Glutathione Sepharose™ 4 Fast Flow GE Healthcare 
 Protino® Glutathione Agarose 4B Macherey-Nagel 
 
InstantBlue™ Expedeon 
 Lysing Matrix B Bulk MP Biomedicals 
 Steril filter (0.2 µm) Millipore 
 Dialysis visking, type 27/32 exclusion 14‘000 Roth 
 
 
Non-listed chemicals, materials and enzymes were purchased from following 
companies: 
Fluka (Munich, Germany), Merck (Darmstadt, Germany), Roth (Karlsruhe, 
Germany), Sigma (Munich, Germany), MP Biomedicals (Illkirch, France), GE 
Healthcare (Munich, Germany). 
 
 
2.2   Bacterial Strains and Plasmids  
 
 
All bacterial strains and plasmids used in this work are listed in Tab. 3 and  
Tab. 4. 
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Tab. 3: Bacterial Strains 
Strain Genotype Reference 
Escherichia coli DH10β F-  mcrA ∆(mrr-hsdRMS-mcrBC) 
φ80lacZ∆M15∆lacX74 recA1 endA1 araD139 
∆(ara, leu)7697 galU galK λ- rpsL (StrR) nupG 
GibcoBRL 
(Invitrogen) 
 
  
Escherichia coli BL21(DE3)pLysS F- ompT hsdS(r-B-mB) dcm+ gal λ(DE3) [pLysS 
cmR] 
Stratagene 
Escherichia coli BL21(DE3)RIL F- ompT hsdS(rB-mB-) dcm+ tetR galʎ(DE3) endA 
Hte[argU ileY leuW cmR] 
Novagen 
 
 
Tab. 4: Plasmids 
Conservative amino acid exchanges in the R. capsulatus hemA gene were highlighted in light 
pink 
Plasmid Description Reference 
pGEX-6P-1 Expression vector carrying N-terminal sequence for GST 
from Schistosoma japonicum and recognition sequence 
from PreScission™Protease, lac promotor, ampR 
Amersham 
Bioscience 
pRc-A pGEX-6P-1 derivative encoding R. capsulatus 
aminolevulinc acid synthase. Resulting protein is referred 
to as wild-type. 
This work 
pRcA-N54Q pRcA derivative with exchange of triplet AAC to CAG, 
protein carries glutamine instead of asparagine in  
position 54. 
This work 
pRcA-N54D pRcA derivative with exchange of triplet AAC to GAC, 
protein carries aspartic acid instead of asparagine in 
position 54. 
This work 
pRcA-R21K pRcA derivative with exchange of triplet CGC to AAG, 
protein carries lysine instead of arginine in position 21. 
This work 
pRcA-R21E pRcA derivative with exchange of triplet CGC to GAG, 
protein carries glutamic acid instead of arginine in  
position 21. 
This work 
pRcA-D47E pRcA derivative with exchange of triplet GAC to GAG, 
protein carries glutamic acid acid instead of aspartic acid in 
position 47. 
This work 
pRcA-D47S pRcA derivative with exchange of triplet GAC to AGC, 
protein carries serine acid instead of aspartic acid in 
position 47. 
This work 
pRcA-T83S pRcA derivative with exchange of triplet ACC to AGC, 
protein carries serine instead of threonine in position 83. 
This work 
pRcA-T83L pRcA derivative with exchange of triplet ACC to CTC, 
protein carries leucine instead of threonine in position 83. 
This work 
pRcA-N85Q pRcA derivative with exchange of triplet AAC to CAG, 
protein carries glutamine instead of asparagine in  
position 85. 
This work 
pRcA-N85F pRcA derivative with exchange of triplet AAC to TTC, 
protein carries phenylalanine instead of asparagine in 
position 85. 
This work 
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Tab. 4 (continued): 
Plasmid Description Reference 
pRcA-I86L pRcA derivative with exchange of triplet ATC to CTC, 
protein carries leucine instead of isoleucine in position 86. 
This work 
pRcA-I86H pRcA derivative with exchange of triplet ATC to CAC, 
protein carries histidine instead of isoleucine in  
position 86. 
This work 
pRcA-M309L pRcA derivative with exchange of triplet ATG to CTG, 
protein carries leucine instead of methionine in  
position 309. 
This work 
pRcA-M309W pRcA derivative with exchange of triplet ATG to TGG, 
protein carries tryptophan instead of methionine in 
position 309. 
This work 
pRcA-C52S-C201S-C400S pRcA derivative with exchange of triplets TGC and TGT 
to AGC, TCT or TCC, protein carries serine instead of 
cysteine in positions 52, 201 and 400. 
This work 
pRcA-N54Q-C52S-C201S-
C400S 
pRcA derivative with exchange of triplets AAC, TGC and 
TGT to CAG, AGC, TCT or TCC, protein carries 
glutamine instead of asparagine and serine instead of 
cysteine in positions 52, 201 and 400. 
This work 
pRcA-N54D-C52S-C201S-
C400S 
pRcA derivative with exchange of triplets AAC, TGC and 
TGT to GAC, AGC, TCT or TCC, protein carries aspartic 
acid instead of asparagine and serine instead of cysteine 
in positions 52, 54, 201 and 400. 
This work 
pRcA-T365C-C52S-C201S-
C400S 
pRcA derivative with exchange of triplets ACG, TGC and 
TGT to TGC, AGC, TCT or TCC, protein carries cysteine 
instead of threonine and serine instead of cysteine in 
positions 52, 54, 201 and 400. 
This work 
pRcA-T365S-C52S-C201S-
C400S 
pRcA derivative with exchange of triplets ACG, TGC and 
TGT to TCG, AGC, TCT or TCC, protein carries serine 
instead of threonine and serine instead of cysteine in 
positions 52, 201, 365 and 400. 
This work 
pRc-βSCS pGEX-6P-1 derivative encoding the R. capsulatus  
β-subunit of the succinyl-Coenzyme A synthetase (sucC). 
Resulting protein is referred to as wild-type.  
This work 
   
 
 
2.3   Media and Media Additives 
 
 
2.3.1  Media 
 
 
The rich medium Luria Bertani (LB) was used for the cultivation of the E. coli 
cells (Sambrook et al., 1989). 
 
 
LB-medium   
     tryptone   10  g/L 
     NaCl   10  g/L 
     yeast extract    5  g/L 
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For solid media 15 g/L agar was added before sterilization. 
 
 
2.3.2  Media Additives 
 
 
The additives for the media were prepared as concentrated stock solutions. 
They were sterile filtrated and added to the chilled medium. Stock solutions 
were frozen with the exception of ALA (4 °C) at -20  °C. 
Tab. 5 shows the stock solutions which were used in this work. 
 
 
Tab. 5: Medium additives 
Medium additive Stock solution End concentration 
Chloramphenicol (Cm) 
  34   mg/mL in 70 % ethanol (v/v)   34 µg/mL 
Ampicillin (Amp) 100   mg/mL in H2Odest 100 µl/mL 
Isopropyl-1-thio-β-D-galactoside 
(IPTG) 
    1   Molar in H2Odest   50 µM 
5-Aminolevulinic acid hydrochloride 
(ALA) 
    0.1 Molar in H2Odest     5 mM 
 
 
2.4   Microbiological Techniques 
 
 
2.4.1  Sterilization 
 
 
If there is no other information solutions were sterilized for 20 min at 120 °C and 
1 bar overpressure. 
In case of sterile filtration a sterile filter with a pore size of 0.2 µm was used. 
 
 
2.4.2  Cultivation of Bacteria and Long-Term Storage 
 
 
Cells for recombinant protein production were cultivated under vigorous 
aeration. For the preparatory culture E. coli cells containing appropriate 
plasmids were grown in LB medium (100 mL) containing the required additives 
in Erlenmeyer flasks. The incubation was carried out over night at 37 °C and 
200 rpm. From these preparatory cultures the main cultures (500 mL) were 
inoculated with a dilution of 1:100 in Erlenmeyer flasks with fresh medium. The 
bacterial suspension was cultivated to an OD600 of 0.6 - 0.8 at 37 °C and  
200 rpm and the induction of protein production was initiated by the addition of 
200 µM isopropyl-1-thio-β-D-galactoside (IPTG). Further growth occurred at  
25 °C or 17 °C, respectively. 
For cultivation on agar plates the required antibiotics were added to LB-agar-
medium. After plates were congealed a bacteria suspension (50 - 250 µL) was 
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plated with a Drigalski spatula. The dried plates were incubated at 37 °C over 
night. Storage of the agar plates occurred at 4 °C for no more than four weeks. 
For long-term storage at -80 °C glycerol stocks wer e prepared by mixing 800 µL 
of a bacterial culture with 300 µL of a sterile 80 % (v/v) glycerol stock solution. 
Stocks were immediately frozen and stored at -80 °C . 
 
 
2.4.3  Determination of Cell Density 
 
 
For the determination of cell density the optical density (OD) was measured at a 
wavelength of 600 nm. For cell densities with an OD600 ≥1 dilutions were 
prepared (1:10). An OD600 of 1 corresponds to a cell count of 1 x 109 E. coli 
cells per mL. 
 
 
2.5.   Molecular Biology Techniques 
 
 
2.5.1  Production and Transformation of Rubidium Chloride Competent  
   Escherichia coli Cells  
 
 
Competent cells are cells which are able to take up external DNA from the 
environment after a chemical treatment. For the production of competent cells 
100 mL LB-medium with required additives was inoculated with a corresponding 
overnight-culture (1:100) and incubated at 37 °C an d 200 rpm up to an OD600 
0.6 - 0.8 (logarithmic growth phase). The bacterial suspension was then 
centrifuged for 5 min at 4 °C and 4’500 x g. The supernatant was discarded and 
the sediment was washed with 0.4 volume ice-cold TBF-1 and incubated for  
5 min on ice. After a new centrifugation step for 5 min at 4 °C and 4’500 x g the 
supernatant was discarded again and the cell sediment was dissolved in  
1/25 volume ice-cold TBF-2. After an incubation time of 15 - 60 min on ice the 
cells were aliquotated in 50 µL aliquots into precooled reaction tubes and stored 
at -80 °C.  
For the transformation of RbCl2 cells, 50 µL of these cells were mixed with  
1 - 3 µL (50 µg/mL) of the desired plasmid DNA and incubated for 30 min on 
ice. The mixture was subjected to a heat shock at 42 °C for 60 sec and 
afterwards cooled on ice for 2 min. Finally, 500 µL preheated LB-medium was 
added and cells were incubated at 37 °C for 15 - 45  min and 200 rpm. 
Depending on the expected colony density, different volumes were streaked on 
agar plates containing the appropriate antibiotics and plates were incubated 
overnight at 37 °C. 
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TBF-1 
    potassium acetate  30  mM 
    CaCl2   10 mM 
   MnCl2  50  mM 
   RbCl2   100  mM 
   glycerol  15  % (v/v) 
   in H2Odest; adjust to pH 5.8 with 1 M HCl 
 
 
TBF-2 
   3-(N-morpholino)propane- 
   sulfonic acid (MOPS)  10  mM 
   CaCl2   75  mM 
   RbCl2   10  mM 
   glycerol  5  % (v/v) 
   in H2Odest; adjust to pH 6.5 with 1 M KOH 
 
 
2.5.2  Preparation of Plasmid DNA  
 
 
The isolation of plasmid DNA was based on the principle of the alkaline lysis of 
the cell wall and a concomitant denaturation step. In the following decrease of 
pH resulted in the renaturation of DNA whereas the genomic DNA and the 
proteins precipitated. 
LB-medium (5 mL) with required antibiotics was incubated with a colony of an 
agar plate in a test tube overnight at 37 °C. Three  mL from this overnight culture 
were centrifuged at the beginning of the preparation in two centrifugation steps 
for 3 min and 11’000 x g at 4 °C. The cell sediment was dissolved in  
300 µL buffer-P1 and subsequently mixed with buffer-P2. The mixture was 
carefully inverted and incubated at RT for 5 min. Next, 300 µL of neutralization 
buffer-P3 were added, carefully inverted and further incubated on ice for 5 min. 
The precipitated cell debris and proteins were separated by centrifugation from 
the supernatant (15 min at 4 °C and 11’500 x g). Six hundred µL of the 
supernatant were transferred into a fresh reaction tube and 420 µL (0.7 volume) 
isopropanol were added, mixed and incubated for 10 min at RT. In this step 
plasmid DNA was precipitated and harvested in a following centrifugation step 
(15 min at RT and 11’000 x g). The supernatant was discarded and plasmid 
DNA was washed twice with 500 µL 70 % ethanol. Each washing step went 
along with a centrifugation step (15 min at 4 °C an d 13’400 x g). After all traces 
of ethanol had evaporated, the DNA was solubilized in 60 µL of H2Odest. 
 
 
Buffer-P1 
  Tris-HCl  50  mM 
  ethylene diamine  
  tetraacetic acid (EDTA)   10  mM 
  RNAse A  100 µg/mL 
  in H2Odest; pH 8.0 
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Buffer-P2 
  NaOH  200  mM 
  sodium dodecyl sulfate 
  (SDS)  1  % (w/v) 
  in H2Odest; pH 8.0 
 
 
Buffer-P3 
  potassium acetate  3  M 
  in H2Odest; pH 5.5 
 
 
2.5.3  Agarose Gel Electrophoresis 
 
 
Charged DNA molecules with a different charge/mass proporption were 
separated by agarose gel electrophoresis. Gels consisted of 1 % (w/v) agarose 
in TAE buffer. Depending on gel size, a voltage of 80 - 100 V was applied. The 
negative charged DNA molecules migrate towards the anode with a different 
velocity depending on their size. Prior to loading, DNA samples were mixed with 
loading dye to facilitate loading and indicate the progress of the samples in the 
gel. GeneRulerTM DNA Ladder Mix or MassRulerTM DNA Ladder Mix (MBI 
Fermentas, St. Leon-Rot, Germany) were used as size standards according to 
manufacturer’s instructions. After electrophoresis gels were stained with 
ethidium bromide for 15 - 40 min. This dye is incorporated into DNA helices and 
under UV light it shows fluorescence at a wavelength of 312 nm. After staining 
the gels were rinsed with H2O and DNA was detected via its fluorescence due 
to incorporated ethidium bromide. If DNA fragments were to be extracted from 
the gel, extraction was carried out using the QIAquick Gel Extraction Kit 
(Qiagen, Hamburg, Germany) according to manufacturer’s instructions.  
 
 
TAE-buffer 
  Tris-acetate  40  mM 
  EDTA  1  mM 
  in H2Odest; pH 8.0 
 
 
5 x DNA loading dye 
  bromphenol blue     0.35  mM 
  xylen cyanol FF     0.45  mM 
  orange G     0.25  mM 
  sucrose  115  mM 
  in TAE-buffer 
 
 
Ethidium bromid  
  ethidium bromide    0.1  % (v/v) 
  in H2Odest 
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2.5.4  Site-Directed Mutagenesis of DNA 
 
 
Site-specific mutations can be inserted into the DNA sequence of a gene of 
interest whereby single amino acids in the corresponding protein are 
exchanged. In this work the QuikChange Site-directed Mutagenesis Kit (Qiagen, 
Hamburg, Germany) served for the development of several ALASRc variants. 
This method (Fig. 12) utilizes a dsDNA plasmid carrying the gene of interest 
and two synthetic oligonucleotide primers which contain the desired mutation 
(Tab. 6) and are complementary to opposite strands of the vector. In a 
polymerase chain reaction (PCR) with PfuTurbo DNA polymerase (Fermentas, 
St. Leon-Rot, Germany) or Phusion DNA polymerase (Finnzymes, Frankfurt am 
Main, Germany) a mutated plasmid is generated. The PCR reactions with the 
QuikChange Site-Directed Mutagenesis Kit were carried out according to 
manufacturer’s instruction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12: Site-Directed Mutagenesis. 
Overview of the QuikChange Site-Directed Mutagenesis method (modified from Stratagene 
Instruction Manual, 1998). Black line: parental DNA; blue line: mutated DNA; red cross: position 
of the desired mutation; blue cross: introduced mutation; blue arrow: mutagenic primer.  
A detailed description is given in the text.  
 
 
In a following step with the endonuclease DpnI which digests specifically 
partially methylated DNA, the parental template DNA is digested. After isolation 
of the newly synthesized unmethylated and mutated DNA plasmid, the DNA 
was transformed into the E. coli strains XL1Blue or DH10B. Here, a DNA ligase 
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closes the nicked DNA circles. DNA sequencing was used for the determination 
of all mutated genes. 
 
 
Tab. 6: Oligonucleotide primers used for site-directed mutagenesis of ALASRc. 
Only oligonucleotide primers in forward orientation are listed. The second oligonucleotide primer 
(reverse) always corresponds to the reverse complementary sequence. Conservative amino 
acid exchanges were highlighted in light pink. 
Mutant designation in ALASRc Sequence of oligonucleotide primer (forward) (5’3’) 
R21K CGAGGGACGTTACAAGACGTTCATCG 
R21E CGAGGGACGTTACGAGACGTTCATCG 
D47E GCGGCAAGCAGGAGATCACCGTCTG 
D47S GCGGCAAGCAGAGCATCACCGTCTG 
N54Q CTGGTGCGGCCAGGACTATCTGGGC 
N54D CTGGTGCGGCGACGACTATCTGGGC 
T83S GGTTCGGGCGGCAGCCGCAACATCTC 
T83L GGTTCGGGCGGCCTCCGCAACATCTC 
N85Q GCGGCACCCGCCAGATCTCGGGCAC 
N85F GCGGCACCCGCTTCATCTCGGGCAC 
I86L GCACCCGCAACCTCTCGGGCACCAC 
I86H GCACCCGCAACCACTCGGGCACCAC 
M309L CGCGCAACAGCTGCACGCGAAGG 
M309W CGCGCAACAGTGGCACGCGAAGG 
C52S ATCACCGTCTGGAGCGGCAACGACTAT 
C201S ATCAAGGAAATCTCCGACATCGCCGAT 
C400S CTCTGGGCGCGCTCTGCGTGATCGAGC 
T365C ATCAACTTCCCGTCGGTGCCGCGCGGC 
T365S ATCAACTTCCCGTGCGTGCCGCGCGGC 
 
 
2.5.5  Amplification of DNA Fragments by PCR 
 
 
2.5.5.1  Design and Synthesis of Oligonucleotide Primers 
 
 
Oligodeoxynucleotides are short single stranded DNA fragments which are also 
used as primers in PCR. There, they serve as a starting point for the 
polymerase by binding at complementary sequences of melted DNA. 
For amplification of the hemA and sucC genes of R. capsulatus oligonucleotide 
primers were designed with the aim of subsequent cloning into the pGEX-6P-1 
vector. Recognition sequences for restriction endonucleases were inserted via 
these primers at both ends of the gene. The orientation of the primer is given by 
the abbreviation ‘forw’ for forward, ‘rev’ for revers and recognition sequences 
were underlined. Oligonucleotide primers are outlined in Tab. 7 with recognition 
sequences of restriction underlined.  
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Tab. 7: Oligonucleotide primers used for the amplification of DNA fragments. 
The restriction sites for the amplification of hemA and sucC from the genomic DNA of  
R. capsulatus are marked thick and underlined in the respective primers. ‘Forw’ refers to 
forward primer and ‘rev’ to reverse primer. 
Primer Sequence of oligonucleotide primer (5’3’) Restriction site 
RcWTHemAforw CGCGGATCCGCGATGGACTACAATCTCGCG BamHI  
RcWTHemArev CCGCTCGAGCGGTCACGCACAGCGCGCCCA  XhoI  
RcSucforw CGGCCCGTCGACAAATGAACATCCACGAAT SalI  
RcSucrev CTCGCGGCCGCTTATCCCTTCACCGCTTTGAC NotI  
 
 
2.5.5.2  Polymerase Chain Reaction 
 
 
PCR serves as an in vitro amplification of a DNA molecule which is defined with 
two specific primers. The first step of PCR was an initial DNA denaturation step 
which was followed by a cycle of three steps: denaturation, primer annealing 
and primer elongation for 30 times. By continuous repetition of these three 
cycles the amount of the desired DNA fragment will be increased exponentially. 
The final step then was a terminating elongation. Denaturation and elongation 
temperatures of 95 °C and 72 °C, respectively, rema ined unchanged. In 
contrast, the annealing temperature depended on oligonucleotide length and 
the G+C content and was also influenced by the insertion of mismatches. The 
melting temperature (Tm) was calculated as following: 
 
 
Tm [°C] = 69.3 + 0.41 (% G+C) – 650/ n 
 
 
The G+C content of the primer is denoted by G+C in % while n represented the 
number of nucleotides. 
 
 
Phusion DNA polymerase (Finnzymes, Frankfurt am Main, Germany) was used 
for all reactions. According to manufacturer’s instructions the duration of 
elongation was chosen according to the length of the amplifying DNA fragment. 
 
Standard thermocycler program  
First denaturation 95 °C  5  min 
Denaturation  95 °C  1  min 
Primer hybridization  50 - 60 °C   30  s 
Elongation 71 °C   1 - 4  min 
Final elongation  71 °C   5 - 10  min 
    4 °C   ∞ 
 
 
 
 
 
 
30 x 
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2.5.5.3  Purification of PCR Products 
 
 
Agarose gel electrophoresis was used for quality control of the amplified DNA. 
By using this method an aliquot of the PCR reaction was loaded onto an 1 % 
agarose gel and after chromatography it could be detected under UV light  
(s. 2.5.3). If only one PCR product could be detected, the whole sample was 
purified with the QIAquick PCR Purification Kit (Qiagen, Hamburg, Germany). If 
more than one PCR product were detected, the DNA fragment of interest was 
excised from the gel and purified with the QIAquick Gel Extraction Kit (Qiagen, 
Hamburg, Germany). All kits were used according to manufacturer’s 
instructions. With this purification step polymerases, buffers and unbound 
nucleotides also can removed from the sample.  
 
 
2.5.6  Enzymatic Modification of DNA 
 
 
2.5.6.1  DNA Cleavage with Restriction Endonucleases 
 
 
Bacteria can accumulate the so called restriction endonucleases to protect 
themselves against external DNA. The class II endonucleases are the most 
occurring restriction enzymes. They recognize a palindromic arranged DNA 
sequence with four or eight nucleotides. The restriction reaction catalyzes the 
hydrolysis of two phosphordiester bonds inside the recognition sequence that 
leads to ‘blunt’ or ‘sticky’ ends. 
Restriction of DNA, vectors and PCR products, was carried out using restriction 
endonucleases purchased from New England BioLabs (Frankfurt am Main, 
Germany). According to manufacturer’s instruction reaction buffers, 
concentrations of enzymes, DNA and incubation temperature were selected as 
prescribed. The digestion was proceeded for 1 - 4 h and if it was possible 
enzymes were heat inactivated. 
 
 
2.5.6.2  Ligation 
 
 
The ligation reaction is the covalent connection between the free 5’-phosphate 
group of one DNA fragment with the free 3’-hydroxyl group of a second DNA 
fragment. Such a reaction is catalyzed by ligases (T4 DNA ligase; New England 
Biolabs, Frankfurt am Main, Germany). 
Before a ligation reaction could be performed the two DNA fragments (vector 
and insert) had to have compatible ends. Additionally, the 5’-phosphate groups 
of linearized vectors were removed to avoid re-circularization of digested vector 
DNA by adding 1 U/µg DNA of antarctic alkaline phosphatase (New England 
BioLabs, Frankfurt am Main, Germany). The mixture with digested vector and 
phosphatase was incubated at 37 °C for 30 min, foll owed by heat inactivation 
(15 min at 65 °C). After this step the two fragment s can covalently attach to 
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each other. The ligation reaction was performed for 2 h at 25 °C with 25 - 50 ng 
vector DNA and insert DNA in excess (insert to vector ratio with regard to molar 
concentrations was 10:1 or 5:1, respectively). After the incubation time it 
followed a transformation into the E. coli strain DH10β. 
Conditions and buffers were used according to manufacturer’s instructions. 
 
 
2.5.7  DNA Sequencing 
 
 
DNA sequences were obtained with an Abi Prism™ 310 Genetic Analyzer 
(Applied Biosystems, Darmstadt, Germany) in our laboratory. The required 
preparatory PCR with fluorescence-labeled ddNTPs (dideoxyribonucleotide 
triphosphates) and purification of the PCR product were carried out as 
described by manufacturer’s instruction. 
 
 
Standard PCR program 
  96 °C  1  min 
  96 °C  30  sec 
  50 °C  15  sec 
  60 °C  4  min 
      4 °C  ∞ 
 
 
Tab. 8: Oligonucleotide primers. 
Oligonucleotide primers used for sequencing. 
‘Forw’ refers to forward primer and ‘rev’ to reverse primer. 
primer Sequence of oligonucleotide primer (5’3’) application 
T7 Promoter TAATACGACTCACTATAGGG DNA sequencing of 
several vectors 
T7 Terminator CTAGTTATTGCTCAGCGGT DNA sequencing of 
several vectors 
 
 
2.6  Protein Biochemical Methods 
 
 
2.6.1  Production and Purification of Rhodobacter capsulatus 
Aminolevulinic Acid Synthase 
 
 
2.6.1.1  Cell Growth and Cell Disruption 
 
 
A total of 10 liters (20 x 500 mL) vapor sterilized LB medium containing  
100 µg/mL ampicillin and 34 µg/mL chloramphenicol in 1 L Erlenmeyer flasks 
were each inoculated with 5 mL of an overnight culture of E. coli BL21(DE3)RIL 
or BL21(DE3)pLysS, respectively, carrying pGEX-6P-1-Rc-A (pGEX-6P-1 
30 x 
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vector with the R. capsulatus wild-type hemA gene) and incubated under 
vigorous aeration at 37 °C. After cells reached an OD600 of 0.6 the expression of 
hemA was initiated by addition of IPTG (end concentration: 200 µM). The 
optimal growth temperature was 25 °C or 17 °C, resp ectively, for 22 h and  
180 rpm. Cells were harvested by centrifugation for 20 min at 3’000 x g and  
4 °C. The cell sediment was suspended in 15 - 40 mL  lysis buffer. Cells were 
disrupted using FastPrep®24 (MP Biomedicals, Illkirch, France) at 4 °C  
(three times for 45 sec). For this method 125 mg/mL Lysing Matrix B Bulk  
(MP Biomedicals, Illkirch, France) were added into a 2 mL reaction tube and 
filled up with suspended cell sediment. FastPrep®24 conditions were used 
according to manufacturer’s instructions. Cell debris and insoluble protein 
fractions were removed by centrifugation for 30 - 45 min at 4 °C and 14’000 x g. 
The resulting supernatant was loaded onto a glutathione sepharose column. 
 
 
Lysis buffer 
  Hepes, pH 7.5  20  mM 
  sodium chloride  200  mM 
  dithiothreitol (DTT) 10  mM 
  PLP   20  µM 
  Benzonase  20  µL 
  complete protease Inhibitor  1  tablet 
  in H2Odest 
 
 
2.6.1.2  Affinity Chromatography Using Glutathione Sepharose 
 
 
After harvesting cells were suspended in lysis buffer and subsequently broken 
by FastPrep®24 (s. 2.6.1.1). The cell-free extract was cleared by centrifugation 
at 14’000 x g for 30 min. An empty Econo-Pac Chromatography column (Bio-
Rad, Hercules, USA) was packed with 5 - 10 mL Glutathione SepharoseTM 4 
Fast Flow (GE Healthcare, Munich, Germany) and equilibrated with 25 - 50 mL 
of elution buffer. The cell-free extract was mixed with the column resin and 
incubated for 1 h under mild rotation conditions. The flow through was collected 
and the column was washed 6 times with 10 mL of elution buffer to remove 
unbound proteins and other cell debris. The next step was incubation with 
PreScisionTM Protease (GE Healthcare, Munich, Germany) for 48 hours to clip 
the GST-tag. Protein elution with 10 mL of elution buffer and regeneration of the 
columns with 60 - 100 mL of regeneration buffer were the last steps for protein 
purification. Proteins were analyzed by SDS-PAGE as described previously 
(Laemmli, 1970) with modifications by Righetti (Righetti, 1990). Protein 
concentrations were determined with the Bradford assay (Bradford, 1976) with 
BSA (bovine serum albumin) as standard. All concentrations are reported on 
the basis of a subunit molecular weight of 43’575 Da. If it was necessary protein 
containing fractions were pooled and concentrated by ultrafiltration. 
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Elution buffer 
  Hepes, pH 7.5  20  mM 
  sodium chloride  200  mM 
  DTT  10  mM 
  PLP   20  µM 
  in H2Odest; sterile filtrated and degased 
 
 
Regeneration buffer 
  Hepes, pH 7.5  20  mM 
  sodium chloride  200  mM 
  DTT   10  mM 
  PLP   20  µM 
  glutathione  10  mM  
  in H2Odest; sterile filtrated and degased 
 
 
2.6.1.3  Dialysis of Protein Solutions 
 
 
For removal of salt in protein solutions or for buffer alterations, samples were 
dialyzed. The dialysis tubes were boiled up for 5 min in H2Odest, chilled and 
washed with H2Odest prior to use. Subsequently, the sample was filled inside, the 
tube sealed and the dialysis was started under slight shaking at 4 °C overnight. 
After 24 h the buffer was changed against fresh buffer for 3 - 4 h. Before loading 
of the sample onto a chromatography column it was sterile filtrated and 
centrifuged at 5’000 x g for 15 - 30 min to remove precipitated protein. 
 
 
Dialysis buffer for ALASRc 
For MonoQ  
  Hepes, pH 7.5 20 mM 
  DTT 10 mM 
  PLP 20 µM 
  Mini Complete Protease  
  Inhibitor 1 tablet 
  in H2Odest 
 
 
For gel permeation chromatography 
  Hepes, pH 7.5 20 mM 
  sodium chloride 200 mM 
  DTT 10 mM 
  PLP 20 µM 
  in H2Odest 
 
 
2.6.1.4  Ion Exchange Column Chromatography (MonoQ) 
 
 
Anion exchange chromatography using MonoQ was performed as second 
purification step at RT. Pooled protein containing fractions were sterile filtrated 
and applied at a flow rate of 1 mL/min to a 1 mL MonoQ column equilibrated 
with buffer-A. To remove unbound proteins the column was washed with  
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7 column volumes of buffer-A. Bound proteins including recombinant ALASRc 
were eluted with 1 M NaCl in buffer-B. Fractions containing recombinant 
ALASRc were identified via SDS-PAGE-analysis, pooled and concentrated by 
ultrafiltration. 
 
 
Buffer-A 
  Hepes, pH 7.5 20 mM 
  DTT 10 mM 
  in H2Odest 
 
 
Buffer-B 
  Hepes, pH 7.5 20 mM 
  DTT 10 mM 
  sodium chloride 1 M 
  in H2Odest 
 
 
2.6.1.5  Gel Permeation Column Chromatography (Superdex-200) 
 
 
The matrices of a gel permeation chromatography (GPC) column consist of a 
porous material. Proteins with a higher size or hydronamic volume than the 
pores of the material cannot remain on the column and are eluted first, while 
smaller proteins can permeate the material and remain longer on the column. 
The GPC was used for the determination of the oligomerization state of ALASRc 
as well as for further protein purification. Before ALAS was loaded onto the 
GPC it was concentrated with a VIVASPIN 4 mL or 15 mL concentrator 
membrane. A 30 mL Superdex-200 HR 10/30 was equilibrated with GPC buffer. 
The column was calibrated using carbonic anhydrase (Mr = 29’000), bovine 
serum albumin (Mr = 66’000) and yeast alcohol dehydrogenase (Mr = 150’000) 
as marker proteins. One mg of these substances was dissolved in 1 mL of the 
GPC buffer and 100 µL of these suspensions were loaded onto the column. All 
proteins were chromatographed under identical conditions at a flow rate of  
0.5 mL/min. With the elution profiles the elution volume (Ve) of the proteins from 
the column could be determined. The natural logarithm of the molecular weight 
of the proteins (ln (MW)) was plotted against Ve divided with the ‘dead volume’ 
(V0) of the column. 
For purification of the protein elution was carried out in 100 - 500 µL fractions 
which were subsequently analyzed via SDS-PAGE, pooled and concentrated if 
necessary. For long-term storage 100 % glycerol were added with a final 
concentration of 10 % and samples were frozen at -80 °C. 
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Fig. 13 Calibration curve for GPC Superdex-200 for the determination of the 
oligomerization state of ALASRc. 
The natural logarithm of the molecular weight (ln (MW)) of the marker proteins is plotted against 
their elution volume (Ve) divided with the ’dead volume’ (V0) of the column. 
 
 
GPC buffer 
  Hepes, pH 7.5 20  mM 
  NaCl  200  mM 
  DTT 10 mM 
  PLP 20 µM 
  in H2Odest; sterile filtrated and degased 
 
 
2.6.2  Concentrating Protein Solutions 
 
 
The concentration of protein solutions was performed with the ultrafiltration 
membrane system VIVASPIN concentrator (Sartorius stedim biotech, 
Göttingen, Germany) with a start volume of 4 - 15 mL. All proteins with a 
molecular mass less than Mr = 10’000 could pass the membrane. Initially the 
membrane was equilibrated four times with the buffer in which the protein was 
dissolved. Finally, it was centrifuged at 4 °C and 2’500 - 3’000 rpm. 
 
 
2.6.3 Determination of Protein Concentrations 
 
 
In this work the Bradford Protein Assay Method (Bio-Rad, Munich, Germany) 
was used for the determination of protein concentrations. This is a photometric 
method that based on the formation of complexes of proteins and the dye 
Coomassie Brilliant Blue G-250. These complexes were formed in acidic 
solutions from the dye with the cationic as well as with the non-polar, 
hydrophobic side chains of the proteins. Due to the complex formation the 
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absorption maximum was shifted from 470 nm to 595 nm because the dye was 
stabilized here in its blue, non-protonated, anionic sulfate form. Furthermore, 
the extinction coefficient from the protein-dye-complex is higher than the 
coefficient from the free dye. An increase in absorption at 595 nm due to the 
complex formation could be measured with a high sensitivity against the free 
dye. Thus, the complex represented a mass for the protein concentration. 
BSA with a known concentration was used for the calibration curve. The 
resulting curve is shown in Fig. 14. The assays contained 1.5 mL Bradford 
reagent (Sigma-Aldrich, Munich, Germany) and 1 µL, 10 µL or 100 µL of the 
protein solution. After mixing and incubation for 25 min at RT the absorption at 
595 nm was measured against the reference (Bradford reagent only). The data 
were compared with the calibration curve and the protein concentration could 
be determined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: BSA calibration curve for the determination of protein concentrations. 
The used amount of BSA was plotted against the absorption at 595 nm after incubation with the 
Bradford reagent. 
 
 
2.6.4 Discontinuous SDS Polyacrylamide Gel Electrophoresis  
 
 
The cell sediment of a 1 mL cell culture was dissolved in H2Odest and in a 
corresponding amount of 2 x SDS-loading buffer (~ 20 - 240 µL) to mask the 
charge at the surface of the proteins which leads to a separation according to 
their size. To denature the proteins in the analytes they were heated for 5 min at 
95 °C in a thermomixer and then electrophoretically  separated in a 12 % SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) at 45 mA per gel. In the 
stacking gel (pH 6.8) a potential difference between the slow glycine ions 
(because they are predominantly uncharged) and the fast chloride ions is 
generated. When the proteins arrive at the resolving gel (pH 8.8) they are 
decelerated because of the little size of the pores. At this point the glycine ions 
pass the proteins. Due to the pH-shift in the resolving gel the glycine ions are 
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now completely charged and the field force in the gel is constant. Due to the 
change of the migration speed of the glycine ions, the proteins are concentrated 
in the gel matrix according to their denaturell molecular weight. Subsequently, 
the gel was stained with Instant Blue™ solution (Expedeon, Eching, Germany) 
in order to visualize the location of the analytes in the gel matrix. After an 
incubation time of 15 - 30 min on a shaker the gel was washed with water. 
Afterwards the gel was scanned and dried between two cellophane films. 
 
 
Molecular weight standard 
  Protein Molecular Weight Marker (Fermentas) 
 
 
SDS running gel (12 %) 
  acrylamide stock solution  2 mL 
  Tris-HCl (1.5 M)                   1.25  mL 
  H2Odest 1.75  mL 
  tetramethylen diamine 
  (TEMED) 5 µL 
  APS solution 50 µL 
  in H2Odest; pH 8.8 
 
 
SDS stacking gel (12 %) 
  acrylamide stock solution     0.5  mL 
  Tris-HCl (0.5 M)                   0.62  mL 
  H2Odest                                1.37  mL 
  TEMED                               2.5  µL 
  APS solution                       5  µL 
  in H2Odest; pH 6.8 
 
 
APS solution ammonium peroxodisulfate 10% (w/v) 
  in H2Odest  
 
 
Acrylamide stock solution Rotiphorese®Gel 30 (37.5:1)  (Roth) 
 
 
Electrophoresis buffer 
   glycine 380  mM 
  Tris-HCl 50 mM 
  SDS  0.1 % (w/v) 
  in H2Odest; pH 8.3 
 
 
SDS-loading dye 
  Tris-HCl 100  mM 
  glycerol  40 % (v/v) 
  β-mercaptoethanol  10 % (v/v) 
  SDS  3.2  % (w/v) 
  bromphenol blue  0.2  % (w/v) 
  in H2Odest; pH 6.8 
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Staining solution  
  InstantBlue™   (Expedeon) 
 
 
2.6.5 Western Blotting 
 
 
This method serves for the transfer of proteins onto a polyvinylidenfluoride 
(PVDF)-membrane. The membrane binds the proteins by polar interactions. 
The first step was PVDF-membrane activation in methanol for 15 min. 
Afterwards, the membrane as well as the SDS-gel and blotting paper were 
incubated in Towbin-buffer. The assembly in the blotting apparatus was the 
following: Cathode, blotting paper, PVDF-membrane, SDS-gel, blotting paper, 
anode (Fig. 15). Proteins were blotted onto the membrane for 30 - 45 min at  
15 V according to manufacturer’s instruction. Non-specific binding sites of the 
membrane were saturated in blocking solution for 1 h at 4 °C under slight 
shaking. Proteins immobilized on a PVDF-membrane were specifically detected 
by antibodies. Primary antibodies were directed against the GST- or other tags 
while the secondary antibodies were directed against the primary antibody and 
were coupled to an alkaline phosphatase. Incubation with the first antibody was 
carried out in blocking solution for 1 h at RT and slight shaking. Three washing 
steps followed, 10 min for each with washing buffer. After incubation with the 
second antibody for 45 min and four additional washing steps with PBS/Tween 
buffer (10 min each), membranes were incubated for 5 min in alkaline 
phosphatase buffer and exposed to staining solution until bands became visible. 
During exposure alkaline phosphatase, the enzyme bound to the secondary 
antibody, catalyzes the reaction of 5-bromo-4-chloro-3-indolylphosphate (BCIP) 
with nitroblue-tetrazolium (NBT). Fig. 15 shows a schematic representation of 
the Western blotting assembly. 
 
 
 
 
 
 
 
Fig. 15: Schematic representation of a Western blotting apparatus. 
 
 
Towbin-buffer 
 Tris-HCl  25  mM 
 glycine   192  M 
 methanol  10 % (v/v) 
 in H2Odest; pH 8.5 
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10 x Phosphate-buffered saline (PBS) 
 NaCl    1.37 M 
 KCl  27  mM 
 Na2HPO4  100  mM 
 KH2PO4  20  mM 
 in H2Odest 
 
 
Blocking solution 
 skim milk powder    5  % (w/v) 
 Tween20       0.1  % (v/v) 
 10 x PBS      10  % (v/v) 
 in H2Odest 
 
 
Washing solution 
 skim milk powder     0.5  % (w/v) 
 Tween20         0.1  % (v/v) 
 10 x PBS  10  % (v/v) 
 in H2Odest 
 
 
PBS/Tween buffer 
 10 x PBS   10  % (v/v) 
 Tween20           0.1  % (v/v) 
 in H2Odest 
 
 
Alkaline phosphatase buffer 
 Tris-HCl 100 mM 
 NaCl 100 mM 
 MgCl2 5 mM 
 in H2Odest; pH 9.5 
 
 
Staining solution 
 NBT solution    0.33 % (v/v) 
 BCIP solution    0.33 %(v/v) 
 in alkaline phosphatase buffer 
 
 
NBT solution 
 nitroblue-tetrazolium 10 % (w/v) 
 dimethylenformamide  
 (DMF) 70 % (v/v) 
 in H2Odest 
 
 
BCIP solution 
 5-brom-4-chloro- 
 3-indolylphosphate 5 % (w/v) 
 in DMF solution 
 
 
Antibodies 
  Anti-Glutathione-S-Transferase  
  (Rabbit-anti-GST)  1:2000 
  Anti-Rabbit IgG, Alkaline  
  Phosphatase Conjugated  1:5000 
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2.7  Determination of ALAS Activity 
 
 
The enzyme activity assay was performed as described previously (Hunter and 
Ferreira, 1995). In this assay the enzyme concentration ranged from  
0.2 - 2 µM in a total volume of 200 µL. Data were taped using a Jasco V-550 
UV/VIS spectrophotometer (Jasco®, Gross-Umstadt, Germany) and analyzed 
with SigmaPlot11 software (Systat, Erkrath, Germany). 
 
 
2.7.1  Determination of Kinetic Parameters of ALAS 
 
 
2.7.1.1  Steady State Kinetics 
 
 
ALAS activity was determined on a Shimadzu UV2100 UV/VIS dual beam 
spectrophotometer in Florida, Tampa, USA in a coupled enzyme assay: the 
production of CoA (Equation (3)) was coupled to the reduction of nictotinamide 
adenine dinucleotide (NAD+, Equation (4)). Experiments were carried out at  
30 °C in a total volume of 150 µL over a time perio d of 5 min. The reaction 
mixture contained reaction buffer, ALAS, glycine and succinyl-CoA. The 
coupling enzyme, α-ketoglutarate dehydrogenase (α-KGD), was added directly 
to the assay as supplied by Sigma (St. Louis, MO, USA and Munich, Germany, 
respectively). The amount of NADH was analyzed by measuring the 
absorbance at 340 nm with an extinction coefficient of ɛ340 = 6’560 M1 x cm-1 
(Hunter and Ferreira, 1995). For the determination of the kinetic parameters KM, 
kcat and the ‘real’ vmax, the concentrations of the substrates were varied  
(in matrices of five glycine and five succinyl-CoA concentrations). The observed 
rates were fitted to the Michaelis-Menten equation using the nonlinear 
regression analysis software program SigmaPlot (SigmaPlot11, Systat Software 
Inc., Erkrath, Germany).  
 
 
                  glycine + succinyl-CoA            ALA + CoASH + CO2                       (2) 
 
 
   CoASH + NAD+ + α-ketoglutarate             succinyl-CoA + NADH + CO2       (3) 
 
Equation 2 and 3: Coupled enzyme reaction of ALAS and α-KGD. 
Equation (2) describes the reaction catalyzed by ALAS. It catalyzes the condensation of the 
amino acid glycine and succinyl-CoA with the products ALA, carbon dioxide and CoA.  
Equation (3) describes the ALAS-coupled α-KGD reaction with CoA, NAD+ and α-ketoglutarate 
as educts as well as succinyl-CoA, NADH and carbon dioxide as products.  
 
 
The reduction of NAD+ to NADH is stoichiometric with ALA formation and 
succinyl-CoA was generated by α-KGD. The NADH concentration can be 
quantified via the Beer-Lambert law (Equation (4)): 
 
ALAS 
α-KGD 
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                                                                                               (4) 
 
Equation 4: Beer-Lambert law. 
The Beer-Lambert law relates the absorption of light to the properties of the material through 
which the light is traveling. It is useful for the determination of unknown concentrations in a 
solution. A: absorption; ε: extinction coefficient of NADH [M1cm-1]; b: cell diameter [cm];  
c: concentration of NADH [M]. 
 
 
Kinetic parameters were calculated as follows: 
 
 
                                                            (5) 
 
Equation 5: Calculation of the ‘real’ vmax. 
For the calculation of the ‘real’ vmax both vmax values for succinyl-CoA and glycine have to be 
determined. vmax = maximal velocity; c = concentration of NADH [M1cm-1]. 
 
For the calculation of the turnover number kcat, the ‘real’ maximal velocity vmax 
was divided by the corresponding enzyme concentration (Equation (6)). 
 
 
                                                                                                            (6) 
 
Equation 6: Calculation of the turnover number kcat. 
For the calculation of the turnover number kcat the maximal velocity has to be divided by the 
enzyme concentration used in the assay. vmax = maximal velocity; [E] = enzyme concentration 
used in the assay [µM]; kcat = catalytic constant [s-1]. 
 
KM describes the substrate concentration where the rate of turnover is half of 
vmax. It is an approximation of the affinity of the enzyme for its substrate based 
on the rate constants within the reaction. A high KM value denotes that the 
enzyme is half-saturated at high substrate levels; its substrate affinity is low. 
Contrary, a low KM implies that the enzyme needs low levels of substrate to be 
half-saturated; its substrate affinity is high. The kcat is the rate constant of a first 
order enzyme kinetic with its unit s-1. It correlates to the amount of substrate 
molecules which are converted into product by one enzyme molecule per 
second. With the knowledge of the KM and kcat values the constante kcat/KM was 
calculated. The kcat/KM is the rate constant of second order (s-1 * M-1) and 
describes the catalytic efficiency or specificity of the enzyme if more than one 
substrate is available. The factor kcat/KM cannot be higher than k1 which is the 
rate constant for the formation of the enzyme-substrate-complex. This denotes 
that the decay of the enzyme-substrate-complex cannot occur more often than 
enzyme and substrate collide with each other. The kcat/KM is used to measure 
enzyme’s substrate preference or its catalytic efficiency. The higher the kcat/KM 
ratio, the better the enzyme catalyzes the substrate conversion and the more 
efficient the enzyme works. Using the software SigmaPlot11 the rates of each 
reaction [mAbs/min] were plotted against the consumed glycine [mM] and 
succinyl-CoA [µM] concentrations, respectively, resulting in secondary plots for 
glycine and succinyl-CoA. The KM values for both substrates resulted from 
these secondary plots as well as their vmax values.  
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Reaction buffer 
  Hepes 20 mM 
  magnesium chloride 3 mM 
  α-ketoglutaric acid  
  sodium salt 1 mM 
  nicotinamid adenine 
  dinucleotide (NAD+) 1 mM 
  thyamine pyrophosphate 
  (TPP)                                  0.25 mM 
  in H2Odest; pH 7.5 
 
 
ALAS solution 
  ALAS                                   0.2-2 µM 
 
 
Glycine solution 
  glycine  1 M 
  in H2Odest 
 
 
Succinyl-CoA solution 
  succinyl-CoA  1 mM 
  in H2Odest 
 
 
2.7.1.2  Single Turnover Reactions 
 
 
ALAS catalysis to synthesize ALA is a multiple-step catalytic conversion 
(‘Introduction’, Fig. 7). In order to monitor single turnover reactions transient 
kinetic analyses were performed. Aim of these single turnover reactions is to 
have ALAS performs only one catalytic half cycle, i.e. each ALAS binds to one 
glycine molecule. This is achieved by using higher enzyme concentrations than 
the substrate concentration of succinyl-CoA.  
Rapid scanning stopped flow measurements were performed under aerobic 
conditions by using an OLIS model RSM-1000 stopped-flow spectrophotometer 
(On-line Instrument Systems Inc., Bogart, USA). This instrument has a dead 
time of approximately 2 ms and an observation chamber path length of 4 mm. 
Spectral scans, covering a wavelength range of 200 - 600 nm, were collected at 
a rate of 1’000 scans/sec and then averaged to 62 scans/sec reducing time 
course data files to an appropriate size for global fit analyses. Stopped flow 
experiments were carried out at 30 °C with an exter nal water bath to maintain a 
constant temperature. 
The stopped-flow was useful for those experiments because the reactants could 
be rapidly mixed in a small volume. The mixing solutions flow into an 
observation cell while the previous contents are flushed and replaced with 
freshly mixed reactants. A stop syringe is used to limit the volume of solution 
expended with each measurement (Fig. 16). 
Syringe one contained the enzyme (127 – 442 µM) and a high concentration of 
the first substrate glycine (30 mM). The second syringe was filled with the 
second substrate, succinyl-CoA (60 µM), in a lower concentration than glycine 
and buffer-A. Both syringes contained a total volume of 1 mL. The 
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concentrations of reactants loaded into both syringes are in each experiment 
two-fold greater than in the reaction cell. The final concentrations of the 
reactants for the ALASRc-catalyzed reactions were: 63.5 – 220.7 µM bacterial 
ALAS, 15 mM glycine and 30 µM succinyl-CoA. Fluorescence at 510 nm 
resulting from formation of the second quinonoid was recorded via excitation at 
400 nm and emission measurement above 500 nm. Time courses were 
analyzed with the decomposition software (SIFIT) provided by OLIS. 
 
 
 
Equation 7: Fitting equation for time courses at wavelengths of interest (Hunter and 
Ferreira, 1999). 
Time courses at wavelengths of interest were analyzed by fitting to equations for one to three 
exponentials. At = Absorbance at time t; a = amplitude of each phase; k = observed rate 
constant for each phase; c = final absorbance.  
 
 
Single turnover reactions were evaluated using a three-step mechanism as 
described in Equation (8).  
 
 
                                     A          B          C          D                                              (8) 
Equation 8: Visualization of a three step reaction mechanism with its educt, product and 
intermediates. 
A three step mechanism starts with an educt (A) followed by two intermediates (B and C) and 
ended with a product (D). The observed rates are described by k1obs, k2obs and k3obs. 
 
 
Buffer-A 
   N-(1,1-Dimethyl-2- 
   hydroxyethyl)-3-amino-2- 
   hydroxypropanesulfonic  
   acid (AMPSO) 100  mM 
   in H2Odest; pH 9.5 
 
 
Glycine solution 
  glycine 1 M 
  in H2Odest  
 
 
Succinyl-CoA solution 
  succinyl-CoA  1 mM 
  in H2Odest 
 
 
ALAS solution 
  ALAS                            > 60 µM 
 
 
k1obs k2obs k3obs 
(7) 
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Fig. 16 shows a schematic representation of a stopped-flow apparatus used for 
these measurements.  
 
 
 
Fig. 16: Schematic representation of a stopped flow apparatus. 
The syringes A and B contain the different solutions, here: the enzyme-glycine mixture in one 
syringe and the succinyl-CoA buffer mixture in the other one. By pushing both syringes at the 
same time, a defined volume of both solutions flow into a mixer and thus into the observation 
cell. The volume in this chamber is regulated by the stop syringe. The excitation is given by an 
UV-lamp and the fluorescence of the reacting solution could be observed in dependency on 
time. 
 
 
2.7.2  Substrate Specificity 
 
 
Substrate specificity determinations were carried out at 30 °C. The experimental 
set-up was similar as for the steady state kinetics (2.7.1.1). The difference was 
the utilization of other amino acids than glycine, but with the physiological 
second substrate succinyl-CoA. In a further approach glycine served as first 
substrate, but different acyl-CoA derivatives were used as second substrate. 
 
 
Amino acid solutions 
   D-alanine 1 M 
   L-alanine 1 M 
   L-cysteine 1 M 
   L-threonine                          0.5 M 
   L-serine 1 M 
 
 
Acyl-CoA solutions 
  succinyl-CoA   0.1 mM 
  octanoyl-CoA  0.1 mM 
  butyryl-CoA  0.1 mM 
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2.7.3  Quinonoid Formation 
 
 
Experiments for detection of the second quinonoid in absorbance mode were 
carried out at 30 °C at a wavelength range from 650  to 200 nm in a total volume 
of 150 µL. Twenty µM enyzme was mixed with AMPSO-buffers with a pH of 7.5 
or a pH of 9.5, respectively. ALA had to be neutralized with the same amount of 
sodium hydroxide (NaOH) solution before starting the reaction by adding 5 mM 
ALA (Sigma, Hamburg, Germany). A Shimadzu spectrophotometer served for 
data collection. Data were evaluated with SigmaPlot11 software (Systat, 
Erkrath, Germany). 
 
 
AMPSO-buffer 
   AMPSO 100 mM 
  in H2Odest; pH 7.5 and pH 9.5 
 
 
NAOH solution 
  NaOH 100 mM 
  in H2Odest 
 
 
ALA solution 
  ALA  100 mM 
  In H2Odest 
 
 
2.7.4  Reaction of ALAS with Glycine-methylester and O-methylglycine 
 
 
Identification of the 2-amino-3-beta-ketoadipate intermediate results from the 
reaction of ALAS with glycine-methylester and succinyl-CoA as described for 
AONS (Kerbarh et al., 2006). In this reaction the reactive β-ketoacid PLP-
aldimine will be trapped in the enzyme-bound form so it cannot undergo 
decarboxylation and thus will accumulate. The chemical nature of the putative 
β-ketoacid-methylester-aldimine intermediate is determined by reducing the 
unstable imine bond with sodium cyanoborohydride. Subsequently, the products 
were analyzed by electrospray mass spectrometry (Kerbarh et al., 2006). These 
experiments were performed with the ALASRc-N54 mutant enzymes as well as 
with the mouse ALAS2-N119 mutant in Florida by Greg Hunter (Prof. Dr. Gloria 
C. Ferreira’s laboratory, Tampa, University of South Florida, Florida, USA). For 
the detection of the first quinonoid O-methylglycine was used as 
pseudosubstrate instead of glycine. The generated methylester of the  
β-ketoacid-aldimine complex does not decarboxylate to afford the second 
quinonoid intermediate. Similar to the reaction of the ALAS-glycine complex with 
succinyl-CoA (2.7.1.1), the kinetic trace for the reaction of the  
ALAS-O-methylglycine complex with succinyl-CoA was best described by a 
three-step process. These experiments also were performed with the  
ALASRc-N54 mutant enzymes as well as with the mouse ALAS2-N119 mutant in 
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Florida by Greg Hunter (Prof. Dr. Gloria C. Ferreira’s laboratory, Tampa, 
University of South Florida, Florida, USA). 
 
 
2.7.5 Glycine Binding Experiments 
 
 
The ALAS shows a characteristical peak at 420 nm. If glycine is bound changes 
in this absorption peak were observable. Glycine binding experiments were 
carried out at 30 °C at a wavelength range from 650  to 200 nm in a total volume 
of 150 µL. Twenty µM enyzme was mixed with AMPSO-buffer, pH 9.5. After a 
spectrum of enzyme only was taken, 5 mM glycine was added and a new 
spectrum was recorded. A Shimadzu served for data collection. Data were 
evaluated with SigmaPlot11 software (Systat, Erkrath, Germany). 
 
 
AMPSO-buffer 
   AMPSO 100 mM 
  in H2Odest; pH 9.5 
 
 
Glycine solution 
  glycine 100 mM 
  in H2Odest 
 
 
2.7.6 Dynamic Loop Experiments 
 
 
In the ALASRc crystal structure two different conformations were observed, an 
open and a closed conformation. The open enzyme conformation differs from 
the closed one in two areas located between amino acids 358 - 374 and  
332 - 348 (Astner, 2007). The closed conformation is comparable to the 
product-bound structure of AONS. In dynamic loop experiments carried out in 
Tampa, Florida, USA (Ferreira and coworkers) the movement of the dynamic 
loop should be analyzed. For this purpose, a cysteine-free ALASRc-T365C 
mutant (correspond to the murine T430 residue) was labelled on the cysteine 
with a fluorophore for studying the kinetics of the change from open to closed 
conformation (data not shown; still in progress). 
 
 
2.8  Crystallization of Rhodobacter capsulatus Aminolevulinic Acid 
Synthase 
 
 
The holo form of the ALASRc was crystallized and the X-ray crystal structure 
was solved at 2.1 Ǻ resolution (Astner et al., 2005) as well as enzyme-substrate 
complexes with glycine and succinyl-CoA, respectively. 
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2.8.1  Crystallization Conditions 
 
 
For the crystallization of purified ALASRc the vapour diffusion method was 
applied allowing a slow and controlled growth of protein crystals. Crystallization 
experiments with cysteine-less wild-type ALASRc and the ALASRc mutant 
variants N54D and N54Q were carried out under aerobic and anaerobic 
conditions at 17 °C. An MACS MG 1000 anaerobic work station was used for 
anaerobic attempts (Don Whitley Scientific, Lähden-Holte, Germany). A variety 
of buffers, precipitants and salts were used, provided from Qiagen (Hilden, 
Germany) within 96-well sitting drop CrystalClear strip racks (Greiner bio-one, 
Frickenhausen, Germany) with 100 µL reservoir solution. For enzyme-substrate 
attempts 1 µL reservoir and 2.3 µL enzyme-substrate-mix were used while for 
enzyme approaches 1.5 µL reservoir and 1.5 µL enzyme-DTT solution were 
used. An enzyme concentration between 115 µM and 230 µM (5 - 10 mg/mL) 
was used in each assay. Furthermore, crystallization experiments were carried 
out with enzyme only, but also with both substrates. For both substrates 1 µM 
stock solutions were prepared, in the assay they had a final concentration 
between 0.1 µM and 0.25 µM. Additionally, a 70 mM stock solution of DTT was 
prepared and added to each enzyme or enzyme-substrate-mixture right prior to 
usage in the crystallization experiments. The final DTT concentration for all 
crystallization approaches were 0.15 mM. For each variant and the wild-type 
ALASRc we conducted three 96-well plates with enzyme only as well as with an 
enzyme-substrate-mixture under aerobic and anaerobic conditions with four 
different crystal screens (Qiagen, Tab. 2). A total of approximately fourty 96-well 
plates were prepared.  
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3 RESULTS AND DISCUSSION 
 
Based on the solved crystal structure of ALASRc and previous biophysical 
investigation the question for the formation of a potential 2-amino-3-ketoadipate 
intermediate in ALAS catalysis, the recognition of the succinyl-CoA and glycine 
substrates, and finally the molecular basis of ALAS-βSCS interaction were 
investigated.  
For this purpose amino acid residues potentially involved in these processes 
were exchanged in ALASRc. Mutant enzymes were recombinantly produced, 
purified and subjected to advanced steady state kinetic and single turnover 
analyses. Selected ALASRc variants were employed in substrate specificity 
assays and crystallization attempts. 
 
3.1  Rationale for Amino Acid Exchanges in ALASRc for the 
Demonstration of the 2-amino-3-ketoadipate Intermediate 
 
In the ALAS reaction mechanism three different reaction intermediates occur. 
The first and the third one are quinonoids (first and second quinonoid) while the 
second one is a potential ketoadipate (2-amino-3-ketoadipate). The ALAS 
reaction is fast, so that only the second quinonoid is spectroscopically 
detectable. ALASRc-N54 corresponds to the N119 residue of the mouse ALAS2 
enzyme and to N197 of the human ALAS2. Hunter and coworkers (Hunter et al., 
2007) suggested that the N119 residue of murine ALAS2 plays an important 
role in stabilizing or destabilizing the potential 2-amino-3-ketoadipate 
intermediate. The β-ketoadipate was modeled into a murine ALAS2 active site 
model with the conservation of the hydrogen bond interactions found for the 
succinyl-CoA. The found arrangement of hydrogen bonds in this model was 
similar to that observed for the product-bound structure of the homologous 
enzyme AONS (Alexeev et al., 1998) as well as with the product-bound crystal 
structure of ALASRc (Astner et al., 2005). Based on the relative orientation of the 
nitrogen and oxygen atoms of the murine ALAS2-N119 side chain amide, which 
is typically ambiguous in crystal structures (Word et al., 1999; McDonald and 
Thornton, 1995), it was proposed that the murine ALAS2 residue N119 and 
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analogously the ALASRc-N54 either stabilize or destabilize the 2-amino-3-
ketoadipate intermediate. With the ALASRc-N54 variant we intended to prove 
this assumption by performing the ALASRc reaction with glycine-methylester, a 
glycine analog. The ALAS is able to bind but not catalyze this molecule as 
substrate. The reaction mechanism should pause at the step of the 2-amino-3-
ketoadipate intermediate and thus prove its formation.  
 
Furthermore, special consideration was given to the cysteine residues of 
ALASRc, because these amino acids are known to hinder crystallization 
procedures by intermolecular disulfide bridge formation and by their reaction 
with molecular oxygen. C400 is a residue at the surface of the protein and 
located at the C-terminal domain of the ALASRc enzyme and possibly 
responsible for the oxidation sensibility. The residues C52 and C201 are not 
surface exposed. It was suggested that an amino acid exchange of either of 
these both residues affects protein folding and results in an inactive or instable 
protein (Astner, 2007). Therefore, ALASRc variants were produced in which the 
cysteines 400, 201 and 52 were exchanged to serines. Additionally, in two of 
the cysteine-free ALASRc variants the N54 residue was exchanged to aspartic 
acid and glutamine for trapping the 2-amino-3-ketoadipate during crystallization. 
 
3.2  Substrate Recognition and Coordination in ALASRc 
 
3.2.1  Rationale of Amino Acid Exchanges in ALASRc for Functional 
Investigation of Substrate Recognition 
 
Several residues are responsible for a correct substrate recognition and 
coordination in the ALAS active site. The succinyl-CoA carboxylate group is 
coordinated via a salt bridge in the ALASRc crystal structure by the R21 residue 
(‘Introduction’, Fig. 8). Further stabilization is due to two hydrogen bonds to T83 
and N85 as well as van der Waals interactions with I86. The result of the tight 
binding of the succinyl-CoA carboxylate group is suggested to be responsible 
for the slow release of the resulting product ALA. This step is the rate-limiting 
one in ALAS catalysis (Hunter and Ferreira, 1999). By performing ALASRc 
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reactions with substrate analogs we wanted to verify the influence of the 
selected residues on substrate recognition and coordination. Furthermore, the 
hypothesis that the ALA release is the rate-limiting step in ALAS catalysis 
should be analyzed by the characterization of ALASRc carrying these mutated 
residues. 
 
3.2.2  Rationale for Amino Acid Exchanges in ALASRc for the 
Investigation of Enzyme Dynamics during Substrate Recognition 
 
During ALAS catalysis the enzyme undergoes a conformational change due to 
substrate binding and active site loop movement. Ferreira and coworkers 
assume that the major conformational change between the open and closed 
form of the enzyme occurs at the ‘active site loop’ with T365 (T430 in murine 
ALAS2) at its tip (Lendrihas et al., 2010). Furthermore, T365 bridges the 
carboxyl acid moiety of succinyl-CoA and the side chain of R21 to complete a 
hydrogen bonding triad. Thus, the substrate entry into the active site seems to 
be defined by the chemical characteristics of the acyl-tail of succinyl-CoA. In 
‘loop dynamic’ experiments we wanted to clarify the role of the T365 residue in 
the outlined processes using a fluorescent-tag labeled ALASRc-T365 cysteine-
free mutant enzyme. For the investigation of these assumptions we collaborated 
with Prof. Dr. Gloria C. Ferreira’s laboratory in Tampa, Florida, USA.  
Two ALASRc-T365 cysteine-free variants were generated in the framework of 
this thesis and purified proteins were sent to Tampa, Florida, USA (T365S-
C52S-C201S-C400S; T365C-C52S-C201S-C400S). Ferreira and coworkers 
performed the fluorescent labeling and the ‘loop dynamic’ experiments by 
studying the enzyme kinetics for the time from the open to the closed 
conformations. With the achieved results we wanted to get a more detailed look 
in the conformational change of ALAS due to substrate binding.  
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3.3  Rationale for Amino Acid Exchanges in ALASRc for the 
Investigation of ALAS-βSCS Interaction 
 
The ALASRc-D47 and M309 (correspond to D190 and R452 in human ALAS2) 
residues are positioned at the surface of the protein. In humans they play a role 
in interaction with the β-subunit of SCS. Previously, Furuyama and coworkers 
(Furuyama and Sassa, 2000) characterized a D190V variant for the human 
ALAS2 enzyme. This mutation led to a modification of the solvent exposed 
surface of the ALAS2 and seemed to be responsible for decreased protein 
stability while enzyme activity was not affected. The decreased protein stability 
of this ALAS2 variant is currently subject of discussion for the cause of the 
outbreak of XLSA disease. However, treatment of patients with pyridoxine did 
not mitigate the disease. Currently, it is speculated about a disturbed protein-
protein interaction to another protein of importance. With the generation of the 
both ALASRc variants ALASRc-D47 and -M309, we performed interaction studies 
with βSCS of R. capsulatus (βSCSRc) to give evidence for the involved residues 
of the interaction with this enzyme. For the ALASRc-D47 and -M309 variants 
carrying conservative amino acid exchanges we expected to yield enzymes 
where the interaction with βSCSRc is not affected. In contrast in ALASRc with 
non-conservative amino acid exchanges the interaction of both enzymes should 
be interrupted. With the results of these experiments we are able to understand 
the influence of D47 and M309 on the interaction with βSCS and in triggering 
XLSA in humans.  
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Tab. 9: Generated ALASRc variants. 
Listed are the different generated ALASRc variants. For each residue of interest one 
conservative and one non-conservative amino acid exchange were generated.  
Conservative amino acid exchanges were highlighted in light pink. 
residue 
conservative 
amino acid 
exchange 
non-
conservative 
amino acid 
exchange 
interaction with/ 
responsible for 
N54 N54Q N54D 
stabilize/destabilize 2-amino-3-
ketoadipate intermediate 
    
C52-C201-C400 
 
C52S-C201S-C400S 
 
- 
 
C400: oxidization sensitivity 
C52/C201: protein folding 
N54-C52-C201-C400 
 
 
 
N54D-C52S-C201S-
C400S 
 
 
N54Q-C52S-
C201S-C400S 
 
 
stabilize/destabilize 2-amino-3-
ketoadipate intermediate;  
C400: oxidization sensitivity 
C52/C201: protein folding 
    
R21 R21K R21E succinyl-Coenzyme A carboxylate 
    
T83 T83S T83L succinyl-Coenzyme A carboxylate 
    
N85 N85Q N85F succinyl-Coenzyme A carboxylate 
    
I86 I86L I86H succinyl-Coenzyme A carboxylate 
    
T365-C52-C201-
C400 
T365S-C52S-C201S-
C400S - 
involved in change of enzyme 
conformation during catalysis.  
    
 
T365C-C52S-C201S-
C400S - 
involved in change of enzyme 
conformation during catalysis.  
    
D47 D47E D47S succinyl-Coenzyme A synthetase 
    
M309 M309L M309W succinyl-Coenzyme A synthetase 
 
3.4  Production and Purification of Recombinant Wild-type ALASRc 
 
3.4.1  Construction of an Expression Vector for Wild-type ALASRc 
 
First, the R. capsulatus hemA gene was amplified via PCR and cloned into the 
expression vector pGEX-6P-1. Consequently, all proteins were produced as 
fusion proteins with an N-terminal GST-tag. The genomic DNA of R. capsulatus 
for amplification of the hemA gene was received from the DSMZ (‘Deutsche 
Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig-
Stöckheim, Germany). Oligonucleotide primers for hemA amplification 
contained BamHI and XhoI restriction sites for cloning purposes.  
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3.4.2 Production of Recombinant Wild-type ALASRc 
 
To analyze the best protein production host several different E. coli strains were 
tested. Therefore, the wild-type ALASRc expression vector pRc-A was 
transformed into the selected E. coli strains. Recombinant protein production 
studies revealed best results in BL21(DE3)pLysS at 25 °C after 20 h after gene 
induction with 200 µM IPTG. Cell free extracts were separated via SDS-PAGE. 
Fig. 17 shows an SDS gel with the results from recombinant protein production 
experiments for wild-type ALASRc. 
 
 
           
 
 
The observed dominant protein with a relative molecular mass of approximately 
Mr = 66’000 (Fig. 17, lane 6 - 8) was in good agreement with the calculated 
molecular mass of the ALAS-GST-tag-fusion protein of Mr = 68’575. 
 
3.4.3 Detection of Recombinantly Produced Wild-type ALASRc via 
Western Blotting 
 
To test whether the dominant protein visible in the SDS gel (Fig. 17, lane 6 - 8) 
with a relative molecular mass of approximately Mr = 66’000 really was the wild-
type ALASRc, we performed protein detection via Western Blotting (‘Material and 
Methods’, 2.6.5). For this approach we used several protein samples of a test 
Fig. 17: Recombinant wild-
type ALASRc production 
studies. 
Cell free extracts were loaded 
onto a 12 % SDS-PAGE. 
Proteins were separated and 
afterwards visualized by staining 
with InstantBlueTM. The SDS-
PAGE shows recombinant 
protein production of pRc-A in 
BL21(DE3)pLysS at 25 °C.  
Lane 1: before induction of gene 
expression using IPTG; lane 2: 
1 h after induction; lane 3: 2 h 
after induction; lane 4: molecular 
weight marker; lane 5: 3 h after 
induction; lane 6: 4 h after 
induction; lane 7: 5 h after 
induction; lane 8: 20 h after 
induction. 
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protein production of two different R. capsulatus wild-type hemA clones in two 
E. coli strains, BL21(DE3)RIL and BL21(DE3)pLysS, which were cultivated at 
three different temperatures. 
 
 
 
 
 
 
 
 
 
 
Fig. 18: Detection of wild-type ALASRc via Western Blotting. 
PVDF-membrane with blotted proteins from E. coli cell free extracts were incubated with anti-
GST antibodies. Visualization was via the alkaline phosphate catalyzed reaction of 5-bromo-4-
chloro-3-indolylphosphate (BCIP) with nitroblue-tetrazolium (NBT). A dominant protein band 
with a relative molecular mass of approximately Mr = 65’000 became visible.  
Lane 1: molecular weight marker; lane 2: positive control (T. elongatus uroporphyrinogen III 
synthase-GST-fusion protein); lane 3: hemA-clone-2 in BL21(DE3)RIL, 37 °C, 5 h after 
induction of gene expression; lane 4: hemA-clone-2 in BL21(DE3)pLysS, 37 °C, before 
induction; lane 5: hemA-clone-2 in BL21(DE3)pLysS, 37 °C, 5 h after induct ion; lane 6: hemA-
clone-2 in BL21(DE3)RIL, 25 °C, 5 h after induction ; lane 7: hemA-clone-11 in 
BL21(DE3)pLysS, 25 °C, 5 h after induction; lane 8:  hemA-clone-2 in BL21(DE3)RIL, 17 °C,  
20 h after induction; lane 9: hemA-clone-11 in BL21(DE3)pLysS, 17 °C, 20 h after indu ction. 
 
The results of the Western Blot analysis (Fig. 18) verified that the dominant 
protein with a relative molecular mass of Mr = 66’000 of the test protein 
production (Fig. 17) was the induced wild-type ALASRc, in this case produced as 
GST-fusion protein. 
 
3.4.4 Purification of Recombinant Wild-type ALASRc 
 
Recombinant wild-type ALASRc was produced as GST-fusion-protein with an  
N-terminal GST-tag. Resulting protein was purified to apparent homogeneity by 
column chromatography with Econo-Pac columns containing glutathione 
sepharose at 4 °C. After chromatography as describe d in ‘Material and 
Methods’ (2.6.1.2) and incubation with PreScission™Protease for 40 h at 4 °C, 
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the protein was eluted and columns regenerated with a GST-containing buffer. 
Washing and elution fractions were analyzed via SDS-PAGEs. 
 
 
 
 
 
 
 
 
 
Fig. 19: Purification of wild-type ALASRc with GST column chromatography. 
After cell disruption and centrifugation, the soluble fractions were separated by 12 % SDS-
PAGE. Proteins were visualized by staining with InstantBlueTM. The SDS-PAGEs shows protein 
purification of wild-type ALASRc at 4 °C.  A: Lane 1: sediment after cell disruption and 
centrifugation; lane 2: supernatant after cell disruption and centrifugation; lane 3: molecular 
weight marker; lane 4: first flow through fraction after incubation of resin and supernatant;  
lane 5: second flow through fraction after incubation of resin and supernatant; lane 6: first 
washing fraction with elution buffer; lane 7: second washing fraction with elution buffer; lane 8: 
third washing fraction with elution buffer; lane 9: fourth washing fraction with elution buffer;  
lane 10: fifth washing fraction with elution buffer; lane 11: sixth washing fraction with elution 
buffer. B: Lane 1: sediment of flow through fraction after 40 h incubation of 
PreScission™Protease and protein solution; lane 2: supernatant of flow through fraction; lane 3: 
sediment of first elution fraction after 40 h incubation with PreScission™Protease; lane 4: 
molecular weight marker; lane 5: supernatant of first elution fraction; lane 6: second elution 
fraction; lane 7: third elution fraction; lane 8: fourth elution fraction; lane 9: fifth elution fraction; 
lane 10: sixth elution fraction; lane 11: first washing fraction with regeneration buffer; lane 12: 
second washing fraction with regeneration buffer; lane 13: third washing fraction with 
regeneration buffer; lane 14: fourth washing fraction with regeneration buffer; lane 15: fifth 
washing fraction with regeneration buffer. 
 
The first column chromatography resulted in isolation of an almost pure protein 
solution (Fig. 19B, lane 5). For further purification two different columns were 
chosen: an anion exchange column chromatography on MonoQ (2.6.1.4) and a 
GPC on Superdex-200 (2.6.1.5). GPC also was used to determine the 
oligomerization state of the protein. After the first purifying GST column 
chromatography samples were dialyzed against low salt buffer prior to the 
MonoQ column chromatography which was performed using a salt gradient 
starting from 0 mM to 1 M sodium chloride at RT. The wild-type ALASRc had an 
eluting salt concentration of 260 mM (data not shown) but showed no further 
purification. Due to the handling at RT where ALASRc was not as stable as at  
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4 °C the wild-type ALAS Rc only was purified with the GST column 
chromatography.  
 
3.4.5 Oligomerization State of Recombinant Wild-type ALASRc 
 
For the determination of the oligomerization state of the wild-type ALASRc we 
used a GPC on Superdex-200. It was shown earlier that ALASRc, but also of 
other bacteria and mouse, occurs as homodimers (Tan and Ferreira, 1996; Bolt 
et al., 1999; Astner et al., 2005). The sizes of the monomers were described 
having a relative molecular mass between Mr = 43’000 and Mr = 66’000. The 
chromatography was carried out as described in ‘Materials and Methods’ 
(2.6.1.5). The elution volume of wild-type ALASRc was approximately 14.25 mL. 
With the calibration curve (Fig. 20) we determined a relative molecular mass of 
approximately Mr = 91’000. This value was in good agreement with the 
calculated relative molecular mass of the ALASRc homodimer of Mr = 87’332.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 20: Determination of the oligomerization state of wild-type ALASRc. 
The natural logarithm of the molecular weight (ln (MW)) of the marker proteins was plotted 
against their elution volume (Ve) divided with the ‘dead volume’ (V0) of the column. A molecular 
mass of approximately Mr = 91’000 was determined for ALASRc matching with the calculated 
molecular mass of Mr = 87’332. The column was calibrated using carbonic anhydrase  
(Mr = 29’000), bovine serum albumin (Mr = 66’000) and yeast alcohol dehydrogenase  
(Mr = 150’000) as marker proteins. 
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3.5   Generation, Production and Purification of Recombinant ALASRc 
Enzyme Variants 
 
The expression vector pRc-A carrying the wild-type hemA gene of  
R. capsulatus served as template for site-directed mutagenesis. For each 
residue of interest (Tab. 9) we developed one conservative and one non-
conservative amino acid exchange whereby one, three or four amino acid 
exchanges were conducted. The resulting constructs were verified for their 
correct gene sequence. Analogously to the wild-type ALASRc protein, we tested 
two different E. coli strains, BL21(DE3)RIL and BL21(DE3)pLysS, for each 
ALASRc variant with regard to best protein production. Tab. 10 shows a 
summary of obtained results.  
 
Tab. 10: ALASRc variants, their best protein producing E. coli strain and optimal growth 
temperature. 
The time point of highest protein production was identical for all ALASRc variants (20 h), but they 
differed in the growth temperature of the producing strain and in the protein producing  
E. coli strain itself. Conservative amino acid exchanges were highlighted in light pink. 
n/a: non-available.  
ALASRc variant E. coli strain temperature growth time 
N54Q BL21(DE3)pLysS 17 °C 20 h 
N54D BL21(DE3)pLysS 17 °C 20 h 
C52S-C201S-C400S BL21(DE3)pLysS 17 °C 20 h 
N54Q-C52S-C201S-C400S BL21(DE3)pLysS 25 °C 20 h 
N54D-C52S-C201S-C400S BL21(DE3)pLysS 25 °C 20 h 
R21K BL21(DE3)pLysS 17 °C 20 h 
R21E BL21(DE3)pLysS 17 °C 20 h 
T83S BL21(DE3)pLysS 17 °C 20 h 
T83L n/a n/a n/a 
N85Q BL21(DE3)RIL 25 °C 20 h 
N85F BL21(DE3)pLysS 17 °C 20 h 
I86L n/a n/a n/a 
I86H BL21(DE3)RIL 25 °C 20 h 
T365S-C52S-C201S-C400S BL21(DE3)pLysS 17 °C 20 h 
T365C-C52S-C201S-C400S BL21(DE3)pLysS 17 °C 20 h 
D47E BL21(DE3)pLysS 17 °C 20 h 
D47S BL21(DE3)pLysS 17 °C 20 h 
M309L n/a n/a n/a 
M309W BL21(DE3)RIL 17 °C 20 h 
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Induction of protein production of each ALASRc variant was carried out with  
200 µM IPTG. As an example, the SDS-PAGEs in Fig. 21 show the results from 
recombinant protein production for ALASRc-D47E and the fourfold ALASRc 
variant T365S-C52S-C201S-C400S. The SDS gels for all generated ALASRc 
variants showed similar results like these two mutants (Fig. 21) and the wild-
type ALASRc (Fig. 17). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21: Recombinant protein production studies for the ALASRc variants D47E and 
T365S-C52S-C201S-C400S. 
Cell free extracts were loaded onto a 12 % SDS-PAGE. Proteins were separated and 
afterwards visualized by staining with InstantBlueTM. The SDS-PAGEs show recombinant 
protein production of pRc-A-D47E and pRc-A-T365S-C52S-C201S-C400S in BL21(DE3)pLysS 
at 25 °C. A: D47E variant; lane 1: molecular weight marker; lane 2: before induction of gene 
expression using IPTG; lane 3: 1 h after induction; lane 4: 2 h after induction; lane 5: 3 h after 
induction; lane 6: 4 h after induction; lane 7: 5 h after induction; lane 8: 20 h after induction.  
B: T365S-C52S-C201S-C400S; lane 1: before induction; lane 2: 1 h after induction of gene 
expression using IPTG; lane 3: 2 h after induction; lane 4: 3 h after induction; lane 5: molecular 
weight marker; lane 6: 4 h after induction; lane 7: 5 h after induction; lane 8: 20 h after induction. 
 
The observed dominant protein with a relative molecular mass of approximately  
Mr = 66’000 (Fig. 21A: lanes 5 - 8; Fig. 21B: lanes 6 - 8) was in good agreement 
with the calculated relative molecular mass of the ALASRc-GST-fusion protein of 
Mr = 68’575. Astner and coworkers (Astner, 2007) mentioned that only the 
ALASRc-C400S enzyme was stable enough for protein production. With our 
results (Fig. 21B) in protein production studies for the ALASRc-T365S-C52S-
C201S-C400S variant we demonstrated that this fourfold mutant ALASRc 
enzyme was also stable and suited for protein production. This indicated that 
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the amino acid exchanges of C52 and C201 did not have a notable effect on 
protein folding. 
 
3.5.1 Purification of ALASRc Variants via GST Column Chromatography 
 
Analogously to the wild-type ALASRc affinity column chromatography using GST 
column chromatography was performed for each of the developed ALASRc 
variants. Fig. 22 shows the obtained results with the example of the ALASRc-
D47S variant. The other generated, produced and purified ALASRc variants 
revealed almost identical behavior. 
 
 
 
 
 
 
 
 
 
 
Fig. 22: Purification of the ALASRc-D47S variant via GST column chromatography. 
After cell disruption and centrifugation, the soluble fractions were separated by 12 % SDS-
PAGE. Proteins were visualized by staining with InstantBlueTM. The SDS-PAGE shows protein 
purification of ALASRc-D47S variant at 4 °C.  Lane 1: supernatant of flow through after 40 h-
incubation of PreScission™Protease and protein solution; lane 2: molecular weight marker;  
lane 3: sediment of flow through after incubation with PreScission™Protease; lane 4: 
supernatant of first elution fraction after 40 h-incubation with PreScission™Protease; lane 5: 
sediment of first elution fraction; lane 6: second elution fraction; lane 7: third elution fraction; 
lane 8: fourth elution fraction; lane 9: fifth elution fraction; lane 10: sixth elution fraction; lane 11: 
first washing fraction with regeneration buffer; lane 12: second washing fraction with 
regeneration buffer; lane 13: third washing fraction with regeneration buffer; lane 14: fourth 
washing fraction with regeneration buffer; lane 15: fifth washing fraction with regeneration 
buffer. 
 
After this first affinity chromatography we obtained an almost pure protein 
solution (Fig. 22, lane 4). Protein containing fractions were pooled and 
concentrated using a VIVASPIN concentrator. We recovered protein solutions 
with recombinant ALASRc enzyme amounts between 1 mg/mL (= 23 µM) and  
20 mg/mL (= 460 µM) per 10 liter cell culture depending on the ALASRc variant. 
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Fractions containing ALASRc had a yellowish color which is characteristic for 
PLP-dependent enzymes. Fig. 23 shows a yellowish enzyme solution using the 
ALASRc-R21E variant as an example with a concentration of 455 µM  
(= 19.8 mg/mL). The yellowish color is due to a Schiff’base linkage between the 
PLP-cofactor and the ɛ-amino group of an active site lysine residue. 
 
 
 
 
 
 
 
 
 
Further purification attempts using ion exchange chromatography on MonoQ 
and GPC on Superdex-200 failed to improve enzyme purity. The different 
enzyme solutions could not be concentrated to the same protein amount per mL 
because of differences in their stability at 4 °C a nd their stability during the 
concentrating procedure. Stored at -80 °C protein s olutions showed no 
detectable degradation and were stable for more than several months.  
 
3.6 Experimental Approach 
 
3.6.1 Used Test Systems 
 
3.6.1.1 Approach 1: Steady State Kinetics 
 
Steady state kinetics are useful for the detection of the slowest step in enzyme 
reactions. In case of mouse ALAS2 it is the conformational change of the 
enzyme while ALA is released as it was shown by Hunter and coworkers 
(Hunter and Ferreira, 1999). For the measurement of ALASRc steady state 
kinetics a coupled enzyme assay with the NADH-dependent α-KGD was used. 
Consequently, the stoichiometry of the overall reaction requires one molecule of 
Fig. 23: Yellowish color of purified ALASRc-R21E 
solution. 
The yellow color of ALAS solutions is characteristic for PLP-
dependent enzymes. It was a reliable visible indicator for a 
first estimation if a purification procedure was successful. 
The yellowish color is the result of a Schiff’base linkage 
between the PLP-cofactor and the ɛ-amino group of an 
active site lysine residue.  
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NADH made for every ALA molecule. The Michaelis Menten constant (KM), the 
maximal velocity (vmax) and the catalytic constant (kcat) were determined from 
substrate velocity plots by measuring the constant velocity formation of NADH 
over a substrate range from 0 – 100 mM glycine and 0 – 20 µM succinyl-CoA. 
The NADH concentration was calculated with the Beer-Lambert law with A is 
the Absorption, c is the concentration of NADH [M] and ε is the extinction 
coefficient of NADH [M1cm-1] (2.7.1.1). 
 
 
 
The concentration of NADH was 1.52439 * 10-7 mol/min and necessary for the 
calculation of the ‘real’ vmax. Steady state kinetic parameters were calculated as 
described in ‚Material and Methods‘ (2.7.1.1). 
By performing steady state kinetics for the ALASRc enzyme and mutant variants 
we wanted to verify the significance of selected residues in enzyme catalysis.  
 
Tab. 11: Kinetic parameters for mouse ALAS2 and wild-type ALASRc as well as generated 
ALASRc variants. 
Vmax was the velocity at maximal substrate concentrations; KM was the substrate concentration 
that leads to half-maximal velocity; kcat was the turnover number and kcat/KM was the catalytic 
efficiency of the enzyme. The conservative amino acid exchanges were highlighted in light pink. 
Data for the mouse wild-type ALAS2 enzyme were determined in Tampa, Florida, USA with 
purified enzyme of Professor Dr. Ferreira’s group matching with published values for the murine 
ALAS2. 
nd = non-detectable. Enzyme concentrations varied from 0.2 to 2 µM. 
enzyme/  
ALASRc variant 
vmax 
[µM/min] 
KMsuccinyl-CoA 
[µM] 
KMgly 
[mM] kcat [s-1] 
kcat/KMsuccinyl-CoA 
[s-1 * µM-1] 
kcat/KMgly 
[s-1 * mM-1] 
mouse ALAS2 6.38 2.26 9.89 0.053 0.023 0.005 
Wild-type ALASRc 3.74 0.221 0.273 0.31 1.401 1.136 
N54D nd nd nd nd nd nd  
N54Q 9.5 0.846 1.7 0.32 0.378 0.188 
R21E nd nd nd nd nd nd  
R21K 2.62 4.66 13.54 0.021 0.005 0.002 
T83S 2.28 0.68 0.034 0.019 0.028 0.559 
N85F 18.8 7.46 3.53 1.57 0.21 0.445 
N85Q 5.57 11.06 1.16 0.185 0.017 0.159 
I86H 0.78 0.43 2.93 0.0065 0.015 0.002 
D47E 11.02 0.672 0.362 0.367 0.546 1.014 
D47S 2.95 0.066 0.475 0.163 2.485 0.344 
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The in Tab. 11 listed steady state kinetic parameters will be discussed in detail 
later, together with the subsequently obtained results on the respective single 
turnover experiments. 
 
3.6.1.2 Approach 2: Quinonoid Formation and Single Turnover Reactions 
 
In the ALAS reaction mechanism two different quinonoids occur but only the 
second one is detectable due to the rapid conversion of the first quinonoid  
(Fig. 24)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24: Extract of the ALAS reaction mechanism for the mouse ALAS2 (adapted from 
Hunter et al., 2007). 
Formation of the second quinonoid, its quenching by protonation and ALA release.  
 
To get a first impression we determined the pH-dependency of the formation of 
this second quinonoid of ALASRc. Therefore, the ALASRc was spectroscopically 
analyzed. The experimental set-up was carried out as described in ‘Materials 
and Methods’ (2.7.3). The second quinonoid was observed at an absorption at 
510 nm solely at a pH of 9.5 (Fig. 25).  
 
 
 
 
 
 
 
 
 
 
several steps lead to the 
formation of the second 
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ALA bound external 
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Subsequently, fluorescence stopped-flow experiments for detection of single 
turnover experiments were performed as described in ‘Materials and Methods’ 
(2.7.1.2).  
The formation of the second quinonoid is a three-step mechanism. The first step 
(Fig. 26, (I)) is the decarboxylation of the second intermediate 2-amino-3-
ketoadipate (= α-amino-β-ketoadipate) to form the second quinonoid (Qf with 
k1). The decay occurs in two steps (Qd1 and Qd2): First, quenching of the 
quinonoid is due to its protonation (Fig. 26, (II)). The product ALA is bound at 
the active site (Qd1 with k2). Finally, the ALA release (Fig. 26, (III)) occurs and a 
conformational change of the enzyme takes place (Qd2 with k3). For pre-steady 
state kinetic experiments 60 µM succinyl-CoA were mixed with buffer in one 
syringe of the stopped flow apparatus and 30 mM glycine with enzyme 
Fig. 25: Formation of the 
second quinonoid for the 
wild-type ALASRc and 
various ALASRc variants  
In the ALASRc reaction 
mechanism two different 
quinonoid intermediates are 
generated but only the 
second one is detectable at 
510 nm. Enzyme 
concentrations were 20 µM 
in a total volume of 150 µL. 
Two different pH’s were 
tested.  
A. Quinonoid formation 
measurements at a pH of 
7.5. B. Quinonoid formation 
measurements at a pH of 
9.5. 
Black line: N54D; pink line: 
N54Q; green line: R21K; 
blue line: N85F; cyan line: 
R21E; dark red line: T83S; 
green-yellow line: D47E; 
dark green line: wild-type. 
 
 
B 
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concentrations ranging from 60 µM to 220 µM in the second one. Collection 
time was 60 seconds, 3’750 scans were collected with 62 scans/sec. Rapid 
scanning stopped-flow experiments of murine ALAS2 demonstrated that the 
reaction of the enzyme with glycine and succinyl-CoA resulted in a pre-steady 
state burst of quinonoid intermediate formation (Hunter and Ferreira, 1999). 
Thus, a step following binding of substrates and initial quinonoid intermediate 
formation is rate-determining. At the very beginning of reactions, known as pre-
steady state or transient phase kinetics, the enzyme-substrate-complex 
concentration rises from zero to its steady state value. In contrast to steady 
state kinetics, in transient phases the rate of the enzyme catalyzed reaction is 
not defined since the reactants are not used at a one-to-one stoichiometry. 
Nevertheless, for measurements of such fast reactions including the pre-steady 
states special high resolution methods and assay setups are necessary. A 
stopped-flow apparatus was employed where the first milliseconds (ms) of a 
reaction can be analyzed. In our case, we measured single turnover reactions 
by using high amounts of glycine to saturate the enzyme, but only a low 
concentration of succinyl-CoA, so that only one catalytic cycle can occur 
(‘Materials and Methods’, 2.7.1.2).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 26 shows the typical single turnover reaction using the wild-type ALASRc as 
example. After initiation of the reaction there exists an initial burst of second 
quinonoid formation, i.e. the assembly of enzyme-substrate-complexes.  
 
 
Fig. 26: Single turnover reaction 
of the ALASRc wild-type. 
Single turnover reactions were 
carried out with a stopped flow 
apparatus. The time [sec] was 
plotted against the absorbance of 
the second quinonoid at 510 nm. 
Stopped flow measurements of 
second quinonoid formation, 
quenching and ALA release The 
first observable step is quinonoid 
formation (I), the decay occurs in 
two steps: quenching of the 
quinonoid (II) and ALA release (III). 
Green line: raw date; black line: 
fitted curve for a three-step 
reaction. 
(I) 
(II) 
(III) 
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3.6.2 Kinetics of Wild-type ALASRc 
 
The only available crystal structure for ALAS is for the enzyme from  
R. capsulatus. However, in contrast to the detailed structural picture available, 
almost nothing is known about the kinetic characteristics of the enzyme. For the 
wild-type ALASRc we expected a reaction mechanism with a similar kinetic 
behavior as observed for other well characterized ALAS enzymes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Steady state kinetics of wild-type ALASRc. 
Steady state kinetics were determined with five different glycine and five different succinyl-CoA 
concentrations. Enzyme concentration was 0.2 µM in a total volume of 150 µL. A. Steady state 
kinetic data for succinyl-CoA. Black dots: 0.5 µM succinyl-CoA; red dots: 1 µM succinyl-CoA; 
green dots: 2 µM succinyl-CoA; blue dots: 5 µM succinyl-CoA; pink dots: 10 µM succinyl-CoA. 
B. Steady state kinetic data for glycine. Black dots: 0.5 mM glycine; white dots: 1 mM glycine; 
black triangles: 5 mM glycine; white triangles: 10 mM glycine; black squares: 20 mM glycine.  
C. Secondary plot for glycine with glycine concentrations ranging from 0.5 mM to 20 mM 
glycine. D. Secondary plot for succinyl-CoA with succinyl-CoA concentrations ranging from  
0.5 µM to 10 µM succinyl-CoA.  
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Fig. 27 shows steady state kinetic mesaurements of wild-type ALASRc. From 
these results the kinetic parameters were calculated (2.7.1.1). We compared 
these kinetic data for wild-type ALASRc with the well kinetically characterized 
mouse ALAS2 enzyme (Ferreira and coworkers). In Tab. 12 the corresponding 
kinetic parameters for the wild-type ALASRc and for the mouse ALAS2 are 
summarized.  
 
Tab. 12: Kinetic parameters for mouse wild-type ALAS2 and wild-type ALASRc.  
Vmax was the velocity at maximal substrate concentrations; KM was the substrate concentration 
that leads to half-maximal velocity; kcat was the turnover number and kcat/KM was the catalytic 
efficiency of the enzyme.  
ALAS enzyme 
vmax 
[µM/min] 
KMsuccinyl-CoA 
[µM] 
KMgly 
[mM] kcat [s-1] 
kcat/KMsuccinyl-CoA 
[s-1 * µM-1] 
kcat/KMgly  
[s-1 * mM-1] 
mouseALAS2 6.38 2.26 9.89 0.053 0.023 0.005 
Wild-type ALASRc 3.74 0.221 0.273 0.31 1.401 1.136 
 
Compared to the mouse enzyme ALASRc showed lower KM values for both 
substrates. In the literature the KM’s for glycine range from 0.2 mM 
(Rhodopseudomonas sphaeroides; Jordan and Laghai-Newton, 1986) to 51 mM 
(murine ALAS2; Ferreira and Dailey, 1993b) while the KM’s for succinyl-CoA 
range from 5 µM (R. sphaeroides; Jordan and Laghai-Newton, 1986) to 55 µM 
(murine ALAS2, Ferreira and Dailey, 1993b). For the wild-type ALASRc enzyme 
we measured a KM for glycine of 0.273 mM and for succinyl-CoA 0.221 µM. The 
turnover number kcat was 0.31 * s-1 and thus approximately six times higher than 
for the mouse enzyme. In contrast the vmax of wild-type ALASRc was two times 
lower (vmax for the wild-type ALASRc was 3.74 µM/min and for the mouse 
enzyme vmax was 6.38 µM/min). Furthermore, kcat/KMsuccinyl-CoA for the mouse 
ALAS2 was 61fold lower than the catalytic efficiency of the R. capsulatus 
enzyme while kcat/KMgly even was 227fold lower. The kcat/KM ratio describes 
enzyme specificity if more than one substrate is available such as in the ALAS 
reaction mechanism. These values indicated that the murine ALAS2 showed a 
less high efficiency for both substrates glycine and succinyl-CoA than its 
bacterial counterpart. Consequently, the turnover number is lower for the mouse 
enzyme (kcat = 0.053 * s-1) than for R. capsulatus (kcat = 0.31 * s-1) indicating that 
the bacterial ALAS is more specific for its substrates resulting in a more efficient 
product formation. Although the mouse ALAS2 enzyme needed higher amounts 
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of glycine and succinyl-CoA to be half-saturated (KM for glycine was 9.89 mM 
and KM for succinyl-CoA was 2.26 µM) the reaction occurred fast, but product 
release was slow. This phenomenon could be the result of a tighter product 
binding in the mouse wild-type ALAS2 enzyme. The conclusion is that, although 
the mouse enzyme showed a faster reaction, the product formation is less 
efficient. In contrast, the wild-type ALASRc enzyme needed low substrate 
amounts to be half-saturated, but although the reaction is not as fast as the 
mouse ALAS2 reaction the product binding is more loosely and occurred faster 
with the bacterial ALAS enzyme.  
With the measured kinetic parameters (Tab. 12) we now knew substrate 
concentrations necessary for the wild-type ALASRc single turnover reaction. 
Getting further impressions of the kinetic behavior of the ALASRc enzyme 
quinonoid formation was determined spectroscopically prior to use fluorescence 
stopped-flow.  
 
 
 
 
 
 
 
 
 
 
As outlined before, the wild-type ALASRc enzyme showed a distinct quinonoid 
formation at 510 nm but only at a pH of 9.5 (Fig. 28). At a lower pH less 
intermediate was detectable. R. capsulatus is a bacterium that occurs in fresh 
water, marine and hypersaline habitats (Stahl et al., 1992), i.e. biotopes with 
more reduced pH values (5 - 7). However, pH-dependent spectroscopy clearly 
showed that ALA was preferably produced at pH 9.5. An explanation for the 
detection of the second quinonoid at higher pH’s might be provided by a 
deceleration of the ALASRc reaction in more alkaline solutions. This slowdown 
enabled the detection of the quinonoid at 510 nm. The ALASRc was not the only 
Fig. 28: Formation of the second 
quinonoid in wild-type ALASRc 
reaction. 
The formation of the second 
quinonoid in the ALASRc reaction 
mechanism is detectable at 510 nm. 
Enzyme concentration was 20 µM in 
a total volume of 150 µL. Two buffer 
solutions with a different pH were 
tested. 
Red line: pH 9.5; green line: pH 7.5. 
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recombinant produced enzyme which was tested for second quinonoid 
formation. For the mouse wild-type ALAS2 e.g. also could be shown that 
quinonoid formation is better at a higher pH (Prof. Dr. Gloria C. Ferreira, 
personal communication). With these results we now could perform 
fluorescence single turnover reactions for the detection of the second 
quinonoid. In single turnover reactions for the wild-type ALASRc the three steps 
(I, II, III) of quinonoid formation and decay were clearly visible. They are shown 
and explained in Fig. 26 on page 78. 
 
Tab. 13: Stopped-flow single turnover rates for ALASRc wild-type. 
The ALASRc reaction was fitted to a three-step reaction with three observable rates. k1: rate of 
the decarboxylation step of the 2-amino-3-ketoadipate intermediate, formation of second 
quinonoid. The decay occurs in two steps. k2: rate of second quinonoid quenching; k3: ALA 
release. 
ALASRc variant k1 [s-1] k2 [s-1] k3 [s-1] 
Wild-type ALASRc 5.4 ± 1 0.48 ± 0.03 0.0050 ± 0.0009 
 
In Tab. 13 the observable rates of second quinonoid formation and decay for 
the wild-type ALASRc are summarized. The second step of quinonoid decay 
(Qd2, ALA release and conformational change of the enzyme, with the rate k3) 
should have the same value as the turnover number (kcat) of steady state 
kinetics (Tab. 12). Qd2 with its rate k3 describes the ALA release while kcat is the 
amount of ALA formed in one second. This means both values describe the 
same parameter, i.e. the amount of formed ALA. The consequence for the 
ALASRc catalysis seems to be that the ALA release is not the rate-limiting step. 
It should be considered that steady state kinetics were performed at a pH of 7.5 
and transient kinetic analysis at a pH of 9.5 due to a better quinonoid 
observation at higher pH’s. For a final conclusion concerning the rate-limiting 
step of the ALASRc reaction it is necessary to peform steady state kinetics as 
well as transient kinetic analysis at a higher pH. The pH optimum of the 
coupling enzyme α-KGD ranging from 5.7 for Bos taurus (Bunik et al., 2005) to 
8.5 for Aspergillus niger (Meixner-Monori et al., 1985) should be taken into 
account. However, we also have to consider the instability of NADH at higher 
pH’s. We tried to perform steady state kinetics at a pH of 9.5 where the buffer 
already showed a yellow color after 1 h incubation in assay buffer indicating the 
conversion of NAD+ into NADH. Therefore, it was not possible to determine 
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steady state kinetics at a pH of 9.5. For this reason steady state kinetics for all 
constructed ALASRc variants had to be performed at a pH of 7.5 and single 
turnover reactions at a pH of 9.5. 
 
3.6.3 Kinetics of ALASRc Variants Involved in Ketoadipate Formation 
 
In the ALASRc reaction cycle three different intermediates are proposed to be 
generated: 1. first quinonoid, 2. 2-amino-3-ketoadipate, 3. second quinonoid. 
The ALAS reaction is fast, so that only the third intermediate, i.e. second 
quinonoid is detectable. Kerbarh and coworkers (Kerbarh et al., 2006) provided 
the first definitive evidence for a β-ketoacid intermediate in the α-oxoamine 
synthase mechanism of AONS. They were able to trap the reactive β-ketoacid 
PLP-aldimine formed in the condensation step of the AONS by carrying out the 
reaction with L-alanine-methylester and pimeloyl-CoA generating the more 
stable methylester of the putative intermediate. Given that AONS and ALAS 
belong to the same α-oxoamine synthase family, they also catalyze the same 
chemical reaction consisting of the unusual cleavage of two α-carbon bonds in a 
Claisen condensation reaction between amino acids and acyl-CoA thioesters 
(Kikuchi et al., 1958; Alexeev et al., 1998).  
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Fig. 29: Extract of the ALAS reaction mechanism for the mouse ALAS2 enzyme (adapted 
from Hunter et al., 2007). 
In the murine ALAS2 reaction mechanism the first quinonoid (I) was formed after condensation 
of the enzyme-glycine bound structure (external aldimine) with succinyl-CoA. Next, the 2-amino-
3-ketoadipate intermediate (III) was formed after CoAS- release. The second quinonoid (IV) was 
in equilibrium with its enol (V) and was generated by decarboxylation of the ketoadipate. 
 
From the analysis of the ALASRc crystal structure, we deduced that the ALASRc-
N54 variant (corresponds to N119 of murine ALAS2) might be a good target for 
site-directed mutagenesis. We hypothesized that ALASRc-N54 (or mouse 
ALAS2-N119) has a role in stabilizing (or destabilizing) the 2-amino-3-
ketoadipate intermediate. To get a first impression of enzyme activity we 
performed steady state kinetics for both generated ALASRc-N54 variants  
(Tab. 14).  
 
Tab. 14: Kinetic parameters for wild-type ALASRc and ALASRc-N54 variants. 
Vmax was the velocity at maximal substrate concentrations; KM was the substrate concentration 
that leads to half-maximal velocity; kcat was the turnover number and kcat/KM was the catalytic 
efficiency of the enzyme. The conservative amino acid exchanges were highlighted in light pink.  
nd = non-detectable. Enzyme concentrations varied from 0.2 to 2 µM. 
ALASRc variant 
vmax 
[µM/min] 
KMsuccinyl-CoA 
[µM] 
KMgly 
[mM] kcat [s-1] 
kcat/KMsuccinyl-CoA 
[s-1 * µM-1] 
kcat/KMgly 
[s-1 * mM-1] 
Wild-type ALASRc 3.74 0.221 0.273 0.31 1.401 1.136 
N54D nd nd nd nd nd nd 
N54Q 9.5 0.846 1.7 0.32 0.378 0.188 
 
 
 
(I) 
(II) 
(V) (IV) 
(III) 
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It was understandable that the amino acid exchange from asparagine to 
aspartic acid (N54D) led to a completely inactive enzyme. Aspartic acid has an 
additional carboxyl group while asparagine harbors an amino group. The 
change from a polar to an acidic amino acid seemed to be that dramatic that no 
enzyme activity was traceable. The conservative ALASRc variant with glutamine 
instead of asparagine (N54Q) yielded a protein with a similar turnover number 
(kcat = 0.32 * s-1) as the wild-type ALASRc. Glutamine has a carbon backbone 
with five carbon atoms while in asparagine the backbone consists of only four 
carbon atoms. N54 coordinates the PLP-glycine intermediate via a hydrogen 
bond (2.9 Å). If asparagine is replaced by a longer amino acid the distance to 
the intermediate is reduced. Although the substrate affinities were higher than in 
the wild-type ALASRc enzyme (N54Q KMgly = 1.7 mM; KMsuccinyl-CoA = 0.846 µM), 
the amino acid exchange had no drastic effect on enzyme activity. This means 
that N54 cannot be replaced by other amino acids unless it is of similar 
chemical nature. The result of these experiments was that the amino acid 
exchange to glutamine led to a protein with higher KM values for both substrates 
but a similar kcat. The conclusion was that a polar amino acid in position 54 is 
necessary for enzyme catalysis. 
 
The second step in analyzing ALASRc-N54 acitivity was the measurement of 
formation of the second quinonoid spectroscopically as well as with 
fluorescence single turnover experiments.  
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Fig. 30: Detection of the second quinonoid in the reaction mechanism of the ALASRc wild-
type and ALASRc-N54 variants. 
The second quinonoid is the third intermediate in the ALAS reaction cycle. The first two 
intermediates are not detectable due to a fast conversion into the second quinonoid which 
shows an absorption at 510 nm. A. Detection of the second quinonoid using absorbance 
spectroscopy. B. Detection of the second quinonoid using a fluorescence stopped-flow 
apparatus. Raw data and fitting curves (black lines, three-step reaction fits). The first observable 
step is quinonoid formation, the decay occurs in two steps: quenching of the quinonoid and ALA 
release. 
ALASRc-N54Q: pink line; ALASRc-N54D: blue line; wild-type ALASRc: dark-green line.  
 
In Tab. 15 the corresponding rates of second quinonoid formation and decay 
are listed. The non-conservative amino acid exchange N54D resulted in an 
A 
B 
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almost inactive enzyme which did not yield any detectable quinonoid formation 
(Fig. 30A and Fig. 30B, blue line) at 510 nm.  
 
Tab. 15: Stopped-flow single turnover rates for wild-type ALASRc and N54-ALASRc 
variants. 
The ALASRc reaction was fitted to a three-step reaction with three observable rates. k1: rate of 
the decarboxylation step of the 2-amino-3-ketoadipate intermediate; formation of second 
quinonoid. The decay occurs in two steps. k2: rate of second quinonoid quenching; k3: ALA 
release. 
nq:no quinonoid. Conservative amino acid exchanges were highlighted in light pink.  
ALASRc variant k1 [s-1] k2 [s-1] k3 [s-1] 
Wild-type ALASRc 5.4 ± 1 0.48 ± 0.03 0.0050 ± 0.0009 
N54Q 11 ± 2 3 ± 0.3 0.038 ± 0.007 
N54D nq nq nq 
 
It was not possible to fit the ALASRc-N54D reaction to a three step mechanism 
like the wild-type ALASRc or the ALASRc-N54Q variant. In contrast, the single 
turnover reaction of the ALASRc-N54Q variant (Fig. 30A und 30B, pink line) 
showed fast quinonoid formation. This residue is also necessary for the 
coordination of glycine via a hydrogen bond. Glycine is the first substrate 
required for the ALA formation and a prerequisite for onset of the reaction 
process. The reaction is slowed down or interrupted once the amino acid 
substrate cannot bind in such a manner that the reaction can occur. The 
conclusion of both approaches is that the N54 residue is important for ALASRc 
activity. To test whether the ALASRc-N54 variants trapped the second 
intermediate, 2-amino-3-ketoadipate, we wanted to take a similar experimental 
approach like Kerbarh and coworkers did. They conducted the AONS reaction 
using the methylester of L-alanine as a pseudosubstrate which forms a stable 
quinonoid species after proton abstraction (Kerbarh et al., 2006). Thus, this 
species also might undergo condensation with pimeloyl-CoA integrating the 
methylester into β-ketoacid-aldimine complex. Hence, the complex cannot 
undergo decarboxylation and thus it should accumulate. Previously, amino acid 
methylester analogs were successfully used in studies of PLP-dependent 
enzymes (Hayashi et al., 1993; Moore et al., 1997; Olmo et al., 2002; Ikushiro et 
al., 2004). During the reaction of AONS with the amino acid methylester in the 
presence of pimeloyl-CoA a new enzyme bound intermediate accumulated 
which had an absorbance maximum at 454 nm. To verify that the 454 nm 
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absorption had been due to the β-ketoacid-methylester aldimine complex, a 
sodium cyanoborohydride reduction was carried out to reduce the unstable 
imine bond of the complex (Kerbarh et al., 2006). Additionally, in electrospray 
mass spectrometry experiments of the products a new peak had occurred, 
which had not corresponded to the peaks of the apo- and holoenzyme, but to 
AONS monomer plus the reduced β-ketoacid-methylester aldimine. This was 
the evidence for the β-ketoacid intermediate in the reaction mechanism. A 
similar approach to identify the β-ketoacid intermediate was undertaken for the 
ALASRc-N54 variant using glycine-methylester as amino acid pseudosubstrate.  
 
To get a first impression of the behavior of the wild-type ALASRc and the 
ALASRc-N54D and –N54Q variants in glycine-methylester binding experiments 
we measured their absorption changes due to glycine binding capacity. The 
spectra covered a wavelength range from 200 to 600 nm. At first view the 
spectra looked similar but zooming in identified differences at 420 nm.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31: Absorbance spectra of the wild-type ALASRc enzyme and ALASRc-N54 variants. 
For the wild-type ALASRc enzyme and the ALASRc-N54 variants, N54D and N54Q, absorbance 
spectra were recorded within a wavelength range from 200 to 600 nm.  
Green line: wild-type ALASRc; pink line: N54D; blue line: N54Q. 
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The absorbance spectrum of the ALASRc-N54D mutant (Fig. 31, pink line) 
indicated why this amino acid exchange led to an inactive enzyme. The protein 
lacked the characteristical peak at 420 nm. Usually, in glycine binding 
experiments a change in peak height was observable (Fig. 32).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With these results it became apparent why the ALASRc-N54D variant was 
inactive. The amino acid exchange from asparagine to aspartic acid destroyed 
the glycine binding ability of the enzyme. For this reason experiments with 
glycine-methylester for trapping the β-ketoadipate only were conducted with the 
ALASRc-N54Q variant. In Prof. Dr. Gloria Ferreira’s laboratory in Tampa, 
Florida, USA the reaction with glycine-methylester was conducted and 
compared to the results given with the corresponding mutation in the mouse 
ALAS2 enzyme (N119Q). These experiments are under current performance. 
Furthermore, reactions with O-methylglycine had been executed with the focus 
on the formation and decay of the first generally difficult to detect quinonoid. 
The O-methylglycine pseudosubstrate was used instead of glycine, since the 
generated methylester of the β-ketoacid-aldimine complex does not 
decarboxylate to afford the second quinonoid intermediate. Similar to the 
reaction of the ALAS-glycine complex with succinyl-CoA, the kinetic trace for 
the reaction of the ALAS-O-methylglycine complex with succinyl-CoA was best 
 
Fig. 32: Glycine 
binding experiments 
with the ALASRc-N54Q 
variant.  
Glycine binding 
experiments were 
carried out with the 
ALASRc-N54Q mutant at 
30 °C. Different glycine 
concentrations were 
used and changes at 
420 nm were recorded.  
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described by a three-step process (data not shown). The ALAS reaction was 
similar to that of the AONS where the second intermediate, 2-amino-3-
ketoadipate, was detected. By trapping the first and the second quinonoid we 
were now able to assume the occurrence of this β-ketoadipate intermediate in 
the ALASRc reaction mechanism.  
 
The ultimate experiment giving the evidence of the occurrence of the  
β-ketoadipate would be its trapping in a crystal structure of a ALASRc variant. 
Although the ALASRc-C400S was crystallized earlier (Astner et al., 2005), 
crystals with substrates incorporated in the active site only were achieved with 
impregnation experiments of before obtained substrate-less ALASRc crystals 
with substrate solutions. Here, direct enzyme-substrate crystallization 
experiments were conducted with the N54 variants of the ALASRc enzyme as 
well as with enzyme only. First crystallization tests were executed using same 
buffers identical to crystallization experiments of ALASRc carried out before 
(Astner et al., 2005; Astner, 2007). However, with these buffers no results were 
achieved why a variety of different buffers, precipitants and salts provided from 
Qiagen were tested under aerobic and anaerobic conditions at 17 °C. The 
PEGs II Suite, the Cryos Suite, the Classics II Suite and the Classics Lite Suite 
(Qiagen, Nextal) were tested with enzyme only as well as with enzyme together 
with both substrates, glycine and succinyl-CoA. We performed crystallization 
assays with the wild-type ALASRc but also with the ALASRc-N54Q and ALASRc-
N54D mutant enzymes. Crystallization experiments were carried out as 
described in ‘Materials and Methods’ (2.8.1) with the following enzyme 
concentrations: wild-type ALASRc: 6 mg/mL and 9.8 mg/mL; ALASRc-N54Q:  
6.7 mg/mL and 11.25 mg/mL as well as ALASRc-N54D: 9.6 mg/mL, respectively. 
If substrates were added they had concentrations between 0.1 µM and 0.25 µM. 
After six to eight weeks crystals of the cysteine-free wild-type ALASRc  
(9.8 mg/mL) were obtained under following conditions: Classics Suite A11 
containing 200 mM ammonium acetate, 100 mM Tris-HCl pH 8.5 and 30 % v/v  
2-propanol as well as with Classics Suite B10 containing 100 mM Hepes pH 7.5 
and 70 % v/v 2-methyl-2,4-pentandiol under aerobic atmosphere. Further 
crystals were observed in Classics Suite B11 containing 100 mM Tris pH 8.5 
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and 25 % v/v tert-Butanol. X-ray diffractions were performed at the HZI 
(Helmholzzentrum für Infektionsforschung, Braunschweig, Stöckheim, 
Germany) with crystals grown in Classics Suite A11 and B10 due to low 
dimensions of the other achieved crystals. After fishing crystals were frozen in 
liquid nitrogen. Unfortunately, the crystals (Fig. 33) diffracted poorly. All 
crystallization attempts are still routinely screened to obtained better diffracting 
ALASRc crystals.  
 
 
 
 
 
 
 
 
Fig. 33: Cysteine-less wild-type ALASRc crystals under aerobic conditions. 
Wild-type ALASRc crystals were achieved within conditions A11, B10 and B11 of Classics Suite 
(Qiagen) after approximately five to eight weeks and aerobic conditions at 17 °C. A. Achieved 
wild-type ALASRc crystals in Classics Suite condition A11. B. Acieved wild-type ALASRc crystals 
in Classics Suite condition B10. Unfortunately, X-ray diffraction revealed poor diffraction.  
 
3.6.4 Kinetics of ALASRc Variants Involved in Substrate Recognition 
 
The ALASRc enzyme utilizes two different substrates for the formation of its 
product ALA. On the basis of the solved crystal structure several residues were 
suggested to be involved in substrate recognition and coordination. With the 
possibility of measuring enzyme kinetics we wanted to functionally prove these 
structural assumptions. Fig. 8 of the introduction shows that R21 forms a salt 
bridge to to the carboxylate group of succinyl-CoA while T83, N85 and I86 
coordinate this group via hydrogen bonds. After generating ALASRc variants of 
the residues R21, T83, N85 and I86 we performed steady state kinetics for the 
determination of their activities and kinetic parameters. Fig. 34 shows steady 
state kinetics with the example of the ALASRc-N85F variant. The steady state 
kinetics for all other ALASRc variants were performed analogously and looked 
similar to the steady state kinetics for the ALASRc-N85F variant.  
 
B 
wild-type ALASRc  
 
A 
wild-type ALASRc  
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Fig. 34: Steady state kinetics of the ALASRc-N85F variant. 
Steady state kinetics were determined with five different glycine and five different succinyl-CoA 
concentrations. Enzyme concentration was 0.2 µM in a total volume of 150 µL. 
A. Steady state kinetic data for succinyl-CoA. blue dots: 2 µM succinyl-CoA; green dots: 5 µM 
succinyl-CoA; pink dots: 10 µM succinyl-CoA; black dots: 15 µM succinyl-CoA; red dots: 20 µM 
succinyl-CoA. B. Steady state kinetic data for glycine. Black dots: 1 mM glycine; dots: 5 mM 
glycine; black triangles: 10 mM glycine; triangles: 20 mM glycine; black squares: 50 mM glycine. 
C. Secondary plot for glycine with glycine concentrations ranging from 1 mM to 50 mM glycine. 
D. Secondary plot for succinyl-CoA with succinyl-CoA concentrations ranging from 2 µM to  
20 µM succinyl-CoA.  
 
 
The achieved kinetic constants, vmax, kcat and KM values for both substrates, 
respectively, are summarized in Tab. 16 as well as the catalytic efficiencies for 
succinyl-CoA and glycine (kcat/KMsuccinyl-CoA and kcat/KMgly). 
 
 
 
 
B 
D 
A 
 
 
 
 
 
C 
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Tab. 16: Kinetic parameters for wild-type ALASRc and ALASRc variants involved in 
substrate recognition and coordination. 
Vmax was the velocity at maximal substrate concentrations; KM was the substrate concentration 
that leads to half-maximal velocity; kcat was the turnover number and kcat/KM was the catalytic 
efficiency of the enzyme. The conservative amino acid exchanges were highlighted in light pink. 
nd = non-detectable. Enzyme concentrations varied from 0.2 to 2 µM. 
ALASRc variant 
vmax 
[µM/min] 
KMsuccinyl-CoA 
[µM] 
KMgly 
[mM] kcat [s-1] 
kcat/KMsuccinyl-CoA 
[s-1 * µM-1] 
kcat/KMgly 
[s-1 * mM-1] 
Wild-type 
ALASRc 3.74 0.221 0.273 0.31 1.401 1.136 
R21K 2.62 4.66 13.54 0.021 0.005 0.002 
R21E nd nd nd nd nd nd 
T83S 2.28 0.68 0.034 0.019 0.028 0.559 
N85F 18.8 7.46 3.53 1.57 0.21 0.445 
N85Q 5.57 11.06 1.16 0.185 0.017 0.159 
I86H 0.78 0.43 2.93 0.0065 0.015 0.002 
 
 
Furthermore, formation of the second quinonoid was detected by absorbance 
spectroscopy and further with single turnover experiments using fluorescence 
spectroscopy (Fig. 35). 
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Fig. 35: Detection of the second quinonoid in the reaction mechanism of the ALASRc wild-
type and ALASRc variants involved in substrate recognition and coordination. 
The second quinonoid is the third intermediate in the ALAS reaction cycle. The first two 
intermediates are not detectable due to a fast conversion into the second quinonoid which 
shows an absorption at 510 nm. A. Detection of the second quinonoid using absorbance 
spectroscopy. B. Detection of the second quinonoid using fluorescence spectroscopy. The first 
observable step is the formation of the second quinonoid; the decay occurs in two steps: 
quenching of the second quinonoid and ALA release. Raw data and fitting curves (black lines, 
three step reaction fits). 
ALASRc-R21K: green line; ALASRc-R21E: cyan line; ALASRc-T83S: dark red line; ALASRc-N85F: 
blue line; wild-type ALASRc: dark-green line. 
 
In Tab. 17 the corresponding rates of second quinonoid formation and decay 
are listed. 
 
 
 
A 
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Tab. 17: Stopped-flow single turnover rates for wild-type ALASRc and developed ALASRc 
variants. 
The ALASRc reaction was fitted to a three-step reaction with three observable rates. k1: rate of 
the decarboxylation step of the 2-amino-3-ketoadipate intermediate, quinonoid formation. The 
decay occurs in two steps. k2: rate of quinonoid quenching; k3: ALA release. 
nq:no quinonoid. Conservative amino acid exchanges were highlighted in light pink.  
ALASRc variant k1 [s-1] k2 [s-1] k3 [s-1] 
Wild-type ALASRc 5.4 ± 1 0.48 ± 0.03 0.0050 ± 0.0009 
R21K nq nq nq 
R21E nq nq nq 
T83S 4 ± 0.4 0.057 ± 0.003 0.013 ± 0.001 
N85F 14 ± 2 0.49 ± 0.02 0.003 ± 0.002 
 
Arginine 21 is a residue coordinating the carboxylate group of succinyl-CoA via 
a salt bridge (2.8 Å). The non-conservative exchange from arginine to glutamic 
acid (R21E) led to an inactive enzyme. Arginine possesses a guanidine group 
(HN=C(NH2)-NH-R) at its carbon backbone instead of a carboxyl group as in 
glutamic acid. Once, the guanidine group is lacking, the residue is unable to 
coordinate the carboxylate group of succinyl-CoA correctly which results in an 
inactive enzyme. The conservative amino acid exchange to lysine (R21K) 
yielded an enzyme with an approximately fifteen times lower kcat value of  
0.021 * s-1 than the wild-type ALASRc (kcat = 0.31 * s-1). Additionally, high 
amounts of both substrates were necessary for half saturating the enzyme 
(KMgly = 13.54 mM; KMsuccinyl-CoA = 4.66 µM). This amino acid exchange led to an 
enzyme where the active site and thus the binding of both substrates was 
negatively affected. Due to single amino group of the lysine residue, the 
coordination of the carboxylate group of succinyl-CoA becomes difficult. 
Furthermore, R21 is located close to T365, a residue positioned at the tip of the 
dynamic active site loop which is responsible for the conformational change 
between the open and closed enzyme conformation. Once the hydrogen bond 
triad responsible for the correct succinyl-CoA coordination (s. ‘Introduction’,  
Fig. 8) in the active site cannot be formed due to the lysine residue in the 
ALASRc-R21K variant, enzyme catalysis is dramatically affected. Thus, R21 is 
essential in this position since modification even of the length of the carbon 
backbone yielded an enzyme reduced in its activity. R21 is consequently a 
residue that is necessary for correct substrate coordination. This ALASRc-R21E 
variant contained the non-conservative amino acid exchange of arginine to 
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glutamate. For the ALASRc-R21E variant no steady state kinetics could be 
determined. In single turnover reactions both ALASRc variants carrying amino 
acid exchanges of the R21 residue did not show any detectable second 
quinonoid formation at 510 nm although steady state kinetic analyses of the 
ALASRc-R21K yielded an active enzyme (Tab. 16). Their single turnover curves 
overlapped each other and could not been fit to a three step mechanism like the 
wild-type ALASRc. The undetectable second quinonoid could be explained by a 
reaction mechanism with a fast occurring decarboxylation step. The 
consequence is that the protonation of the quinonoid intermediate, the 
penultimate step in this reaction cycle, could occur immediately. Thus, the ALA 
release is not the rate-limiting step in the reaction of ALASRc-R21K rather the 
saturation of the enzyme with the first substrate glycine. The KM value for this 
variant was determined with 13.54 mM and was 50fold higher than the wild-type 
ALASRc.  
 
The ALASRc residues T83 and I86 from the second monomer coordinate the 
carboxylate group of succinyl-CoA via a hydrogen bond (2.6 Å) and van der 
Waals interactions, respectively. The conservative amino acid exchange of 
threonine to serine (T83S) yielded an enzyme with a sixteen fold lower kcat  
(kcat = 0.019 * s-1). Its side-chain methyl group is in direct van der Waals contact 
(3.9 Å) with the Cα-atom of the PLP-glycine intermediate (Astner et al., 2005).  
A reason for the slower enzyme reaction could lie in the decreased binding of 
the substrate due to the lacking methyl group in serine compared to threonine. 
Although the ALASRc-T83S variant only needed small amounts of glycine to be 
half-saturated (KM = 0.034 mM), it required a 3fold higher succinyl-CoA 
concentration (KM = 0.68 µM) than the wild-type ALASRc. However, the glycine 
binding was faster and the binding of succinyl-CoA was decreased resulting in 
an enzyme with a lower kcat. In single turnover experiments T83S (Fig. 35, dark 
red line) also revealed a slower reaction than the wild-type ALASRc. Less tight 
binding of succinyl-CoA should also lead to a slowed down release of the 
resulting product. The residue can be designated as super particular concerning 
its amino acid exchange against other amino acids. 
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The amino acid substitution of isoleucine to histidine (I86H) also resulted in a 
less active protein (kcat = 0.0065 * s-1). The I86 residue from the second 
monomer is responsible for the coordination of the carboxylate group of 
succinyl-CoA via van der Waals interaction. Here, the measured turnover 
number was so low that the enzyme could be denoted as de facto inactive. 
Histidine lacks the methyl groups necessary for the formation of important van 
der Waals interaction. Due to small amounts of enzyme soluable we were not 
able to perform single turnover reactions with this variant. 
 
N85 from the second monomer also coordinates the succinyl-CoA carboxylate 
group via a hydrogen bond with a distance of 3.1 Å (Astner et al., 2005). 
Unexpectedly, a non-conservative amino acid exchange (N85F; Fig. 35, blue 
line) led to an enzyme with a faster reaction course compared to wild-type 
ALASRc. This might be explained by a less tight binding of the carboxylate 
group. Usually, a non-conservative amino acid exchange should result in 
interrupted catalysis due to an incorrect protein folding or an insufficient binding 
of the required substrates. The conservative exchange from asparagine to 
glutamine (N85Q) showed a nearly 1.5 fold lower kcat (kcat = 0.185 * s-1) than the 
wild-type (kcat = 0.31 * s-1). The only difference between asparagine and 
glutamine is one more carbon atom in the backbone of glutamine. This 
extension seems to be responsible for a less enzyme affinity for its second 
substrate succinyl-CoA yielding to a 50fold greater KM value (KMsuccinyl-CoA = 
11.06 µM) for this molecule. The smaller distance between the interacting 
groups in the ALASRc-N85Q variant seemed to be accountable for a tighter 
binding of the second substrate and thus for a retarded catalysis. The non-
conservative amino acid exchange to phenylalanine (N85F) yielded a protein 
with a 5fold increased kcat (kcat = 1.57 * s-1). In this case the substitution from a 
polar to a non-polar amino acid generated an ALASRc enzyme with higher 
activity, most likely due to a less tight coordination of the carboxylate group of 
succinyl-CoA. Phenylalanine is a more bulky residue and lacks the coordinating 
carbon acid amide group (R-CONH2). If the succinyl-CoA carboxylate group 
was bound less tightly than in the wild-type ALAS enzyme all following steps 
after succinyl-CoA binding can occur faster. As a result a faster ALA release 
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was possible and thus the enzyme showed a higher turnover number than the 
wild-type. In summary, an ALASRc enzyme with a higher activity than the 
naturally occurring enzyme, however, with less affinity for both substrates 
(N85F: KMgly = 3.53 mM; KMsuccinyl-CoA = 7.46 µM) was generated. Furthermore, 
this mutation allows the loop in the active site to move forward and backward 
very fast. In single turnover experiments and in comparison to wild-type ALASRc 
the reaction with ALASRc-N85F was over after approximately 10 sec instead of 
more than 20 sec for wild-type ALASRc (Fig. 35B).  
 
In summary, the residues R21, T83 and I86 seemed to be essential for catalysis 
and their substitution resulted in enzymes less active than the wild-type. In case 
of N85 a variant was generated that was more active with a non-conservative 
amino acid exchange than the wild-type ALASRc while with a similar amino acid 
in this position the activity was slowed down. This residue appeared not to be 
essential for catalytic activity because both substitutions led to an active protein. 
 
The third approach to the question of substrate recognition by ALASRc were 
reactions of the ALASRc variants with substrate analogs. In the past, several 
assumptions have been made and experiments have been executed to 
determine substrate specificity of ALAS enzymes of different organisms. On the 
one hand the residue T83 was shown to be responsible for the coordination of 
the carboxylate group of succinyl-CoA via a hydrogen bond and on the other 
hand the methyl group in its side chain was necessary for the specific 
recognition of the substrate glycine (Astner, 2007). Shoolingin-Jordan and 
coworkers (Shoolingin-Jordan et al., 2003) showed that the T83S variant of  
R. sphaeroides ALAS accepted other amino acids as substrate like threonine, 
serine and alanine. For the wild-type ALASRc it was shown that other substrates 
than glycine are bound in the active site. There, they block the access for the 
second substrate, succinyl-CoA based on the X-ray crystal structure of wild-type 
ALASRc (Astner, 2007). To prove these presumptions we conducted activity 
assays (steady state kinetics) with the wild-type ALASRc and the ALASRc-T83S 
variant with the amino acids L-serine, L-cysteine, L-threonine, L-alanine and  
D-alanine as alternative substrates instead of glycine (Fig. 36). Generally, all 
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organisms use L-amino acids in their proteins, but bacteria also utilize some  
D-amino acids such as D-alanine or D-glutamate as components of their cell 
walls (Lam et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 36: Structures of amino acids used for substrate specificity assays compared to 
glycine. 
Structures of amino acids used in substrate specificity assays. A. L-alanine. B. D-alanine.  
C. L-cysteine. D. L-threonine. E. L-serine. F. glycine. All amino acids, instead of glycine which is 
non-chiral, have a ‘D’ and an ‘L’ form (lat: D = dexter = ‘right’, L = laevus = ‘left’). Usually, amino 
acids are only useful in their ‘L-form’, but bacteria also use D-alanine e.g. as a component of 
their cell walls.  
 
Substrate specificity assays revealed that the wild-type ALASRc was specific for 
glycine as first substrate. Even with a high amount of succinyl-CoA (20 µM) no 
notable activity was observed with the other tested amino acids (data not 
shown). In contrast the ALASRc-T83S variant showed enzyme activity with  
L-alanine, but not with the other tested amino acids.  
Tab. 18 shows the determined kinetic parameters for the wild-type ALASRc and 
ALASRc-T83S variant reaction with glycine as well as with L-alanine. The 
reaction of the ALASRc-T83S mutant enzyme with L-alanine showed a 1.5fold 
higher kcat (kcat = 0.029 * s-1) than the reaction with the physiological substrate 
glycine although the KML-alanine was much higher (KML-alanine = 0.143 mM). The 
affinity of the mutant enzyme for succinyl-CoA was approximately the same in 
both reactions. Thus, the rate-limiting factor seems to be the binding of the first 
substrate while the condensation with the second one was not affected. The 
conclusion is that the wild-type ALASRc enzyme is specific for glycine. 
L-alanine 
 
 
D-alanine 
 
L-cysteine 
 
 
L-threonine L-serine 
 
glycine 
B 
D E F 
A C 
Results and Discussion 
 
100 
 
Furthermore, it was shown that ALASRc-T83S plays an important role in glycine 
binding as assumed from Astner and coworkers (Astner, 2007) and shown by 
our kinetic investigations. Interestingly, L-alanine was also the only alternative 
substrate used by AONS of E. coli (Alexeev et al., 1998). Alanine habors a 
methyl group lacking in serine. The difference between the two amino acids  
L-alanine and glycine also lies only in one additional methyl group in L-alanine. 
The other tested amino acids were most likely too bulky for binding in the active 
site and hence, avoided binding of the second substrate succinyl-CoA.  
 
Tab. 18 Substrate specificity tested for the ALASRc-T83S variant with glycine and  
L-alanine. 
Different amino acids were tested as glycine alternative with the wild-type ALASRc and the 
ALASRc-T83S variant. For T83S only the reaction with L-alanine as substrate showed enzyme 
activity. 
 reaction with L-alanine
 
reaction with glycine
 
KMsuccinyl-CoA [µM] 0.81 0.68 
KMgly [mM] -   0.034 
KML-alanine [µM] 0.143 - 
vmax [µM/min] 4.47  2.28 
kcat [s-1] 0.029   0.019 
kcat/KMgly [s-1 * mM-1] - 0.56 
kcat/KML-alanine [s-1 * mM-1] 0.203 - 
kcat/KMsuccinyl-CoA [s-1 * µM-1] 0.036   0.028 
 
Furthermore, we performed single turnover reactions with the ALASRc-T83S 
mutant as described in ‘Materials and Methods’ (2.7.1.2) with the physiological 
substrate succinyl-CoA and the amino acid alternative L-alanine. For both 
approaches 60 µM succinyl-CoA were mixed with buffer in one syringe of the 
stopped flow apparatus and 30 mM glycine with 70 µM protein in the second 
one. Collection time was 300 seconds, 3’125 scans were collected with  
10 scans/sec. Fig. 37 illustrates the results of these experiments indicating that 
the reaction with L-alanine took more than 250 sec instead of approximately  
50 sec for the reaction with glycine.  
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As steady state kinetics for the wild-type ALASRc had revealed, the enzyme did 
not show any detectable second quinonoid formation with L-alanine as amino 
acid alternative. In contrast the ALASRc-T83S variant was able to use L-alanine 
as first substrate (Fig. 37).  
Comparison of the ALASRc-T83S single turnover reactions using the 
physiological substrates glycine and succinyl-CoA with L-alanine and succinyl-
CoA (Fig. 38) indicated that the reaction occurred slower with L-alanine due to a 
slower binding of the amino acid in the active site. Both reactions of ALASRc-
T83S with glycine and L-alanine showed identical rates for the quinonoid decay 
(k2 and k3), only the quinonoid formation (k1) was 15fold lower when L-alanine 
was used as substrate. Furthermore, the L-alanine-reaction took more than  
200 seconds compared to approximately 100 seconds in the glycine reaction 
(Fig. 38). 
 
 
 
 
 
 
 
 
 
 
Fig. 37: Single turnover reaction for 
the wild-type ALASRc and the 
ALASRc-T83S variant with L-alanine 
as first substrate.  
Single turnover reactions were 
conducted with a stopped-flow 
apparatus. L-alanine was added in 
excess so that only one reaction cycle 
occurred. The absorbance at 510 nm 
was plotted against the time in sec. 
The picture shows the raw data (dotted 
lines) for wild-type ALASRc (dark green 
line) as well as for the ALASRc-T83S 
variant (dark red line) and fitting curve 
(T83S, straight black line, three step 
reaction fit). 
 
Fig. 38: Stopped flow reaction of 
ALASRc-T83S variant with 
glycine and L-alanine as first 
substrates.  
The absorbance at 510 nm was 
plotted against the time in 
seconds.  
Green line: ALASRc-T83S reaction 
with L-alanine; dark red line: 
ALASRc-T83S reaction with 
glycine; black lines: three step 
reaction fits for both reactions.  
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In Tab. 19 the corresponding rates of second quinonoid formation and decay 
are listed.  
 
Tab. 19: Stopped-flow single turnover rates for wild-type ALASRc and the ALASRc-T83S 
variant with L-alanine or glycine.  
The ALASRc reaction was fitted to a three step reaction with three observable rates. k1: rate of 
the decarboxylation step of the 2-amino-3-ketoadipate intermediate; formation of second 
quinonoid. The decay occurs in two steps. k2: rate of second quinonoid quenching; k3: ALA 
release. 
nq:no quinonoid  
variant k1 [s-1] k2 [s-1] k3 [s-1] 
 
 
Reaction with L-alanine 
 
Wild-type ALASRc nq nq nq 
ALASRc-T83S 0.26 ± 0.04 0.052 ± 0.005 0.015 ± 0.006 
    
  
Reaction with glycine 
 
Wild-type ALASRc 5.4 ± 1 0.48 ± 0.03 0.0050 ± 0.0009 
ALASRc-T83S 4 ± 0.4 0.057 ± 0.003 0.013 ± 0.001 
 
The second substrate, succinyl-CoA, binds in a hydrophobic pocket at the 
entrance of the first channel leading to the active site. Its carboxylate group is 
coordinated by several residues: T365 and R21 of the first monomer as well as 
by T83 of the second monomer (Astner, 2007). Shoolingin-Jordan and 
coworkers (Shoolingin-Jordan et al., 1997) and Lendrihas and coworkers 
(Lendrihas et al., 2009) tested different acyl-CoA derivatives with ALAS from  
R. sphaeroides and mouse, respectively. They found that acyl-CoA chain 
lengths and their hydrophobicity influences the position of the carboxylate group 
and thus ALAS acitivity. Lendrihas and coworkers tested four different acyl-CoA 
derivatives (octanoyl-CoA, butyryl-CoA, β-hydroxybutyryl-CoA and glutaryl-CoA) 
with three generated murine ALAS2 variants (R85L, R85K and R85L/T430V). 
They demonstrated that acyl-CoA substrates of increased hydrophobicity (e.g., 
octanoyl-CoA and butyryl-CoA) showed greater affinity for the ALAS2 variants 
with a substituted aliphatic amino acid (R85L and R85L/T430V). They 
suggested that the chemical characteristics of the CoA-derived tail and the 
hydrogen-bonding potential of the invariant acyl-CoA binding residues are 
responsible for reaction specificity. In contrast, the replacement of arginine to 
lysine (R85K) yielded an enzyme similar to the murine wild-type ALAS2 due to 
the preservation of the positive charge and hydrogen bonding properties. With 
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regard to these results we executed substrate specificity assays with two 
different acyl-CoA derivatives (butyryl-CoA and octanoyl-CoA) with the ALASRc-
R21K variant and the wild-type ALASRc, respectively. ALASRc-R21E was not 
tested due to its catalytic failure. The obtained results are summarized in  
Tab. 20 and compared to the physiological acyl-CoA substrate succinyl-CoA.  
 
Tab. 20: Comparison of steady state kinetic constants for wild-type ALASRc and its 
variant R21K with acyl-CoA derivatives as second substrate. 
Steady state kinetic analysis were performed with two different acyl-CoA derivatives and 
compared to the kinetic constants for the physiological substrate succinyl-CoA.  
 wild-type ALASRc ALASRc-R21K 
 
succinyl-CoA as substrate 
 
KMsuccinyl-CoA [µM]       0.221   4.66 
KMgly [mM]       0.273 13.54 
Vmax [µM/min]     3.74     2.617 
kcat [min-1]  18.6   1.26 
kcat/KMsuccinyl-CoA [min-1 * µM-1]    84.16    0.27 
kcat/KMgly [min-1 * mM-1]    68.13    0.09 
 
butyryl-CoA as substrate 
 
KMbutyryl-CoA [µM]        1.213       3.049 
KMgly [mM]        0.483   14.73 
Vmax [µM/min]    10.96       2.334 
kcat [min-1]   21.9        1.165 
kcat/KMbutyryl-CoA [min-1 * µM-1]    18.05        0.382 
kcat/KMgly [min-1 * mM-1]    45.34      0.08 
 
octanoyl-CoA as substrate 
 
KMoctanoyl-CoA [µM]       0.954        0.727 
KMgly [mM]       0.124    20.01 
Vmax [µM/min]     5.79    1.5 
kcat [min-1]     2.88      0.78 
kcat/KMoctanoyl-CoA [min-1 * µM-1]      3.019       1.073 
kcat/KMgly [min-1 * mM-1]   23.23       0.039 
 
The results of steady state kinetics revealed enzyme activity independent of the 
used acyl-CoA substrate. The wild-type ALASRc exhibited high values for the 
reaction with succinyl-CoA: kcat/KMsuccinyl-CoA = 84.16 min-1 * µM-1. The high 
substrate specificity was still visible with butyryl-CoA (kcat/KMbutyryl-CoA =  
18.05 min-1 * µM-1). The only difference of these two molecules is the terminal 
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carboxyl group of succinyl-CoA lacking in the butyryl-CoA structure (Fig. 39C). 
In contrast, substrate specificity was decreased using octanoyl-CoA as second 
substrate. Here, kcat/KMoctanoyl-CoA (kcat/KMoctanoyl-CoA = 3.019 min-1 * µM-1) was 
approximately thirty times lower than with the physiological substrate 
(kcat/KMsuccinyl-CoA = 84.16 min-1 * µM-1). The tail of octanoyl-CoA consists of 
seven methyl-groups, two more than in succinyl-CoA, but lacks the carboxyl 
group (Fig. 39B). A consequence of this larger tail is a positive charge due to 
the electron shifting properties of the methyl groups towards the oxygen atom. 
The conservative replacement from arginine to lysine retains the positive 
charge. This positive charge at the active site could be responsible for a 
decreased binding ability of the positive charged octanoyl-CoA due to a 
rejecting effect. In contrast to the results of the wild-type ALASRc, the R21K 
variant revealed another phenomenon. Here, the substrate specificity increased 
during utilization of the alternative substrates in the following order: succinyl-
CoA; butyryl-CoA and octanoyl-CoA. kcat/KMsuccinyl-CoA were 0.27 min-1 * µM-1 in 
contrast to the higher values of kcat/KMbutyryl-CoA = 0.382 min-1 * µM-1 for butyryl-
CoA and kcat/KMoctanoyl-CoA = 1.073 min-1 * µM-1 for octanoyl-CoA, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 39: Structures of succinyl-CoA and its derivatives octanoyl-CoA and butyryl-CoA. 
The different acyl-CoA molecules differ in their length of the acyl-residue. A similarity is the 
Coenzyme A consisting of (from right to left) a 3’-phosphorylated adenosine, diphosphate,  
2,4-dihydroxy-3,3-dimethyl-butyric acid, β-alanine and cysteamine. A. succinyl-CoA.  
B. octanoyl-CoA. C. butyryl-CoA. 
 
 
 
 
A 
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This phenomenon could be the result of the difference in the amino acid 
backbone between arginine and lysine which lacks an imine and amino group 
(Fig. 40).  
 
 
 
 
 
 
 
 
Fig. 40: Structures of the amino acids lysine and arginine.  
Both amino acids belong to the group of alkaline amino acids. Arginine has an additional amino 
and imine group in one of its side chains. A. lysine. B. arginine. 
 
The consequence of these lacking imine and amino groups is a more positively 
charged side chain end due to an electron pushing effect of the methyl groups 
towards the nitrogen atom at the α-C-atom. The carboxylate group of succinyl-
CoA is coordinated by one amino group of the arginine residue whereas the 
lysine residue overall only possesses one amino group in this position. This 
could be the reason for a reduced binding of the physiological substrate 
succinyl-CoA by the ALASRc-R21K variant. Furthermore, due to the lacking 
carboxylate group in octanoyl-CoA and butyryl-CoA the coordination of the acyl-
CoA derivatives was hindered. Interestingly, the highest substrate specificity 
was measured for octanoyl-CoA which can be explained by the large tail widely 
extended into the active site so that the reaction can occur. Although the 
ALASRc-R21K mutant variant is the conservative amino acid exchange 
significant difference in substrate coordination as observed. Results indicated 
that this residue is responsible for the recognition and correct coordination of 
the succinyl-CoA carboxylate group.  
 
3.6.5 Kinetics of ALASRc Variants Involved in Loop Flexibility 
 
In the ALAS reaction cycle two different enzyme conformations occur. In the 
open conformation the two loops at ALASRc amino residues 332 – 348 and  
  
A B 
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358 – 374 of the C-terminal domain move outwards, widening the active site 
channel and even opening a second one. In particular T365, located at the tip of 
second loop (ALASRc amino acid residues 358 – 375), moves inward by 3.5 Å 
during this transition. In the closed conformation T365 is firmly positioned 
among the residues of the active site stabilized by hydrogen bonds to R21 and 
by van der Waals interactions to I361 and M190. The functional consequences 
of the observed two conformations have not been analyzed yet.  
Lendrihas and coworkers generated a mouse ALAS2-T430 variant 
(corresponds to T365 in ALASRc) to study loop dynamics during the transition 
from the open to the closed enzyme conformation. The amino acid exchange 
from threonine to valine (T430V) resulted in a poorly expressed, unstable and 
proteolytically susceptible enzyme that could never be purified to homogeneity. 
The T430 amino acid exchange affected protein stability why Lendrihas and 
coworkers suggested that this residue is not only essential for optimal molecular 
recognition of succinyl-CoA but also necessary for stable folding. The threonine 
at position 430 is located at the tip of the active site loop where the major 
conformational changes seem to occur. Our laboratory in close cooperation with 
the laboratory of Prof. Dr. Gloria C. Ferreira wanted to functionally address the 
dynamics of this ALAS loop and corresponding conformational changes of the 
protein. The ALASRc enzyme seems to be a good reporter for these 
approaches. The threonine at position 365 of the bacterial ALAS enzyme was 
mutated to cysteine and serine, produced and purified in my work. The 
cysteine-containing mutant was labeled with a fluorescent tag and used in loop 
dynamic experiments in the laboratory of Prof. Dr. Gloria C. Ferreira in Tampa, 
Florida, USA. This mutation only makes sense if no other cysteines are present 
why we developed a cysteine-free T365C variant. First data were obtained 
(Ferrreira and coworkers, personal communication). Preliminary results 
indicated that the binding of the second substrate succinyl-CoA was responsible 
for a conformational change in the ALAS enzyme (data not shown), thereby 
initiating a loop movement opening the channel for the active site components. 
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3.6.6 Kinetics of ALASRc Variants Involved in Protein-protein 
Interaction with the βSCSRc 
 
The SCS consists of two different subunits. In humans two different isoforms 
exist: one is specific for adenosine (A-SCS), the other for guanosine (G-SCS). 
In humans the β-subunit of the A-SCS interacts with the ALAS2 and an 
interruption in this interaction causes X-linked sideroblastic anemia. The E. coli 
SCS was already crystallized (Wolodko et al.; 1984; Fraser et al., 1999). The  
β-subunits of mammalians and bacteria SCS showed high amino acid sequence 
identity of 45 %. Therefore, bacterial enzymes of ALAS and SCS can serve as 
good models for the determination of the ALAS-SCS-interactions. For this 
approach we designed three different ALASRc variants (D47E, D47S, M309W). 
The D47 residue is localized at the surface of the protein. First, enzyme 
activities and kinetic parameters were determined by measuring steady state 
kinetics. The results are summarized in Tab. 21. 
 
Tab. 21: Kinetic parameters for wild-type ALASRc and ALASRc-D47 variants. 
Vmax was the velocity at maximal substrate concentrations; KM was the substrate concentration 
that leads to half-maximal velocity; kcat was the turnover number and kcat/KM was the catalytic 
efficiency of the enzyme. The conservative amino acid exchanges were highlighted in light pink.  
Enzyme concentrations varied from 0.2 to 0.3 µM. 
variant 
vmax 
[µM/min] 
KMsuccinyl-CoA 
[µM] 
KMgly 
[mM] kcat [s-1] 
kcat/KMsuccinyl-CoA 
[s-1 * µM-1] 
kcat/KMgly 
[s-1 * mM-1] 
Wild-type ALASRc 3.74 0.221 0.273 0.31 1.401 1.136 
D47E 11.02 0.672 0.362 0.367 0.546 1.014 
D47S 2.95 0.066 0.475 0.163 2.485 0.344 
 
The conservative amino acid exchange of aspartic acid to glutamic acid (D47E) 
yielded a similar to wild-type ALASRc kcat value of 0.367 * s-1. Although the other 
kinetic parameters of this mutant differed from those of the wild-type, this amino 
acid exchange had no notable effect on the enzyme activity. Possibly, this 
conservative amino acid exchange led to a modification of the solvent exposed 
surface and seemed to be responsible for decreased protein stability while 
enzyme activity was not affected. This was also observed for the related human 
ALAS2 D190V mutant (Furuyama et al., 1997). The non-conservative amino 
acid exchange of this residue, D47S, seemed to have a decreasing effect on 
enzyme activity with a kcat of approximately half of that of the wild-type ALASRc 
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(D47S kcat = 0.163 * s-1). In contrast to aspartic acid, serine harbors a hydroxl 
group instead of a carboxyl group. Possibly, the additional interaction of D47 
with K35 (Astner, 2007) seemed to be changed in that way that the enzyme 
showed a more reduced affinity for glycine (KM = 0.475 mM) than the wild-type 
enzyme. The affinity for succinyl-CoA was much higher with a KM = 0.066 µM. 
However, glycine binding was the limitating factor since it has to be bound prior 
to succinyl-CoA. Thus, if glycine was bound to the active site, succinyl-CoA 
entering can occur fast but not as fast as in wild-type ALASRc. Our results 
indicated that the D47 residue is necessary for optimal enzyme catalysis. 
Furthermore, the amount of protein of the produced variant M309W was not 
enough to determine its steady state kinetics. This might be due to decreased 
protein stability with this non-conservative amino acid exchange. This mutant 
protein variant could not be analyzed in further experiments.  
 
Subsequently, experiments for the detection of the second quinonoid were 
performed using fluorescence stopped-flow. The ALASRc variants D47E and 
D47S showed good results in single-turnover reactions (Fig. 41, D47E: light 
green line, D47S: red line). The formation of the second quinonoid and its decay 
in two steps were clearly visible and detectable at 510 nm. The residue D47 
located at the surface of the ALASRc protein should not have an effect on ALAS 
catalysis. The quinonoid decay of the wild-type ALASRc and the D47 variants 
took approximately 20 sec. In contrast to ALASRc-D47E the ALASRc-D47S 
variant revealed a faster quinonoid formation and decay although steady state 
kinetics (Tab. 21) showed that this mutant had a lower turnover number (kcat =  
0.163 * s-1) than the wild-type and D47E. The consequence for D47S seemed to 
be a less tight binding of reaction intermediates and its product formation was 
limited by binding of the first substrate glycine. 
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Fig. 41: Detection of the second quinonoid in the reaction mechanism of the ALASRc wild-
type and the ALASRc-D47variants. 
The second quinonoid is the third intermediate in the ALAS reaction cycle. The first two 
intermediates are not detectable due to a fast conversion into the second quinonoid. It shows an 
absorption at 510 nm. A. Detection of the second quinonoid using absorbance spectroscopy.  
B. Detection of the second quinonoid using fluorescence spectroscopy. The first observable 
step is quinonoid formation, the decay occurs in two steps: quenching of the quinonoid and ALA 
release. Raw data and fitting curves (black lines, three-step reaction fits).  
ALASRc-D47S: red line; ALASRc-D47E: light green line; wild-type ALASRc: dark green line. 
 
 
In Tab. 22 the corresponding rates of second quinonoid formation and decay 
are listed.  
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Tab. 22: Stopped-flow single turnover rates for wild-type ALASRc and developed ALASRc-
D47 variants. 
The ALASRc reaction was fitted to a three-step reaction with three observable rates. k1: rate of 
the decarboxylation step of the 2-amino-3-ketoadipate intermediate; formation of the second 
quinonoid. The decay occurs in two steps. k2: rate of second quinonoid quenching; k3: ALA 
release. 
Conservative amino acid exchanges were highlighted in light pink.  
ALASRc variant k1 [s-1] k2 [s-1] k3 [s-1] 
Wild-type ALASRc 5.4 ± 1 0.48 ± 0.03 0.0050 ± 0.0009 
D47E 3.4 ± 0.7 0.59 ± 0.06 0.003 ± 0.0005 
D47S 10.1 ± 0.2 0.85 ± 0.07 0.048 ± 0.005 
 
Next, for the determination of the ALASRc-SCSRc-interaction we amplified the  
β-subunit of the R. capsulatus SCS gene (sucC) via PCR for its cloning into the 
expression vector pGEX-6P-1. The genomic DNA of R. capsulatus for 
amplification of the sucC gene was received from the DSMZ (‘Deutsche 
Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, 
Stöckheim). When the project was started the nucleotide sequence for the 
βSCSRc was not available in the Pubmed data base (updated September 2010). 
Hence, the disposable nucleotide sequence of the β-subunit of the  
R. sphaeroides SCS served as template for primer design. After cloning we 
were able to produce a protein with a relative molecular mass of approximately 
Mr = 60’000 expected to be the β-subunit of the R. capsulatus SCS. As a GST-
fusion protein the enzyme should have a relative molecular mass of around Mr 
= 67’000 which is in good agreement with the achieved results (Fig. 42).  
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Fig. 42: Recombinant βSCSRc 
production studies. 
Proteins of cell free extracts were 
separated by 12 % SDS-PAGE and 
visualized by staining with 
InstantBlueTM. The SDS-PAGE 
showed recombinant protein 
production with the pRc-βSCS plasmid 
in BL21(DE3)RIL at 25 °C.  
Lane 1: before induction of gene 
expression using IPTG; lane 2: 1 h 
after induction; lane 3: 2 h after 
induction; lane 4: 3 h after induction; 
lane 5: molecular weight marker; lane 
6: 4 h after induction; lane 7: 5 h after 
induction; lane 8: 20 h after induction. 
β-SCSRc 
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Due to time constraints it was not possible to perform more experiments with 
this enzyme. However, with the recently submitted nucleotide sequence we 
were able to align both βSCS sequences of R. sphaeroides and R. capsulatus, 
respectively. The alignment showed a high sequence identity and revealed that 
the designed primers for the R. sphaeroides βSCS also matched for the 
amplification of the corresponding gene in R. capsulatus. Next, procedures 
should be βSCS solubilization tests, overproduction and purification as well as 
interaction studies together with ALASRc. 
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4  SUMMARY 
 
Aminolevulinic acid synthase (ALAS) is the initial enzyme of heme biosynthesis 
in humans, animals and some bacteria. It catalyzes the condensation of 
succinyl-CoA and glycine to yield aminolevulinic acid, Coenzyme A and CO2. To 
clarify details of its catalytic mechanism thirteen Rhodobacter capsulatus ALAS 
(ALASRc) variants were generated, purified and kinetically characterized. First, 
variants of ALASRc (N54D, N54Q) for trapping the second intermediate in the 
ALAS reaction mechanism, 2-amino-3-ketoadipate intermediate, in cysteine-
free ALAS background were generated (C52S-C201S-C400S, N54D-C52S-
C201S-C400S, N54Q-C52S-C201S-C400S). By performing single turnover 
experiments we were able to detect the second quinonoid. With the reaction 
with O-methylglycine we experimentally verified for the first time the occurrence 
of the first quinonoid as a clear indication for the presence of ketoadipate 
intermediate. Furthermore, crystallization and initial X-ray diffraction 
experiments were carried out. Second focus was on the binding and supply of 
the succinyl-CoA substrate. Amino acid residues interacting with the 
carboxylate group of succinyl-CoA were exchanged (R21E, R21K, T83S, N85F, 
N85Q, I86H). The results of stopped-flow kinetic analyses indicated that the 
residues R21, T83, N85 and I86 play a pivotal role in binding of the succinyl-
CoA carboxylate group and contribute to a slow ALA release, the rate-limiting 
step of ALAS catalysis. Furthermore, substrate analog studies revealed the 
rather strict specificity of wild-type ALASRc for its substrates glycine and 
succinyl-CoA. Enzyme assays with different amino acid based glycine analogs 
failed to detect significant activity. Interestingly, acyl-CoA derivatives sustained 
partial ALAS acitivity indicating a less strong discrimination. The contribution of 
T365-ALASRc catalysis localized on the dynamic loop region between the amino 
acids 358 – 374 of the C-terminal domain was investigated. Mutant enzymes 
(T365S-C52S-C201S-C400S, T365C-C52S-C201S-C400S) were generated 
and first results indicate that the conformational change of the ALAS enzyme 
was due to succinyl-CoA binding. Finally, amino acid residues which were 
proposed to be responsible for the interaction with the β-subunit of the succinyl-
Coenzyme A synthetase (βSCS) were exchanged (D47E, D47S, M309W) and 
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stand by for interaction studies. In summing crucial steps of ALAS catalysis, 
investigated with a combined kinetic and structural biology approach using 
mutant enzyme variants, were elucidated at the molecular level. 
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5  OUTLOOK 
 
Interaction studies of Aminolevulinic acid synthase and succinyl-Coenzyme A 
synthetase of R. capsulatus variants  
 
Previous studies showed that the interruption of interaction between human 
ALAS2 and the βSCS led to XLSA. To determine the contribution of D47 and 
M309 to this essential protein-protein interaction the following experiments 
should be conducted:  
 
1)  Production and purification of the βSCSRc  
2)  Interaction studies with generated ALASRc variants (D47E, D47S, 
M309W) 
 
Further characterization of ALASRc 
 
Although the ALAS reaction cycle has been well characterized, it was not 
possible to finally proof the occurrence of the central intermediate, 2-amino-3-
ketoadipate. Kerbarh and coworkers (Kerbarh et al., 2006) provided the first 
experimental evidence for a β-ketoacid intermediate in the structurally and 
functionally related enzyme AONS. For the confirmation of the 2-amino-3-
ketoadipate in the ALASRc reaction following approaches have to be taken: 
 
1)  Reaction of ALASRc with glycine-methylester. 
2)  Crystallization attempts with the generated N54Q and N54D 
ALASRc variants. 
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